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Complexes of β-cylodextrin with five nucleotides of adenine (A), thymine (T) 
guanine (G), cytosine (C), and 5-methylcytosine have been investigated using 
Hatree-Fock (HF) and density functional theory (DFT) calculations of different 
quality.  
This work was inspired by recent technological advances made in single-
molecule sequencing of DNA. One molecule of single-stranded DNA can be 
sequenced by using nanopores made of α-hemolysin as the sequencing device. 
An exonuclease enzyme attached to the top of the pore cleaves bases from the 
DNA strand so they can traverse the pore one at a time. The different 
nucleotides then bind to cyclodextrin attached to the inside of the pore [1]. The 
different bases are discriminated by the change they induce in the amplitude of 
the current carried by aqueous ions passing through the pore. Several variants 
of this method are currently developed by different companies and will be 
marketed soon.  
We calculated low energy conformations of complexes of β-cyclodextrin with the 
five different nucleotides mentioned above, using different methods (HF, DFT). 
The interaction energy with β-cyclodextrin was estimated from the energy 
difference between a complex and the molecules it consists of. The presented 
results show, that it is possible to discriminate all five nucleotides very clearly.  
Because one can easily distinguish between cytosine and 5-methyl-cytosine, 
this method can be used to sequence methylated DNA directly in one step 
which might be an advantage compared to other similar sequencing methods. 
[1]  Clarke J, Wu HC, Jayasinghe L, Patel A, Reid S, Bayley H. Continous base identification for single-
molecular nanopore DNA sequencing. Nat Nanotechnol. 2009; 4: 265–270. 
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Cationic lipids spontaneously bind, condense and coat DNA resulting in the 
formation of lipid/DNA complexes, so-called lipoplexes [1]. These complexes 
transduce plasmids into cells causing expression of the genes (transfection).  
Low levels of transfection circumvent therapeutical efficacy of non-viral 
strategies. Nuclear accumulation of plasmid DNA is among the major obstacles 
of non-viral gene delivery [2]. 
This project aims to analyse nuclear transport of lipoplex-released pDNA as a 
potential transfection barrier in two cellular models, A10 and MDCK, which have 
been characterized regarding their endocytic profile and transfectability in 
previous work [3]. To study nuclear import of pDNA, a novel strategy called 
“quantitative imaging” is applied, a combination of confocal laser scanning 
microscopy and image-based analysis using the open source software 
CellProfiler. This technique enables to track cy3-labeled complex DNA inside 
the cell and to quantify the amount of nuclear-accumulated complex released 
pDNA. 
These studies reveal nuclear entry of the pDNA to represent a significant 
transfection barrier in MDCK cells. The investigated cellular models differ 
significantly in the amount of nuclear-accumulated complex DNA: nuclear 
transport is by far more efficient in A10 compared to MDCK cells. 
[1]  Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen 
M. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S 
A. 1987; 84: 7413–7417. doi:10.1073/pnas.84.21.7413 
[2]  Zhang H, Mitin A, Vinogradov SV. Efficient Transfection of Blood-Brain Barrier Endothelial Cells by 
Lipoplexes and Polyplexes in the Presence of Nuclear Targeting NLS-PEG-Acridine Conjugates. 
Biojonjug Chem. 2009; 20: 120–128. doi:10.1021/bc8003414 
[3]  Schneider S. Herstellung, zelluläre Prozessierung und Dissoziation lipid-basierter nanopartikulärer 
Gentransfersysteme. Dissertation, University of Freiburg. 
[4]  Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, Guertin DA, Chang JH, 
Lindquist RA, Moffat J, Golland P, Sabatini DM. CellProfiler: image analysis software for identifying 
and quantifying cell phenotypes.Genome Biol. 2006; 7: R100. doi:10.1186/gb-2006-7-10-r100 592 Scientia  Pharmaceutica  www.scipharm.at 
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Androgens and estrogens increase the number of cell division and the 
opportunity for random genetic errors and are thus involved in carcinogenesis of 
hormone related cancers. Pre-receptor regulatory enzymes interconvert the 
active forms of hormones with high affinities to corresponding receptors to their 
less active forms. They represent interesting targets for development of new 
drugs for prevention and treatment of conditions caused by disturbed hormone 
action. We have focused our attention to four hydroxysteroid dehydrogenases 
(HSDs). AKR1C1 converts potent progesterone to a weak 20α-hydroxy-
progesterone; AKR1C2 inactivates potent androgen 5α-DHT, and AKR1C3 
reduces a weak androgen androstenedione to a potent testosterone. Both 
AKR1C3 and 17β-HSD  type 1 activate weak estrogen estrone to a potent 
estradiol [1, 2]. We have isolated the recombinant AKR1C1, AKR1C2, AKR1C3 
and over-expressed 17β-HSD type 1 in bacterial and mammal cells. Different 
approaches were used for searching the inhibitors of these enzymes and 
structurally different compounds were shown to be potent inhibitors (e. g. [3, 4]). 
Inhibitors with IC50 values in micromolar range are good starting points for 
further design and synthesis of new and improved inhibitors of this important 
group of enzymes. 
This work was supported by a J3-9448 grant to T.L.R. and a young researcher 
grant to P.B., both from the Slovenian Research Agency. 
[1]  Penning TM. Molecular endocrinology of hydroxysteroid dehydrogenases. Endocr Rev. 1997; 18: 
281–305. doi:10.1210/er.18.3.281 
[2]  Penning TM, Drury JE. Human aldo-keto reductases: Function, gene regulation, and single nucleotide 
polymorphisms. Arch Biochem Biophys. 2007; 464: 241–250. doi:10.1016/j.abb.2007.04.024 
[3]  Brozic P,Turk S,Rizner TL,Gobec S. Discovery of new inhibitors of aldo-keto reductase 1C1 by 
structure-based virtual screening. Mol Cell Endocrinol. 2009; 301: 245–250. 
doi:10.1016/j.mce.2008.08.002 
[4]  Stefane B, Brozic P, Vehovc M, Rizner TL, Gobec S. New cyclopentane derivatives as inhibitors of 
steroid metabolizing enzymes AKR1C1 and AKR1C3. Eur J Med Chem. 2009; 44: 2563–2571. 
doi:10.1016/j.ejmech.2009.01.028 
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Deamidation of proteins is probably one of the most common chemical 
degradation pathways in protein pharmaceuticals. The reaction rate for 
deamidation of human growth hormone (hGH) is particularly pH-dependent and 
occurs typically faster at neutral and alkaline pH [1].  
Protamine from salmon is an extremely basic peptide due to its high arginine 
content. It is isolated from sperm cells of salmon where it naturally builds a 
complex with DNA during spermatogenesis due to electrostatic interactions [2]. 
We hypothesize a similar electrostatic effect between negatively charged hGH 
and positively charged protamine residues. Arising cationic complexes are 
stabilized by electrostatic repulsion. This stabilizing complexation allows 
solubilization of hGH down to a pH of 5.4 at high concentrations up to 6.8mg/ml. 
The minimal solubilizing molar ratio between hGH and protamine was found to 
be at least 1:13 (hGH:protamine). Deceleration of deamidation at pH 5.4 could 
be detected by reversed-phase high-performance liquid chromatography (RP-
HPLC). The presence of protamine did not alter the conformational structure of 
hGH which was determined by circular dichroism (CD) spectroscopy and 
fluorescence spectroscopy. Binding interactions between protamine and hGH 
were investigated by isothermal titration calorimetry (ITC) and Small-angle 
X-ray scattering (SAXS). 
Acknowledgement:  This work was supported by FFG, Land Steiermark and 
SFG. 
[1]  Manning MC, Patel K, Borchardt RT. Stability of Protein Pharmaceuticals. Pharm Res. 1989; 6: 903–
918. doi:10.1023/A:1015929109894 
[2]  Ando T, Yamasaki M, Suzuki K. Protamines-Isolation, Characterization, Structure and Function. 
Springer Verlag. 1973: 1–27. 
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Protein denaturation processes involving aggregation are among the prime 
factors impeding the development of stable protein drug formulations. Not only 
does aggregation limit the shelf-life of protein pharmaceuticals and potentially 
decreases the overall efficacy of therapeutic, it may also cause unwanted side 
effects such as immune reactions. Denaturation kinetically coupled to 
aggregation can occur in all stages of the production process and its prevention 
constitutes a major effort in biopharmaceutical technology. A problem in 
designing rational strategies counteracting the aggregation is that a sound 
molecular basis underlying the denaturation process is usually not available. 
Dissecting the overall denaturation pathway into discrete kinetic steps would 
allow one to evaluate stabilizing effects of certain process conditions more 
systematically. Generally, understanding of aggregation during or induced by 
the manufacturing process is an important goal to be achieved by the 
pharmaceutical industry.  
For our studies we used human growth hormone (hGH), which is a common 
therapeutic protein, and examined its aggregation mechanism under a range of 
process conditions. hGH is a single domain, globular protein consisting of 191 
amino acids and has a molecular mass 22 kDa. Its tertiary structure shows 4 
antiparallel α-helices and two disulfide bridges (53 to 165 and 182 to 189).  
Experiments were carried out under accelerated aggregation conditions. We 
show that the gas/liquid interface generated by aeration is strongly promoting 
aggregation. Stirring likewise resulted in aggregation. Results from SEC 
measurements and native or SDS PAGE of time-course experiments should 
help understanding aggregation and its kinetic pathway. This may help in 
developing more stable drug formulations. 
This work was supported by FFG, Land Steiermark and Steirische 
Wirtschaftsförderung (SFG) 
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Unsaturated Monoglycerides (or Phytantriol) dispersed in water form particles 
having a cubic nanostructure over a broad temperature range. The cubic 
structured phase has a high viscosity which requires high energy input in order 
to be dispersed in water.  
By the addition of lipophilic substances the structure can be changed to 
hexagonal, micellar cubic and micellar, respectively [1, 2]. The low viscosity of 
the micellar phase allows the use of more gentle dispersion methods.  
Those nanostructured dispersions have a high interfacial area, which allows 
them to be good carrier systems for amphiphilic substances. Due to their oil and 
water compartments they can also host hydrophilic as well as lipophilic 
molecules. Furthermore, if substances are incorporated in the phases their 
stability against degradation is enhanced. These properties make them 
interesting as possible drug delivery systems.  
With the structural change not only the viscosity of the self assembled phase 
alters but also properties which can affect the release rate. The diffusion inside 
the phase is heavily dependent on the nanostructure.  
The internal structure can further be expanded by the addition of lamellar phase 
forming amphiphiles such as Diglycerol Monooleate and Phosphatidylcholine 
[3]. The symmetry of the structure is maintained even thought the hydrophilic 
compartments are enlarged. This enables the incorporation of larger molecules 
such as proteins.  
In order to be able to use nanostructured dispersions as delivery vehicles it is 
important to gain information about the release mechanism and possible ways 
to control it. For this purpose the release from the self-assembled bulk as well 
as from the dispersed phases is studied. 
[1]  Yaghmur A, de Campo L, Salentinig S, Sagalowicz L, Leser M, Glatter O. Emulsified microemulsions 
and oil-containing liquid crystalline phases. Langmuir. 2005; 21: 569–577. doi:10.1021/la0482711 
[2]  Yaghmur A, de Campo L, Salentinig S, Sagalowicz L, Leser M, Glatter O. Oil-loaded monolinolein-
based particles with confined inverse discontinuous cubic structure (Fd3m). Langmuir. 2006; 22: 517–
521. doi:10.1021/la052109w 
[3]  Yaghmur A, de Campo L, Sagalowicz L, Leser M, Glatter O. Control of the internal structure of MLO-
based Isasomes by the addition of diglycerol monooleate and soybean phosphatidylcholine. Langmuir. 
2006; 22: 9919–9927. doi:10.1021/la061303v 
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In the present investigation, vancomycin was incorporated in liquid crystalline 
gel made of glyceryl monooleate and water, with the aim to achieve a 
sustained-release and to deliver locally sufficient concentrations of vancomycin 
to the eye, improving its efficacy against bacterial infections [1–3]. 
Technique for implants preparation was developed involving combining glyceryl 
monooleate and vancomycin solution by vortex mixing, centrifuging, preparing 
the shape of implants and lyophilization. 
In vitro characterization of liquid crystalline gel/implants included structure 
analyses by light microscope with polariser and small angle X-ray scattering. 
Furthermore, the drug release from the implants was studied. 
Structure analyses of samples with different percentage of water showed, that 
samples with 10% water show a lamellar phase, whereas samples with 23–30% 
of water have a cubic phase, Ia3d, and the samples with 40% of water show a 
mixture of two cubic phases, i. e. Ia3d and Pn3m. 
Investigating release properties of implants with an initial water content of 30% 
slow release was found. Approx. 40% of vancomycin was released within 2 
hours. 
The in vitro characterization of the liquid crystalline gel formulation/implants 
containing vancomycin showed the possibility to obtain different phases, i. e. 
lamellar phase and cubic phase as well as the possibility to sustain the release 
of vancomycin from them. Therefore, the implants show a great potential for the 
local treatment of infections of the eye. 
[1]  Gavini E, Chetoni P, Cossu M, Alvarez MG, Saettone MF, Giunchedi P. PLGA microspheres for the 
ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation 
method: in vitro/in vivo studies. Eur J Pharm Biopharm. 2004; 57: 207–212. 
doi:10.1016/j.ejpb.2003.10.018 
[2]  Chilukuri DM, Shah JC. Local Delivery of Vancomycin for the Prophylaxis of Prosthetic Device-Related 
Infections. Pharm Res. 2005; 22: 563–572. doi:10.1007/s11095-005-2497-7 
[3]  Quedraogo M, Semde R, Some IT, Traore/Quedraogo R, Guissou IP, Henschel V, Dubois J, Amighi K, 
Evrard B. Monoolein-Water Liquid Crystalline Gels of Gentamycin as Bioresorbable Implants for the 
Local Treatment of Chronic Osteomyelitis: In Vitro Characterization. Drug Dev Ind Pharm. 2008; 34: 
753–760. doi:10.1080/03639040801926287 
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Semisolid products are 8–10% of dosage forms, but – in contrast with the solid 
dosage forms – we do not have any validated method for their drug release in 
any Pharmacopoeia. Kinetics of release process and its critical factors in case 
of 1% diclofenac sodium containing hydrogel, organogel, gelemulsion, o/w and 
w/o creams were observed under in vitro conditions. Comparison of results 
between Franz diffusion cell and paddle over disk method was made using 
synthetic cellulose acetate membrane soaked in buffer solution or in isopropyl 
myristate. In vivo studies were carried out on male Wistar rats; the carrageenan 
paw edema decreasing effect of 12 different formulations was measured in 
comparison with a control group. All products reduced paw edema in rats, 
although we found significant differences among them both in vitro and in vivo. 
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Fig. 1. In vitro drug release and penetration 
of 1% diclofenac sodium containing  
1% Carbomer 934 P gel (DC1) 
Fig. 2. In vivo paw edema test of 1 % 
diclofenac sodium containing  
1% Carbomer 934 P(DC1) 
 
[1]  The USP 23, NF 18, 1995. The United States Pharmacopeial Convention, Inc. 1994, pp. 1648–1986. 
[2]  FDA Guidance for Industry: Nonsterile Semisolid Dosage Forms, Scale-Up and Postapproval 
Changes: Chemistry, Manufacturing, and Controls. In Vitro Release Testing and In Vivo 
Bioequivalence Documentation SUPAC-SS. U.S. Department of Health and Human Services, Food 
and Drug Administration, Center for Drug Evaluation and Research, May 1997.  
[3]  FDA Guidance for Industry. Topical Dermatological Drug Product NDAs and ANDAs – In Vivo 
Bioavailability, Bioequivalence, In Vitro Release and Asssociated Studies SUPAC-SS. U.S. 
Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation 
and Research, June 1998.  
[4]  Csóka I, Csányi E, Zapantis G, Nagy E, Fehér-Kiss A, Horváth G, Blazsó G, Erős I. In vitro and in vivo 
percutaneous absorption of topical dosage forms: case studies. Int J Pharm. 2005; 291: 11–19. 
doi:10.1016/j.ipharm.2004.07.038 
[5]  Pénzes T, Blazsó G, Aigner Z, Falkay G, Erős I. Topical absorption of piroxicam from organogels – In 
vitro and in vivo correlations. Int J Pharm. 2005; 298: 47–54. doi:10.1016/j.ipharm.2005.03.13  598 Scientia  Pharmaceutica  www.scipharm.at 
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Gel emulsions represent special drug delivery systems. Up to present only 
some authors dealt with the formation and properties of these systems, 
although the gel emulsions assurance interesting and useful possibility as 
controlled drug delivers systems [1–4]. Several methods can be applied by their 
preparations: i) gelling of internal water phase with hydrophilic polymers, ii) 
gelling of oil-phase with hydrophobic colloids, iii) in situ polymerisation, iv) 
application of gel emulsifying agents. Their advantages are as follows: i) 
prominent mucoadhesion, ii) capable of floating on the gastric fluid [2, 3, 5]. 
In our experiments water-soluble (polar) and water-insoluble (unpolar) active 
agents were applied. Composition of gel emulsions, e. g. the ratio of water- and 
oil phase, the concentration of surface active copolymers, addition of co-
emulsifiers was changed systematically.  
The drug release from emulsions was investigated by Hanson SR8 plus 
equipment and Franz vertical diffusion cell. The rheological characteristics was 
measured by Paar Physica oscillation rheometer Optical studies were 
accomplished with Leica image analyzer, and thermal-analytic investigations 
were carried out with DSC 281. Mettler Toledo equipment.  
Relationships were established between following parameters: i) drug release 
vs. mucoadhesion, ii) concentration of polymer emulsifying agents vs. drug 
release iii) presence of microgel layer surrounding oil droplets vs drug release, 
iv) concentration of oil phase vs drug release. 
[1]  Marquardt D, Sucker H. Oil-in water-emulsion gels: determination and mathematical treatment of flow 
properties. Eur J Pharm Biopharm. 1998; 46: 115–124. doi:10.1016/S0939-6411(97)00167-7 
[2]  Lian G, Malone ME, Homan JE, Norton IT. A mathematical model of volatile release in mouth from the 
dispersion of gelled emulsion particles. J Control Release. 2004; 98: 139–155. 
doi:10.1016/j.jconrel.2004.04.017 
[3]  Sriamornsak P, Thirawong N, Puttipipatkhachorn S. Emulsion gel beads of calcium pectinate capable 
of floating on the gastric fluid: effect of some additives, hardening agent or coating on release behavior 
of metronidazole. Eur J Pharm Sci. 2005; 24: 363–373. doi:10.1016/j.ejps.2004.12.004 
[4]  Murdan S, Andrýsek T, Son D. Novel gels and their dispersions--oral drug delivery systems for 
ciclosporin. Int J Pharm. 2005; 300: 113–124. doi:10.1016/j.ijpharm.2005.06.002 
[5]  Szucs M, Sandri G, Bonferoni MC, Caramella CM, Vaghi P, Szabó-Révész P, Eros I. Mucoadhesive 
behaviour of emulsions containing polymeric emulsifier. Eur J Pharm Sci. 2008; 34: 226–235. 
doi:10.1016/j.ejps.2008.03.005 
 www.scipharm.at Scientia  Pharmaceutica  599 
Presented at the 8
th Central European Symposium on Pharmaceutical Technology, 
September 16
th–18
th 2010, Graz, Austria. 
Conference abstract PDD10 
The Study of Flowing Properties of Hydrogels 
P. HERDOVÁ, Z. VITKOVÁ 
Faculty of Pharmacy, Commenius University, Bratislava, Slovakia  
E-mail: herdova@fpharm.uniba.sk (P. Herdová) 
Sci Pharm. 2010; 78: 599        doi:10.3797/scipharm.cespt.8.PDD10 
The topic of this article was to monitor the impact of excipients on viscosity of gels 
with local anaesthetic. In previous studies the optimal excipients from the group of 
polymers, enhancers and humectants were examinated during the formulation of 
chlorhexidine, trimecain and terbinafine to the medical form – hydrogel [1, 2]. The 
choice of gel creating compound is influencing the reological properties of drug as 
directly affects its consistency. Reological properties – viscosity – are very important 
at dermal semisolid drugs, mainly at gels from the aspect of their use. The 
manufacturing process is significantly influencing the gels consistency as well. 
The reological properties were evaluated in the study of hydrogels prepared from 
various gel creatig compounds (Natrosol 250 HX, Natrosol 250 HHX, Natrosol 250 
HR and Chitosan) with active ingredient of trimecaini hydrochloridum and gels 
without the active ingredient. Then the influence of propylenglycol and glycerol 
humectants in various concentrations on Mesocain gel were examinated. Solitary 
influence of excipients was evaluated using the analyses of reological measurement 
results.  
This work was supported by the Grant VEGA No. 1/ 0320/ 08  
[1]  Vitková Z, Herdová P, Šubová M, Šimunková V. [Formulation of chlorhexidin into gels]. Ceska Slov 
Farm. 2009; 58: 116–118. 
[2]  Herdová P, Vitková Z, Čižmárik J. [Study of local anaesthetics: Part 189. Evaluation of flowing 
attributes of drug Mesocain gel by using different gel- creating compounds]. Farm Obz. 2009; 78: 151–
153. 600 Scientia  Pharmaceutica  www.scipharm.at 
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Quercetin is a flavonol with antioxidant properties, exhibiting poor water 
solubility and transdermal permeation ability. The objective of this study was to 
formulate a new microemulsion for the transdermal delivery of quercetin based 
on the use of Transcutol
® P as a solubilizing agent and absorption promoter. 
Materials and Methods 
Quercetin hydrated (>95%) was purchased from Sigma-Aldrich (Germany). All 
the excipients were kindly supplied by Gattefossé (France). The microemulsion 
was prepared by mixing the water and the lipidic phase under gently and 
continuous stirring at room temperature. Formulations were characterized for 
physical stability (centrifugation), pH, viscosity (viscosimeter Rheomat RM 180), 
internal phase dimensions (optical microscope, Leitz), in vitro transdermal 
diffusion. For this last experiment, 6 vertical Franz’s cells were used. A 
polypropilen membrane (Celgard
® k-381) soaked up with Labrafac
® lipophile 
WL1349/CHCl3 (1:3) was used. The quercetin diffusion was determined by VIS-
spectrophotometry. 
Results 
The solubility of quercetin was spectrophotometrically determined in different 
excipients and whose in which it was more soluble were selected. 
Through a ternary diagram, the percentages of the following phases were 
determined: lipidic phase, water phase, ratio surfactant/co-surfactant. The best 
formulation was: 1% of quercetin, 16.67% of water phase with 40% of 
Transcutol
® P, 16.67% of lipidic phase (Labrafil
®), 66.67% S/coS (Labraso
®l, 
Capryol
® 90). The most stable microemulsion was an O/W microemulsion, 
appearing as a yellow transparent liquid, with an internal phase size of 10–50 
nm and a pH of 5.0. The dynamic viscosity was 0.068±0.003 Pa*s. The 
quercetin diffusion, compared to other different formulation, was good. From 
this study it was possible to highlight the fundamental role of the Transcutol
® P 
in increasing the quercetin solubility in the microemulsion and as absortion 
promoter through the membranes. www.scipharm.at Scientia  Pharmaceutica  601 
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Due to its topical irritant effect on gastric mucosa naproxen is an ideal candidate 
for encapsulation in pH sensitive drug delivery systems such as alginate–
chitosan microparticles. In this study we aimed to investigate the feasibility of 
these carriers for oral delivery of naproxen, and to establish the kinetic 
mechanisms of naproxen release from microparticles under conditions 
simulating gastrointestinal environment. Sixteen different microparticles 
formulations in range between 262.3±14.9 and 358.4±21.7 μm have been 
prepared by well-known two-stage procedure using custom made air-jet device. 
Differences among formulations were hardening time in chitosan solution, 
drug/polymer ratio, chitosan molecular weight and chitosan concentration. After 
2  h in acidic media (pH  1.2), naproxen release was less then 6.18% for all 
investigated formulations due to non-porous surface and low swelling ability of 
chitosan–alginate gel network in acidic environment. When the pH of the 
surrounding media was raised to 6.8, swelling of microparticles occurred, 
leading to the rapid release of encapsulated drug. ANOVA analysis revealed 
that all investigated factors have statistically significant influence on drug 
release from microparticles (p<0.05). Furthermore, ANOVA analysis showed 
existence of statistically significant negative interaction between chitosan 
molecular weight and its concentration in hardening medium. This observation 
may be explained by influence of the hardening medium viscosity on the 
formation of chitosan-alginate gel network. Naproxen release data obtained 
during second phase of experiment (pH 6.8) showed best fit to the Korsmeyer-
Peppas equation, which can be confirmed by comparing the values of the 
correlation coefficient with those of other investigated models. The values of the 
Korsmeyer–Peppas release exponent (n) determined for all investigated 
formulations varied in range from 1.62 to 3.73 suggesting Super Case II 
transport mechanism for the release of naproxen from microparticles. Super 
Case II transport occurred due to a large increase in osmotic pressure driving 
forces, followed by rapid relaxation and swelling of alginate chitosan gel 
network. 
The results indicate that chitosan-alginate microparticles represent convenient 
gastroresistance delivery system for oral administration of naproxen due to 
release controlled by pH dependent swelling ability.  602 Scientia  Pharmaceutica  www.scipharm.at 
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Alginate-based microparticles have been widely investigated for applications 
like enzyme immobilization, immunoisolation in cell transplantation and drug 
release systems. Using the custom made air-jet device, by varying processing 
as well as several formulation factors, we aimed to prepare and investigate 
alginate-chitosan microparticles loaded with phenytoin, a standard antiepileptic 
agent. The extended-release formulations of antiepileptics simplify treatment of 
this chronic condition. Such commercial formulations with phenytoin appear to 
be well designed, with one possible shortcoming being the potential for irregular 
absorption that appears to occur particularly in elderly patients [1]. The final aim 
of the project was to investigate microparticles loaded with phenytoin with 
possibly improved liberation profile. In order to evaluate the influence of 
formulation factors and hardening time in a chitosan solution on drug release 
rate, 2
4 full factorial design was used. The independent variables (inputs) 
investigated were the calcium chloride concentration (X1), chitosan molecular 
weight (X2), chitosan concentration in coating solution (X3) and hardening time 
(X4). The times for 50% and 90% of the drug to be released – t50% and t90% for 
each formulation were calculated and used as response parameters (outputs). 
ANOVA analysis revealed that among investigated factors X2, X3, X4 as well as 
interactions X2–X3  and X3–X4 have statistically significant influence on drug 
release from microparticles (p<0.05). Since no significant influence of X1 on 
drug release rate was observed, it was excluded from further statistical analysis. 
Calculated factor effects of investigated variables indicate that lower level of X2 
(combination of high and low molecular weight chitosan), higher levels of X3 
(0.2% w/w chitosan concentration in coating solution) and X4 (24h hardening 
time) favour sustained release of phenytoin. The present study suggests that 
alginate-chitosan microparticles may be used as a delivery system for sustained 
release of phenytoin with key factor affecting the release rate being the 
combination of hardening time, chitosan concentration and molecular weight. 
[1]  Pellock JM, Smith MC, Cloyd JC, Uthman B, Wilder BJ. Extended-Release Formulations: Simplifying 
Strategies in the Management of Antiepileptic Drug Therapy. Epilepsy Behav. 2004; 5: 301–307. 
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Development of drug delivery systems is an indispensable strategy for 
successful transport of drug to its therapeutic site by the appropriate choice of 
carrier and route. Solid lipid nanoparticles (SLN) include the advantages of 
conventional carriers and are additionally utilized for protection of labile 
compounds, as well as in controlling of drug release, targeting and stability. 
In general, physicochemical characteristics of SLN surface are those, which 
affect their behaviour both in vivo and in vitro [1, 2]. Consequently, development 
of appropriate design technique is crucial to effectively estimate the potential 
offered by SLN. The main objects of current research were to evaluate 
nanoparticles morphology (size, distribution, shape, structure, integrity), and 
their nano-mechanical properties such as adhesion forces and local hardness. 
Atomic force microscopy (AFM) has been used for these studies. More 
precisely, phase imaging as an extension of the tapping mode AFM, provided 
the mapping of the surface properties variations, such as composition, 
adhesion, friction and visco-elasticity. 
SLN unlabelled and particles labelled with different coumarin based fluorescent 
dyes such as SPP 189 (SLN SPP-189) and 6-coumarine (SLN C), produced by 
melt-emulsification process were circular in shape. Photon correlation spectros-
copy and AFM provided approximately the same particle size of investigated 
samples. Surface roughness of SLN SPP-189 was significantly elevated in 
comparison to unlabelled SLN, what should be the consequence of into surface 
incorporated fluorescent dye. Phase imaging and force spectroscopy 
measurement estimated the surface heterogeneity and local surface hardness. 
Phase contrast confirmed two different regions of SLN SPP- 189, which could 
be associated with surface heterogeneity caused by diverse nature of main 
constituents as well as fluorescent dye. Only these nanoparticles demonstrated 
light hallow in phase image, likely related to inhomogeneous distribution of 
lipophilic ingredients that also reflects differences in local surface hardness.  
Current research will be additionally complemented with analysis of particles-
cells interaction in order to improve the understanding of SLN composition 
involved in the cell uptake and in cell drug delivery.  
[1]  Kristl J, Teskač K, Milek M, Mlinarič-Raščan I. Surface active stabilizer Tyloxapol in colloidal 
dispersions exerts cytostatic effects and apoptotic dismissal of cells. Toxicol Appl Pharmacol. 2008; 
232: 218–225. doi:10.1016/j.taap.2008.06.019. 
[2] Teskač K, Kristl J. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int J 
Pharm. 2010; 390: 61–69. doi:10.1016/j.ijpharm.2009.10.011 604 Scientia  Pharmaceutica  www.scipharm.at 
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The enhancement of dissolution rate is one of the most commonly used 
approaches to improve the bioavailability of drugs, since for a great extent of 
new drug substances their absorption is limited with their dissolution rate. The 
aim of this work was to prepare and optimize microparticles containing 
ketoprofen using spray-drying technology, which would enhance the dissolution 
rate of ketoprofen, which is poorly soluble at lower pH values. Different 
hydrophilic polymers with relatively low melting point (polyethylene glycol 4000 
and 6000, poloxamer 188, Gelucire 44/14 and 50/13) were used to prepare 
microparticles by spray drying. Due to the low melting point of the polymers, 
spray drying parameters were carefully optimized to ensure reasonable yields. 
Of the process parameters, atomizing pressure was shown to be the most 
important factor influencing product yield. Product yield was also greatly 
impacted by the adhesion of the particles to the inside wall of the spray dryer 
due to the sticking of the carrier material. A positive correlation between the 
melting point of the polymers and the product yield was established - the lower 
the melting point of the polymer, the lower was the yield. Carriers with promising 
yield (polyethylene glycol 4000 and poloxamer 188 with the average yield of 
34,4% and 43,0%, respectively) were chosen for the preparation of the drug 
loaded microparticles. A reference sample was prepared using lactose as a 
carrier. In all cases ketoprofen was not dissolved in the final mixture and 
ketoprofen suspensions in carrier polymer solutions were spray dried. During 
the preparation of drug loaded microparticles, the drug concentration in the 
suspension was shown to have a great impact on the overall yield. Due to 
extremely poor yield when polyethylene glycol 4000 was used as a carrier, only 
samples prepared with poloxamer 188 and lactose were further studied. Image 
analysis was used to determine the size and shape of microparticles, which 
were recorded by scanning electron microscope (SEM). The dissolution rate of 
ketoprofen from the microparticles prepared with poloxamer 188 was enhanced 
compared to microparticles prepared with lactose as a carrier. All prepared 
microparticles exhibited markedly increased dissolution rate compared to 
ketoprofen alone. The differential scanning calorimetry (DSC) confirmed a 
similar thermal behavior of ketoprofen microparticles and corresponding 
physical mixtures which indicates the absence of chemical interaction between 
ketoprofen and water soluble carrier. It was also shown that there was no 
significant conversion of crystalline ketoprofen to the amorphous form during 
the spray drying process. www.scipharm.at Scientia  Pharmaceutica  605 
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In recent years there has been increasing attention given to the utility of self-
microemulsifying systems (SMES) for improving the gastrointestinal absorption 
of drugs with inadequate biopharmaceutical properties. Microencapsulation of 
those systems into polymeric matrix is one of the solidification techniques that 
allow formulation of solid self-microemulsifing formulations.  
Microcapsules with furosemide-loaded self-microemulsifying core that merge 
the advantages of SMES with those of solid dosage forms where produced by 
co-extrusion of liquid jet by vibrating nozzle device. The composition of self-
microemulsifying core was optimized previously [1]; the aim of this study was 
therefore to modify the shell-forming phase in order to gain repeatable 
production of microcapsules with high encapsulation efficiency. The influence of 
lactose content in microcapsules` shell on drug release profile from dried micro-
capsules and their swelling and erosion behaviour was examined additionally.  
Best shaped microcapsules with highest encapsulation efficiency were obtained 
from the shell-forming phase with the Ca-alginate/pectinate ratio of 1/3 
containing 5–10% lactose [2]. Incorporation of furosemide in self-emulsifying 
core of microcapsules resulted in considerably enhanced drug release profile 
when compared to reference microspheres, which did not contain SMES. Drug 
release from microcapsules containing different content of lactose was further 
affected not only by pore inducing effect of lactose but also by the formation of 
hydrated visocous layer around the capsules, which acted as a barrier to drug 
release. The presented results constitute a step cloaser to a repeatable 
production of microcapsules with self-microemulsifying core by using method of 
liquid jet co-extrusion by vibrating nozzle device. Better solubility and 
permeability properties obtained with self-microemulsifying core also provide a 
promising alternative to ensure succesfull oral delivery of drugs with poor 
biopharmaceutical properties.  
[1]  Zvonar A, Berginc K, Kristl A, Gašperlin M. Microencapsulation of self-microemulsifying systems: 
improving solubility and permeability of furosemide. Int J Pharm. 2010; 388: 151–158. 
doi:10.1016/j.ijpharm.2009.12.055.  
[2]  Zvonar A, Gašperlin M. Microcapsules with self-microemulsifying core: optimization of shell-forming 
phase. Pharmazie. 2010; 65: 390–391. doi:10.1691/ph.2010.9395 606 Scientia  Pharmaceutica  www.scipharm.at 
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Egg lecithin is a complex mixture of phosphatides that consists mainly of 
phosphatidylcholine and phosphatidylethanolamine, combined with various 
amounts of other substances such as triglycerides and fatty acids [1]. As 
pharmaceutical excipient lecithin is used in parenteral emulsions, liposomes 
and mixed micellar solutions. It has been proved, that aqueous dispersions of 
lecithin (Water-Lecithin Dispersion, WLD) may be used as safe and 
biocompatible solubilizing carriers for parenterally administered drugs with low 
solubility, such as paclitaxel [2, 3]. 
The aim of the study was to evaluate the solubilizing properties of WLD 
(containing 5% or 10% of lecithin) using 9 different active substances, 
demonstrating low water solubility: cyclosporin A, sulfamethoxazole, 
metronidazole, dexamethasone, hydrocortisone, carbamazepine, prednisolone, 
theophylline and testosterone. The solubility in water and WLDs was studied for 
untreated and lyophilized substances. 
For solubility determination, active substance was suspended in 10 ml of water, 
5% or 10% WLD and the mixture was stirred for 24 h at room temperature. 
Then the dispersion was centrifuged for 15 min and the supernatant was filtered 
and analysed by means of spectrophotometric or HPLC method. 
Results indicated, that the solubility of the tested drugs in WLD was at least few 
times higher than in water and the amount of dissolved substance increased 
with the increase of the lecithin concentration in WLD. The only exceptions were 
drugs with relatively high water solubility (metronidazole, theophylline), for 
which WLD did not increase solubility. The highest increase in solubility was 
observed for cyclosporin A, for which measured solubilities were as follows 
[mg/ml]: 0.03 (water), 3.9 (5% WLD) and 5.7 (10% WLD). Microscopic analysis 
indicated, that in freeze-drying process reduction of the drug particles size was 
achieved and this resulted in much faster dissolution of the compounds in WLD. 
Due to biocompatibility, WLD may be considered as a carrier for poorly soluble 
parenterally administered drugs. 
[1]  Fowler K. Lecithin, In: Rowe RC, Sheskey PJ, Owen SC. Handbook of Pharmaceutical Excipients. 
Pharmaceutical Press. London 2006: 409–411. 
[2]  Sznitowska M, Klunder M, Placzek M. Paclitaxel solubility in aqueous dispersions and mixed micellar 
solutions of lecithin. Chem Pharm Bull. 2008; 56: 70–74. doi:10.1248/cpb.56.70 
[3]  Sznitowska M, Bodnar M, Petrusewicz J, Janik H, Dabrowska E. A. Preliminary in vivo studies of a 
new lecithin-based formulation of paclitaxel. J Microencapsul. 2009; 26: 588–592. 
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In modern pharmaceutical technology a number of methods offer themselves to 
enhancement of dissolution and rate of dissolution. The insert to a micelle or an 
inclusion complex and conjugatum between active agent and a polymer 
molecule can increase both solubility and the rate of dissolution, but then the 
microencapsulation increases only the rate of dissolution [1–3]. 
Aim of our research was to increase of solubility and rate of dissolution of poorly 
water-soluble active agents. Seven active agents poorly, slightly and very 
slightly soluble in water were investigated. In the course of preformulation the 
wettability of these active agents with different polymer solutions was studied. 
The contact angle of wetting was measured by OCA 20 equipment (produced 
Dataphysics). On the grounds of contact angle values the polymers with best 
wettability was chosen, which – presumaby – is most suitable to prepare 
microcapsules. The microcapsules was produced with Büchi’s spray drying 
equipment. 
 
Fig. 1. Flow diagram 
The microcapsules was produced with Büchi’s spray drying equipment. 
Relationships were appointed between the technical parameters of spraying 
(e. g. rate of spraying, the temperature of incoming and outgoing air) and the 
properties of microcapsules (e. g. size distribution, morphology and surfaces, 
and dissolution rate). 
[1]  Swarbrick J, Boylan JC (eds). Encyclopedia of Pharmaceutical Technology, Marcel Dekker INC, 2002. 
[2]  Banker GS, Rhodes CT (eds). Modern Pharmaceutics. Marcel Dekker, 1997. 
[3]  Machato RI. Pharmaceutical technology and Drug Delivery, CRS Press, 2007. 
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Diazepam is one of most frequently prescribed benzodiazepines. It is classified 
as a class I substance according to the Biopharmaceutics Classification 
Scheme (BCS). Diazepam tablets were prepared using different API raw-
materials.  Before the formulation,  we measured particle size distribution on 
Malvern Instruments Ltd Mastersizer 2000. The tablets were prepared by 
employing conventional wet granulation. The formulations were evaluated for 
hardness, friability, content uniformity, in vitro disintegration time (DT), release 
profiles. The dissolution profile testing is performed on the two formulations with 
different particles size distribution.  
Test parameters were: medium 0.1 mol / l hydrochloric acid, 900 ml, temper-
ature 37°C ± 0.5°C, Mixing Speed 100 rpm, Number of tested tablets 12, 
Testing Cycle 10, 15, 20, 25 and 30 min. Instrument: Varian Van Kel VK7025, 
Varian Cary 50. We used the spectrophotometric method with absorbance 
measuring on 242 nm for quantification. 
Results for particle size distribution for first Diazepam API particle distribution 
were d (0.10): 88.743 µm; d (0.50): 305.231 µm; d (0.90): 655.911 µm, and for 
the second raw-material of API was d (0.10):1.998 µm; d (0.50): 4.419 µm; d 
(0.90): 8.845 µm. The results of diazepam dissolution for two formulations and 
f2 value with reference drug are presented in Table 1: 
 
Tab. 1. 
  Formulation A  Formulation B 
minutes  10 15  20  25  30 10 15 20 25 30 
S.V.  85.34 99.05 100.79 100.39 99.88 99,08 98,49 97,90 97,36 96,89 
SD   4.65   2.57    3.20    3.34   3.31   1,32   1,32   1,28   1,27   1,28 
RSD   5.45   2.60    3.17    3.32   3.31   1,33   1,34   1,31   1,31   1,32 
f2   68,15    99,44 
 
It was concluded on the basis of formulation tests that Formulation B, for which 
micronized API was used, has a similar dissolution profile for API as compared 
to the reference medicine (f2=99.94) in comparison to Formulation A (f2=68.15) 
[1]  George Wong, Charles C. Collins. Pages from Preformulation in Solid Dosage Form Development: 
Dissolution testing: Informa Healthcare USA, Inc. 2008; 44: p.477–555.  
[2]  The United States Pharmacopeia.(2007). 30th revision, United States Pharmacopeial Convention, 
Rockville, MD, USA. www.scipharm.at Scientia  Pharmaceutica  609 
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Many drug substances exhibit low solubility in water, which results in their poor 
bioavailability. Among ophthalmic preparations, oil solutions, suspensions and 
ointments are formulations prepared for such compounds. Promising modern 
drug carries are self-emulsifying drug delivery systems (SEDDS) which are 
isotropic mixtures of oils and surfactants. Due to presence of surfactants 
improved solubility and transcorneal passage of the active substances can be 
expected [1]. 
The aim of this study was to compare the in vitro release of indomethacin (IND) 
and hydrocortisone (HC) from SEDDS and aqueous or oily suspensions. The 
release experiments were carried out for 6 h at 37°C using dialysis cellulose 
membrane and acceptor fluid imitating composition of lacrimal fluid.  
Amount (mg) of the drug and the percentage of the dose delivered to the 
acceptor medium was measured and diffusion coefficients were calculated. 
After 6 h about 7 mg (40%) of IND was released from SEDDS and about 5 mg 
(30%) from 0,6% aqueous and oily suspensions. Only small percentage of HC 
was released (below 20%) from the aqueous and oily suspensions. However 
percentage of hydrocortisone released from SEDDS (containing 1% or 5% 
Cremophor EL) came to over 60%. The results suggest that increased solubility 
in SEDDS [2] does not necessarily increase diffusion through the dialysis 
membrane and in vivo effect on bioavailability can not be easily predicted. 
[1]  Thi T, Speybroeck M, Barillaro V, Martens J, Annaert P, Augustijns P, Humbeeck J, Vermant J, Mooter 
G. Formulate-ability of ten compounds with different physicochemical profiles in SMEDDS. Eur J 
Pharm Sci. 2009; 38: 479–488. doi:10.1016/j.ejps.2009.09.012 
[2] Czajkowska-Kośnik A, Sznitowska M. Solubility of ocular therapeutic agents in self-emulsifying oils. I. 
Self-emulsifying oils for ocular drug delivery: solubility of indomethacin, acyclovir and hydrocortisone. 
Acta Pol Pharm. 2009; 66: 709–713. PMid:20050536 610 Scientia  Pharmaceutica  www.scipharm.at 
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In vitro dissolution testing serves as an important tool for drug manufacturing 
process control and quality assurance. In certain cases it can serve also as an 
indicator of how the formulation will perform in vivo [1].  
Cefaclor, cephalosporin antibacterial drug, was chosen as a model drug, 
classified in BCS class III (high soluble and low permeable) [2]. It is effective 
against many different bacterial organisms such as Staphylococcus aureus, 
Streptococcus pneumoniae, Haemophilus influenzae, E. coli, and many others 
[3]. 
The aim of this study was to investigate the impact of experimental conditions 
on drug release from capsules having the same composition, but containing 250 
mg (product A) and 500 mg (product B) of cefaclor. Solubility, the drug intrinsic 
dissolution rate and in vitro drug release tests were performed in water as well 
as in three EP buffer media: pH 1.2, pH 4.5 and pH 6.8. 
It has been shown that the solubility of cefaclor was two times lower comparing 
to that observed in other tested media. The drug intrinsic dissolution decreased 
in the following order: pH 1.2>pH 6.8>water>pH 4.5. The dissolution media 
composition strongly, and to variable extent, influence cefaclor release from the 
investigated drug products. At pH 1.2 the drug dissolution was very fast with 
more than 85% of cefaclor dissolved within 15 and 30 minutes for product A and 
B, respectively. In the case of EP pH 4.5 buffer medium, the drug dissolution 
was notably slower and, consequently, more than 75% of the drug dissolution 
was accomplished after 60 minutes. The employment of EP pH 6.8 buffer 
medium resulted in slow and incomplete drug release. The differences between 
the release profiles obtained for the investigated drug products A and B in each 
tested dissolution medium were found to be statistically insignificant. In addition 
to the drug characteristics, it is evident that the formulation factors strongly 
affected cefaclor dissolution rate and must be taken into account in selecting a 
test method that will be sensitive enough to reflect its bioavailability. 
[1]  Blume HH, Schug BS. The biopharmaceutics classification system (BCS): Class III drugs-better 
candidate for BA/BE waiver? Eur J Pharm Sci. 1999; 9: 117–121.  
doi:10.1016/S0928-0987(99)00076-7 
[2] http://www.tsrlinc.com/services/bcs/results.cfm   
[3]  Martindale, The Extra Pharmacopoeia, 36
th edition, The Pharmaceutical Press, London, 2009; 218–
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Due to complexity and interplay of variable gastrointestinal conditions with 
matrix tablets which are predominantly erosion controlled it is often difficult to 
predict in vivo release profile [1]. Nascent gel layer of matrix tablets is prone to 
mechanical stress which is difficult to simulate in vitro.  
Present study describes approaches to establish a biorelevant in vitro test for 
evaluation of two different matrix tablets containing a BCS class 2 model drug. 
Mechanism of release was also evaluated. Obtained results were compared 
with in vivo pharmacokinetic data (Cmax) and possibilities for IVIVC or IVIVR 
were explored. 
The tablets were first tested with conventional dissolution tests. Secondly, a test 
that simulates mechanical stress potentially occuring during transition of tablets 
through GI tract was performed [2]. This test incorporates glass beads 
manipulation. Additionally, a new approach using dissolution apparatus USP3 
with plastic beads was also explored.  
Obtained results were used to elaborate the mechanism of release from the 
tablets. One formulation was accelerated after applying the mechanical stress, 
while the other formulation exhibited no changes and followed a 0. order 
release. This was proven by calculating the Korsmeyer-Peppas release rate 
constants.  
The release mechanism was further examined by inspecting the rates of 
dissolution ΔQ/Δt before and after mechanical stress manipulation. IVIVR with 
Cmax results was also shown, the dissolution profile when approximately 70% 
of the drug is released being relevant for in vivo. 
The results from dissolution apparatus USP3 and plastic beads test were used 
to develop an IVIVC model. Based on this model the maximal plasma 
concentration (Cmax) was predicted and compared with the observed values 
from the in vivo BE study. The average absolute percent prediction value for 
each tested matrix tablet was less than 15%, which demonstrates a good 
internal predictability of the IVIVC model. 
[1]  Dokoumentzidis A, Macheras P. IVIVC of controlled release formulations: Physiological–dynamical 
reasons for their failure. J Control Rel. 2008; 129: 76–78. doi:10.1016/j.jconrel.2008.04.005 
[2]  Sako K, Sawada T, Nakashina H, Yokohama S, Sonobe T. Influence of water soluble fillers in 
hydroxypropylmethylcellulose matrices on in vitro and in vivo drug release. J Control Rel. 2002; 81: 
165–172. doi:10.1016/S0168-3659(02)00067-6 612 Scientia  Pharmaceutica  www.scipharm.at 
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The holt-melt extrusion technique has proven to be an advantageous method 
for preparation of solid dosage forms. The aim of this work was to evaluate the 
release profiles of sustained release cylinders produced by hot-melt extrusion. 
The cylinders were composed of inner and outer part, both containing 
theophylline    [1]. Cylinders were 0.5cm or 1cm long. The two parts were 
extruded separately, cut into pieces and joined manually. Dissolution testing 
was performed on USP 2 apparatus at rotation speed 50, 100 and 150 rpm. 
Artificial gastric and intestinal media were used consecutively.  
Due to their hydrophilic / lipophilic properties inner part of cylinder releases the 
drug fast while outer part represents extended release component. No influence 
of stirring rate on theophyline release was observed for 1cm cylinders while for 
0.5cm cylinders the amount of released drug slightly increased with increase of 
stirring rate (Fig.  1). However, due to high variability of release results 
significant differences could not be proven. This high variability of release 
results was beside other factors (poor wettability due to lipophilic components 
etc.) at least partly ascribed to manual preparation of the dosage forms. Manual 
joining of the inner and outer part of the cylinder caused void spaces between 
both parts as shown on the stereomicrographs (Olympus SZX12) (Fig. 2). The 
consequence of void spaces is additional free surface available for dissolution 
which can not be controlled and thus increases the variability of release results. 
Thus, the automatic simultaneous co-extrusion would be better choice when 
preparing co-extrudates as void spaces between two parts of cylinders could be 
avoided and variability at least partly reduced. 
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Fig. 1. Percentage of released drug after 7h 
of release in dependence on stirring rate 
Fig. 2. Stereomicroscopic view of co-extrudates.  
Arrow shows void space between two parts of 
cylinder. 
 
[1]  Quintavalle U, Voinovich D, Perissutti B, Serdoz F, Grassi G, Dal Col A, Grassi M. Preparation of 
sustained release co-extrudates by holt-melt extrusion and mathematical modelling of in vitro/in vivo 
drug release profiles. Eur J Pharm Sci. 2008; 33: 282–293. doi:10.1016/j.ejps.2007.12.008 www.scipharm.at Scientia  Pharmaceutica  613 
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The aim of this research is to prepare Moxifloxacin hydrochloride immediate 
release tablets by wet granulation using experimental design technique. 
Moxifloxacin is a fourth-generation fluoroquinolone that has been shown to be 
effective against Gram-positive, Gram-negative, and atypical strains, as well as 
multi-drug resistant Streptococcus pneumoniae. [1] Optimization has proven as 
an effective tool in product development. The purpose of carrying out 
optimization is to select the best possible formulation from pharmaceutical as 
well as consumer point of view. High dose drug that experience poor flow and 
poor compactibility was granulated to obtain suitable flow and cohesion for 
compaction. The selection of suitable filler and binder in the formulation of 
immediate release tablets and granulate residual moisture are very important 
because they affect physical parameters and in-vitro release profile. [2] The 
experimental design 2
3-1 was applied with following independent variables: filler 
type (X1), binder type (X2), granulate residual moisture (X3). Weight variation, 
thickness, hardness, friability, disintegration time and drug release after 15 
minutes were examined as dependent variables. [2] Different fillers examined 
were Mannitol and Cellulose microcrystalline. Different binders examined were 
Maltodextrin and Povidone. The tablets prepared using Cellulose 
microcrystalline as a filler and Povidone as a binder in optimized formulation 
showed the best comparable results for physical parameters. In-vitro release 
profiles were tested in 900ml 0.1 M HCl, at 37  ±  0.5°C, in USP paddle 
apparatus with stirring rate of 50 rpm. Percent of drug released was determined 
by UV/VIS spectrophotometric method. Taking into consideration the fact that 
more than 85 % of the drug is released from product and optimized formulation 
within 15 minutes, in-vitro release profiles are considered similar without further 
mathematical evaluation. Analysis of the obtained results showed that the 
binder type (X2) and granulate residual moisture (X3) have significant influence 
on response parameters. The other independent variable, filler type (X1) does 
not have significant influence. 
[1]  Miravitlles M, Anzueto A. Moxifloxacin: a respiratory fluoroquinolone. Expert Opin Pharmacother. 
2008; 10:1755–1772. doi:10.1517/14656566.9.10.1755 
[2]  Blaisdell P, Frank M, Busse W D, Chien N C, Dogramatzis D, Raeder M, Rodman L E, Dahl T, 
Pemberton M, Scannon P J, Bristol D R, Burton S, James R, Sidebittom C, Twenty-First Century 
Pharmaceutical Development, 1
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Administration of pellets in fed stomach state can prolong the gastric emptying 
of pellets in comparison to the administration under fasting conditions [1]. On 
the basis of literature data we aimed to investigate the influence of caloric value 
of food on gastric emptying of pellets.  
A systematic literature search on evaluation of human gastric emptying of 
pellets based on the technique of gamma scintigraphy was performed in the 
MEDLINE database. Studies estimating the gastric emptying of pellets under 
fed conditions were focused. In addition to the caloric value of the meal, a 
special attention was made on other factors such as, pellets size and density, 
pellets formulation (filled into capsules or compressed into tablets), a time delay 
for pellets administration in relation to the time of meal completion, and 
refreshments provision. The majority of pellets gastric emptying data was 
presented in terms of pellets t50 values – a time when 50% of the administered 
pellets emptied the stomach. In order to evaluate the influence of the caloric 
value of the meal on pellets t50 values a linear regression model was built. In 
this model the caloric value was regarded as a categorical variable, which was 
recorded into dummy variables with the lowest caloric value set as a reference. 
In total 17 studies were recovered, however, only 6 of them met the selection 
criteria: pellets density between 1.2 and 1.5 g/cm
3, administration of the pellets 
at the time of meal completion, pellets filled into capsules, and pellets size in the 
range from 0.6 to 1.4 mm. In these studies 48 individual values of pellets t50 
were collected (6 or 8 subjects per study) and the obtained caloric values were 
1200, 1500, 2300, 2800, and 3600 kJ. Mean value of t50 of pellets administered 
right after the 1200 kJ meal was 136 min. In comparison to the 1200 kJ meal, 
the mean values of t50 of pellets administered right after 2800 and 3600 kJ meal 
were significantly longer; 212 min (p=0.031) and 263 min (p=0.003), 
respectively. No significant difference in terms of mean values of pellets t50 
could be noted between the 1200 kJ meal and 1500 or 2300 kJ meal. 
Our results suggest that gastric emptying of pellets can be more prolonged if 
administered along with the food with higher caloric value.  
[1]  Yuen KH, Deshmukh AA, Newton JM, Short M, Melchor R. Gastrointestinal transit and absorption of 
theophylline from a multiparticulate controlled release formulation. Int J Pharm. 1993; 97: 61–77. 
doi:10.1016/0378-5173(93)90127-2 
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Introduction: Pellets are an attractive dosage form in the gender specific and 
pediatric therapy, since they offer the possibility of patient adapted dosing. 
Additionally, they are easily swallowed and unpleasant taste masking by coating 
is facilitated due to their smooth and homogenous surface. The development of 
disintegrating pellets is a new and innovative technology. The main advantage 
of this type of dosage form is the circumvention of the hepatic and the first pass 
metabolism [1]. In the present study Ludiflash
®/Kollidon
® CL-SF (crospovidone) 
mixtures were used to prepare disintegrating micropellets via a wet 
extrusion/spheronization process.  
Methods: Powders were blended and wetted with different water/ethanol 
mixtures (i.  e., 10% 20%, 30%, 40% and 50% ethanol). The wet mass was 
subsequently extruded through a 0.8 mm multihole die plate and spheronized at 
different speeds for 2-4 minutes. Finally pellets were dried using three different 
methods (i.e, desiccation, tray drying and fluidized bed technology). The 
disintegration behavior in water at 37  ±  0.5  °C was evaluated according to 
Pharm. Eu. 6.0 2.9.1. In addition, the mechanical characteristics (tensile 
strength, friability) and the pellet shape were investigated. 
Results: For pellet formulations containing 5% Kollidon
® CL-SF a minimum 
ethanol fraction of 30% in the granulation fluid was required for successful 
extrusion/spheronization. At lower alcohol contents extensive liquid movement 
occurred during extrusion resulting in non-reproducible process conditions. 
Pellets prepared with 30% and 40% ethanol disintegrated within 1 minute. 
Using 50% ethanol, however, yielded in increased disintegration times (>1min). 
Pellets containing 10% crospovidone were successfully prepared with all 
granulation liquids under investigation. Disintegration times exceeded 1 minute 
when the ethanol fraction was higher than 20%. All pellet formulations exhibited 
sufficient mechanical stability and an aspect ratio below 1.2. 
Conclusion: Ludiflash
® in combination with either 5% or 10% Kollidon
® CL-SF is 
a promising extrusion and spheronization aid for the preparation of pellets 
showing disintegration times below 1 minute. 
[1]  Birudaraj R, Berner B, Shen S, Li X. Mechanistic Studies on transport pathways. J Pharm Sci. 2005; 
94: 70–78. doi:10.1002/jps.20208 616 Scientia  Pharmaceutica  www.scipharm.at 
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The objective of this study was to develop solid self-emulsifying pellets to 
deliver the poorly bioavailable Milk Thistle extract (Silybum Marianum) [1]. 
These pellets were prepared via extrusion/spheronization procedure, using a 
self-emulsifying system or SES (composed of Akoline MCM
®, Miglyol
®, Tween 
80
®, Soy Lecithin and Propylene Glycol), microcrystalline cellulose and lactose 
monohydrate. To select the most suitable formulations for extrusion and 
spheronization, an experimental design of experiences was adopted. The 
screening amongst formulations (13 different blends) was carried out preparing 
pellets and evaluating extrusion profiles and quality of the spheronized 
extrudates. The pellets were characterized for sizing and shape, density and 
hardness. Although more than one type of pellets demonstrated adequate 
morphological and technological characteristics, pellets having best properties 
were selected for further  biopharmaceutical investigations, including in vitro 
dissolution, determination of released droplet size and in vivo trials on rats to 
study serum and lymph levels after oral administration of the pellets. These 
preliminary technological and pharmacokinetic data demonstrated that 
extrusion/spheronization is a viable technology to produce self- emulsifying 
pellets of good quality and able to improve in vivo oral bioavailability of main 
components of a phytotherapic extract, also enhancing its lymphatic absorption. 
The authors thank Indena for the kind gift of Sylibum Marianum dry extract. 
[1]  Wu W, Wang Y, Que L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery 
system. Eur J Pharm Biopharm. 2006; 63: 288–294. doi:10.1016/j.ejpb.2005.12.005 
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In biomedical applications, it should be useful to have a system easy to 
administrate (the best would be a liquid injectable form), with structural 
properties in physiological conditions (the best would be a soft gel), able to 
resist to external stimulus (such us the erosion from body fluids, in this case the 
surface should be a hard gel). Such a system could be used as a drug delivery 
system, as well as a temporary scaffold.  
From previous investigation, we found out that the acqueous solution of 
Pluronic F127 and alginate (18% F127 + 2% alginate), is liquid at low 
temperature (around 5°C), it gives a soft gel due to the Pluronic thermogelation 
at body temperature (around 37°C), and it gives a hard gel after the exposition 
at solutions of bivalent cations (reticulation, using Ca
2+, Cu
2+).  
Prior of any other application, the system has to be thouroughly characterized. 
Therefore, 1) the mechanical properties of the solution were investigated by 
using rotational rheometry (monitoring 
the increase of solution moduli during 
heating); 2) the compressive behavior 
was investigated with impermeable and 
porous parallel plates (underlining the 
rule of the water to build up the 
properties of the gel); 3) the kinetics of 
cuprum diffusion and of hard gel 
formation were quantified (obtaining the 
thickness of reticulated layer – see the 
Figure – as function of cuprum solution 
concentrations and of exposure time. In 
the Figure, the symbols are experimental 
data and the surface curve is the model 
prediction). Further investigations are still ongoing. The data gatered will be 
used for the proper design of future biomedical applications. 
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The scope of the present work was to establish the role of the polymer charge 
on its ability to enhance the permeability of the urinary bladder wall.  
Cationic poly-L-arginine and chitosan, anionic sodium carboxymethyl cellulose 
(NaCMC) and alginate as well as nonionic hydroxypropyl cellulose (HPC) and 
hydroxypropyl methylcellulose (HPMC) were tested. The polymers were tested 
in concentrations from 0.00005 to 1% (w/v) and a concentration of a model drug 
pipemidic acid (PPA) was 0.014% (w/v) in all experiments. All solutions were 
prepared in phosphate buffer and their pH was adjusted to 4.5. In diffusion cells 
the luminal side of isolated pig urinary bladder wall was exposed to tested 
solutions. In some experiments the tissue was exposed for 60 min to a polymer 
dispersion with PPA, while in other experiments the tissue was first exposed to 
a polymer dispersion for 45 min, rinsed and then the solution of PPA was 
applied for additional 45 min. At the end of the experiment the tissue was frozen 
and sectioned parallel to luminal surface. PPA was extracted from the tissue 
segments and its concentration was determined by HPLC. 
We showed that the charge of the polymer affects its ability to enhance 
permeation of PPA into the urinary bladder wall, but to a limited extent. 
Positively charged chitosan and poly-L-arginine were established as the most 
promising absorption enhancer into the bladder wall. Compared to chitosan, 
higher concentrations of poly-L-arginine were needed to significantly increase 
the tissue permeability. Moreover, poly-L-arginine increased the permeability 
within 90 min constantly, while chitosan reached the plateau of its absorption 
enhancement activity after 60 min. In our previous study anionic polymer 
polycarbophil significantly increased permeation of PPA into the bladder wall 
[1]. However, in this study anionic NaCMC and alginate did not significantly 
influence the permeation of PPA into the tissue. Interactions between NaCMC 
or alginate and PPA might prevail over the potential effect of NaCMC and 
alginate on the tissue permeability. Moreover, nonionic polymers HPMC and 
HPC did not significantly influence the bladder wall permeability. 
We can conclude that positive charge has an important influence, but the 
selection of absorption enhancers for intravesical drug delivery systems can not 
be done exclusively on the basis of a polymer charge.  
[1]  Kerec M, Svigelj V, Bogataj M, Mrhar A. The enhancement of pipemidic acid permeation into the pig 
urinary bladder wall. Int J Pharm. 2002; 240: 33–36. doi:10.1016/S0378-5173(02)00108-4 
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General anesthetic drugs were introduced more than 160 years ago and are 
indispensable in daily surgery at hospitals. Interestingly, their mode of action 
remains largely unresolved. At present, there are two schools, one favoring 
specific (direct) interactions of the drugs with proteins of the central nervous 
system and a second adhering to nonspecific mechanisms through a 
modulation of biophysical membrane properties. We have focused on the latter 
mechanism and studied the effects of R-(−), S-(+)-ketamine and propofol on the 
biophysical properties of lipid model membranes composed of palmitoyl oleoyl 
phosphatidylcholine by a combination of X-ray diffraction and all-atom molecular 
dynamics simulations. In agreement with several previous studies, we do not 
find significant changes to the overall membrane structure up to 8 mol % drug 
content. However, we observed that the insertion of drugs within the lipid/water 
interface caused significant changes of lateral pressures within the membrane 
[1]. The changes are predicted to be stereospecific and large enough to affect 
the opening probability of ion channels at concentrations that compare 
remarkably well to clinically applied concentrations. Our results thus provide a 
novel basis for rational anesthetic drug design. 
[1]  Jerabek H, Pabst G, Rappolt M, Stockner T. Membrane-mediated effect on ion channels induced by 
the anesthetic drug ketamine. J Am Chem Soc. 2010; 132:7990–7997. doi:10.1021/ja910843d 
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Cartilage lesions observed in osteoarthritis (OA) are related to an important 
release of cytokines. Current treatments though oral or systemic administration 
are suboptimal and not curative. Intra-articular administration of drugs is often 
proposed for localized forms of OA. MAPK inhibitors target important cytokines 
pathways and show promise for the treatment of OA [1].  
The aim of the present work was to formulate nano- and microparticles loaded 
with a p38 MAPK inhibitor (VX-745) and to test their in vitro activity on human 
synoviocytes. We anticipated that this novel formulation will provide a high but 
local concentration of the active ingredient with a prolonged retention time.  
Particles of different sizes were produced by a solvent evaporation method 
using a solution of PLGA and of VX-745 in dichloromethane and a solution of 
PVAL. The particles were characterized by laser diffraction, dynamic light 
scattering, scanning electron microscopy and reverse-phase HPLC.  
In vitro studies were conducted by incubating nano- and microparticles with 
subconfluent human synoviocytes culture obtained from OA synovial samples. 
The ability of the particles to release the drug and consequently to inhibit the 
IL-6 biosynthesis was quantified by ELISA (eBioscience, San Diego, CA).  
Spherical particles had a smooth surface and mean diameter of 300 nm, 2.5 µm 
and 25 µm. After 24 h of incubation with synoviocytes, IL-6 production was 
inhibited by VX-745-loaded nanoparticles in a dose-dependent and size-
dependent pattern. For instance, the release of VX-745 from nanoparticles 
loaded at 100 nM inhibited IL-6 release to 52% compare to control and to 71% 
of control for a drug concentration of 800 nM.  
To conclude, VX-745-loaded particles display extended release properties and 
inhibit significantly the production of IL-6 from human synoviocytes.  
This work was supported by the De Reuter Fondation, Geneva, Switzerland. 
[1]  Brown KK, Heitmeyer SA, Hookfin EB, Hsieh L, Buchalova M, Taiwo YO, Janusz MJ. P38 MAP kinase 
inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with 
osteoarthritis. J Inflamm. 2008; 5:22: 1–8. doi:10.1186/1476-9255-5-22  
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Both the active pharmaceutical ingredient and the vehicle physicochemical 
characteristics are retained to be the main features responsible for favorable 
topical bioavailability. Emulsion systems based on natural-origin alkyl 
polyglucoside (APG) emulsifier (cetearyl glucoside & cetearyl alcohol) present 
promising vehicles in contemporary pharmaceutical compounding [1], but 
require further characterization using various model drugs. To this aim, APG 
test vehicles (with and without isopropyl alcohol addition) were loaded with 
ketoprofen as a model NSAID known for its non-optimal skin delivery 
characteristics [2], and compared to corresponding reference vehicles (Non-
ionic hydrophilic cream, DAB 2006). Physicochemical characterization included 
polarization microscopy, rheology and thermal analysis (DSC, TGA). In vitro 
release screening, in vitro skin permeation (Franz-type diffusion cells) and in 
vivo tape stripping were performed in order to evaluate ketoprofen 
biopharmaceutical profile. Additionally, safety considerations were assessed by 
in vitro skin irritation test (citotoxicity assay), alongside in vivo skin 
bioengineering measurements. Results obtained by tape stripping technique, 
showed significantly higher ketoprofen penetration profiles for test samples in 
comparison to reference ones. Although IPA addition tends to enhance 
ketoprofen penetration (probably through solubility enhancement – assessed by 
polarization microscopy) its influence cannot be considered significant (ANOVA, 
post hoc Tukey test). Ketoprofen demonstrated satisfactory but similar 
permeation and release profiles in investigated samples. Results of 
biopharmaceutical characterization comply with conducted physicochemical 
investigation, emphasizing overall difference in test and reference vehicles’ 
microstructure. APG vehicles showed satisfactory safety profile and skin 
performance, as well as suitable characteristics when loaded with ketoprofen. 
[1]  Savic S, Weber C, Tamburic S, Savic M, Müller-Goymann C. Topical Vehicles Based on Natural 
Surfactant/Fatty Alcohols Mixed Emulsifier: The Influence of Two Polyols on the Colloidal Structure 
and In Vitro/In Vivo Skin Performance. J Pharm Sci. 2009; 98: 2073–2090. doi:10.1002/jps.21591 
[2]  Swart H, Breytenbach J, Hadgraft J, du Plessis J. Synthesis and transdermal penetration of NSAID 
glycoside esters. Int J Pharm. 2005; 301: 71–79. doi:10.1016/j.ijpharm.2005.05.030 622 Scientia  Pharmaceutica  www.scipharm.at 
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In recent years, there has been an increasing interest in cocrystallization of 
active pharmaceutical ingredients. For example the physical stability can be 
enhanced by cocrystallizing [1]. Thus, using cocrystals as solid-state forms is an 
attractive alternative. Theophylline and nicotinamide are known to form 
cocrystals for example via solid-state grinding [2]. However, in appropriate 
conditions cocrystals can also form spontaneously [3].  
The purpose of this work was to study whether teophylline and nicotinamide 
form cocrystals spontaneously. Theophylline and nicotinamide powders were 
gently mixed manually at 1:1 molar ratio and stored at different relative humidity 
conditions. The solid state of the samples was analysed by differential scanning 
calorimetry (DSC, Mettler Toledo DSC823) and Raman spectroscopy (Kaiser 
Rxn1 equipped with a PhAT probe). Three different variations of theophylline 
were used as starting materials, e.  g., two size fractions of theophylline 
anhydrate (small: sieved through a 355 µm sieve; large: the fraction remaining 
on the sieve), and monohydrate (recrystallized from water). For reference, pure 
TP-NCT cocrystals were prepared by solid-state grinding with a Retsch MM400 
mixer mill. 
TP-NCT cocrystals can form spontaneously from manually mixed physical 
mixtures of TP and NCT during storage without any mechanical activation. For 
anhydrous samples, increasing storage humidity has an accelerating effect on 
the cocrystal formation. Particle size of the starting material was found to affect 
the cocrystal formation kinetics, especially at high relative humidity conditions. 
Polymorphism of the starting material (i.  e. TP anhydrate vs. monohydrate) 
leads to complicated solid-state behavaviour during storage, particularly when 
TP anhydrate containing samples are stored at high humidity and vice versa. 
[1]  Trask A, Motherwell W, Jones W. Physical stability enhancement of theophylline via cocrystallization. 
Int J Pharm. 2006; 320: 114–123. doi:10.1016/j.ijpharm.2006.04.018 
[2]  Lu J, Rohani S. Preparation and characterization of theophylline-nicotinamide cocrystal. Org Process 
Res Dev. 2009; 13: 1269–1275. doi:10.1021/op900047r 
[3]  Maheshwari C, Jayasankar A, Khan N, Amidon G, Rodríguez-Hornedo N. Factors that influence the 
spontaneous formation of pharmaceutical cocrystals by simply mixing solid reactants. CrystEngComm. 
2009; 11: 493–500. doi:10.1039/b812264d www.scipharm.at Scientia  Pharmaceutica  623 
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Pharmaceutical powders intended to target the deeper regions of the lung have 
to consist of particles with aerodynamic diameters in the range of 
0.5 µm - 5 µm. In such fine powders several forces, mainly Van der Waals and 
electrostatic forces, have strong influence on particle interactions. Particle 
interactions significantly determine material-loss during powder handling for 
example in mixing containers, flow-behavior of the powder and the amount of 
drug released from the inhaler. In addition to this, electrostatic charge affects 
the deposition of the powder in the lung. Since most pharmaceutical powders 
are insulators, electrostatic charge is acquired during every contact of the 
particles among themselves or with other surfaces. The phenomenon of the 
emergence of electrostatic charge in common powder handling processes has 
been investigated by several scientists such as Murtomaa [1], Rowley [2] and 
Zhu [3]. Particularly Zhu examined the charging behavior and influencing 
variables on the arising of charge of an interactive mixture of salbutamol 
sulphate and lactose monohydrate in the mixing process. 
The aim of this work is to extend these mixing studies with respect to powder 
blend composition and mixing conditions. The charging behavior is investigated 
in a T2F Turbula® mixer using a Faraday cup connected to a high resistance 
electrometer for charge measurement. When a powder is mixed the charge 
accumulates until a saturated level is reached. The sign and magnitude of the 
charge and the mixing time required to reach saturation is an important 
information in the evaluation of the charging behavior of the powder blend. The 
acquired charge is determined by several factors such as energy of mixing, 
mixing time, mixing ratio of the blend, relative humidity, particle size, material 
and wall-roughness of the mixing container. Mixing studies are carried out by 
systematically altering these factors in order to be able to perform statistical 
analysis. The results will be highly useful to improve the understanding of the 
emergence and the impact of electrostatic charge on the performance of 
pharmaceutical powders especially for pulmonary application. 
[1]  Murtomaa M, Salvolainen M, Christiansen L, Rantanen J, Laine E, Yliruusi J. Static electrification of 
powders during spray drying. J Electrostat. 2004; 62: 63–72. doi:10.1016/j.elstat.2004.05.001 
[2]  Rowley G. Quantifying electrostatic interactions in pharmaceutical solid systems. Int J Pharm. 2001; 
227: 47–55. doi:10.1016/S0378-5173(01)00784-0 
[3]  Zhu K, Tan R B H, Chen F, Ong K H, Heng P W. Influence of particle wall adhesion on particle 
electrification in mixers. Int J Pharm. 2007; 328: 22–34. doi:10.1016/j.ijpharm.2006.07.041 624 Scientia  Pharmaceutica  www.scipharm.at 
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Onychomycoses, fungal nail infections, are responsible for 50% of all nail 
disorders affecting up to 18% of general population in some countries [1]. 
Nail lacquers (also transungual therapeutic systems) represent new drug 
forms specifically designed to enable longer release and sustained action of 
active principle into the infected nail plate [2].  
We developed six formulations of nail lacquer containing 0,9% (w/v) 
fluconazole, Eudragit RS 100 and acetone. The formulations contain di-butyl 
phthalate, polyethylene glycol 400 or propylene glycol as plasticizers in two 
different concentrations. We characterized the developed formulations with 
regard to the drying time, fineness of formed film, fluconazole assay and 
viscosity.  
The drying time for the formulations with lower plasticizer content was 25 s, 
and for those with higher plasticizer content was 30 s. All developed 
formulations gave homogenous, smooth, glossy and transparent films. 
We developed simple derivative spectrophotometric method for fluconazole 
assay in all six formulations and the obtained results were in range of 97,5–
103,9% of the declared content.  
Viscosity was measured using rotating viscometer in accordance to 
Ph.Eur.6.0 [3]. The viscosity values were in range of 0,0055–0,0079 Pa×s, 
which are 50 times lower viscosity values in comparison to the cosmetic nail 
lacquers. Lower viscosities are preferred since they ensure better coverage 
and intimate contact with the nail plate leading to better therapeutic 
response. 
The obtained results comply with the standards for this type of preparations 
with regard to the drying time, film appearance, as well as good flow 
characteristics. The content of fluconazole is within usually prescribed limits 
of 100±5%. The results indicate good compatibility of the used ingredients in 
all six developed formulations. 
[1]  Baran R, Kaoukhov A. Topical antifungal drugs for the treatment of onychomycosis: an overview of 
current strategies for monotherapy and combination therapy. J Eur Acad Dermatol Venereol. 2005; 19: 
21–29. doi:10.1111/j.1468-3083.2004.00988.x 
[2]  Murdan S. Drug Delivery to the Nail Following Topical Application. Int J Pharm. 2002; 236: 1–26. 
doi:10.1016/S0378-5173(01)00989-9 
[3]  European Pharmacopoeia, 6
th Ed., Council of Europe, Strasbourg, 2007. 
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The drug release from solid matrices systems, made of polymes and drugs, is a 
basic concept for studies on controlled drug release. The most interesting class 
of polymers in this application is given by hydrogels. Matrices based on 
hydrogels, once swallowed (during the in-vitro tests, once immersed in the 
solvent mimicking body fluids), start to absorb water from the surrounding 
(water up-take) and the water causes a number of phenomena: the hydrogel 
swelling, the polymer plasticization (the lowering of the glass transition 
temperature), the increase of the diffusion coefficients, the polymer erosion (due 
to polymer chains disentanglement). As a result, the drug previously embedded 
in the matrix can be released (by diffusion into the matrix and then by 
dissolution in the outer solvent) 
 
Fig. 1. Shape and hydration levels for the 
HPMC-TP 1:1 matrices subjected to the 
hydration. Snapshot of cut matrices 
(experimental) and superimposed simulated 
profiles (model) after 12 hours of hydration. The 
initial, non-swollen half-matrices shape is a 
rectangle (diameter 13 mm, semi-thickness 1.1 
mm). 
 
In this work, a model for the drug release kinetics was pointed out. Basically, it 
consists in differential balances of drug and water in the swelling matrices. It 
takes into account all the relevant phenomena: the diffusion of drug and water 
in polymer (with diffusion coefficients that vary with water concentration in the 
solid phase), the swelling and the dissolution of the polymer (which causes the 
boundary to be moving surfaces). The resulting code reveals itself able to 
correctly quantify all the observed phenomena, in terms of water, drug and 
polymer residual masses in the device, mass fractions of the three species, 
dimensions and shape of the matrix. To our knowledge, such a complete ability 
in description was never attained before. The model, therefore, could be a 
powerful tool in designing novel controlled drug release systems. 
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Drug liberation-release from the dosage form is a  primary cause of the 
movement of a drug in the body. Pharmaceutical availability of the drug 
depends not only on the type of aditives but also on the selected concentration.  
In this study there are compared influence of the concentration of selected 
cationic surfactants on the liberation of antiseptic chlorhexidine from the 
hydrogels prepared on the chitosan basis. 
Objectives: 
–  formulation of hydrogels based on chitosan with chlorhexidine 
dihydrochloride 
–  observation and evaluation of the influence of concentrations of two cationic 
surfactants on liberation of chlorhexidine dihydrochloride 
–  selection of an apropriate concentration of cationic surfactants 
–  determination of the pH value of hydrogels 
–  design of an optimal composition of hydrogels. 
The drug released was determined by using semipermeable membrane on the 
permeating apparatus. the released amounts were determined by 
spectrophotomentric method at 254 nm from 15 min to 3 hours 
Results: 
–  As to pH ranged within 5.44-6.14 the prepared hydrogels were suitable for 
application in stomatology and dermatology. 
–  The release of chlorhexidine dihydrochloride depended on the presence and 
type of cationic surfactant and its concentration. 
–  It was shown that drug liberation increases with increasing lenght of alkyl 
chain at the 0.1 % (w/w) concentration 
–  Ten times reduction of surfactant concentration incured average increse of 
the released amount of chlorhexidine dihydrochloride by 15 %(w/w) 
–  The greatest released amount of chlorhexidine dihydrochloride was released 
from hydrogel of the following composition: 0.1% chlorhexidine dihydro-
chloride +  2.5% chitosan in the environment of lactic acid +  0.01% tetra-
decyltrimethylammonium bromide + 10% glycerol. This hydrogel was chosen 
as the most appropriate. 
This work was supported by the Grant VEGA No. 1/ 0320/ 08  
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The drugs in a dosage form is rarely alone. Usually the dosage form is a system 
of several adjuvances and these more or less influence physico-chemical 
properties and the drug effect. 
From the reason of increasing drug solubility many drugs and adjuvances have 
amphiphilic structure and are able to create associates. Since the drug is 
effective exclusively in monomeric form for formulation of a dosage form we 
need to know concentration at which the associates are created – so called 
critical micellar concentration (CMC).  
The objective of this study is to observe the effect of adjuvances on hydrogel – 
surfactant  
1-ethoxy-N,N,N-trimethyl-1-oxohexadecan-2-aminium bromide (Septonex  – 
concentration 0.01% w/w) and polymer – Chitosan (2.5% w/w) on the release of 
chlorhexidine – member of group of antiseptics (CHH – 0.01% w/w). 
Both substances – the drug and surfactant have amphiphilic structures, thus 
create micelles. CMC of the both was evaluated from conductivity and 
spectrophotometric dependences [Septonex at the temperature 25–50 °C, CMC 
increases non linearly in interval (8.07–9.59)·10
−4 mol dm
−3 and CHH at 25 °C – 
CMC = 7.25·10
−5 mol dm
−3]. 
The partition coefficients in system octanol / water were determined for both 
substances at the temperature 25 °C. Release profiles were evaluated at the 
temperature 25  °C. The released amount of drug was determined spectro-
photometrically at λ = 281 nm. 
The presence the Septonex as an adjuvance in the prepared hydrogel 
increased the amount of released drug (after 180 minutes 98.79 %) as 
compared with hydrogel containing polymer and drug only (51.9 %). 
Conclusion: Surfactant used in prepared hydrogels positive effected the drug 
release. 
This work was supported by the Grant VEGA No. 1/ 0320/ 08  
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The pharmaceutical industry currently experiences a trend towards continuous 
manufacturing as there are many advantages, including better control of 
process conditions, effectively eliminating batch-to-batch variability, and the lack 
of scale-up problems, since even bench-top continuous systems can produce 
the desired quantities required in the pharmaceutical or fine-chemicals industry. 
We present the development of continuous processes for the synthesis of active 
pharmaceutical ingredients (APIs). The set-ups include heterogeneous 
organometallic catalysts (titanocenes and Pd-complexes) that are ideally suited 
for these continuous processes. The covalent bond between the catalysts and 
the solid support effectively prevents metal leaching into the product. For this 
purpose we developed novel methods for catalyst immobilization [1, 2] including 
photolithographic techniques that allow a precise molecular control of the 
location and dispersion of the catalytic sites on the surface of the materials.  
The application of the heterogeneous catalysts for the synthesis of chiral 
amines and substituted biphenyls [3] and the successful implementation in 
different lab-scale continuous flow systems, such as packed bed reactors, 
monolithic structures and microfluidic devices, showed that the continuous flow 
setups lead to improved practicability and flexibility of the processes. Thus, 
these novel reaction systems constitute promising alternatives to existing batch 
applications.  
This work was supported by the Austrian Science Fund (Project No. 19410) 
[1]  Gruber-Woelfler H, Rivillon Amy S, Chabal YJ, Schitter G, Polo E, Ringwald M, Khinast JG. UV-
Induced Immobilization of Tethered Zirconocenes on H-terminated Silicon Surfaces. Chem Commun. 
2008; 1329–1331. doi:10.1039/b717817d 
[2]  Jeanquartier C, Schider G, Feichtenhofer S, Schwab H, Schennach R, Stettner J, Winkler A, Gruber-
Woelfler H, Schitter G,
 Eder RJP, Khinast JG. A Two-step Method to Covalently Bind Biomolecules to 
Group-IV Semiconductors: Si(111)/1,2-Epoxy-9-decene/Esterase. Langmuir. 2008; 24: 13957–13961. 
doi:10.1021/la802075t 
[3]  Gruber-Woelfler H, Radaschitz P, Feenstra P, Khinast J. Non leaching heterogeneous catalyst 
systems for coupling reactions, Patent, Application Number EP09165768.4, 07-17-2009. 
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The broad application of the tetrazole scaffold in different fields, such as general 
and coordination chemistry, material science, microbiological and medicinal 
chemistry in recent years demands robust and safe methods for their 
preparation on production scale. From the many developed methods for the 
synthesis of the tetrazole nucleus, the [3+2] cycloaddition of an azide partner to 
a nitrile is by far the most simple, atom efficient and inexpensive strategy. 
However, hydrazoic acid (HN3) and its salts are extremely toxic and many metal 
azides and hydrazoic acid itself are extremely explosive.  
Great advances in the synthesis of substituted tetrazoles were achieved since 
the first reports dating back to the mid 1950’s. Today, a variety of protocols are 
available that allow the synthesis of tetrazoles from azides and nitriles. 
However, none of these routes are suitable for a genuinely scalable production 
route, as these batch protocols often involve toxic/explosive intermediates or 
explosive sublimates, the use of toxic and/or expensive reagents or 
stoichiometric amounts of inorganic salts, in addition to long reaction times. 
Here we present a simple, safe, fast and inexpensive protocol for the synthesis 
of 5-substituted tetrazoles under continuous flow conditions. We have 
discovered that the reaction can be cleanly performed using in-situ formed 
hydrazoic acid at very high temperatures and comparatively short reaction times 
using a process intensification regime to yield tetrazole products in excellent 
yields. The details of our microreactor strategy will be discussed. 
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Continous flow processing is a key enabling technology when it comes to scale-
up microwave synthesis protocols to production scale quantities [1, 2]. 
Organic chemistry in microreactors, being generally characterized as chemistry 
in miniaturized reaction devices, comprising channel diameters below 1000 μm 
have many benefits. Mixing and heat transfer are exceptionally fast on the 
microscale, taking advantage of very short diffusion paths and a very high 
surface-to-volume ratio, which enables a very efficient heat transfer in both 
directions, flash heating, as well as excellent process control. Strongly 
exothermic reactions as well as transformations involving hazardous reactants 
or products can be handled safely on a large scale.  
Very notably, microreactor techniques can be used to overcome the scale-up 
limitations inherent to high-speed microwave batch processing in sealed 
vessels. Vice versa, microwave reactors can be used for rapid reaction 
optimization for a given transformation conducted under continuous flow 
conditions, since the reaction time at a certain temperature obtained in a 
microwave reactor can be directly translated to a residence time in a flow 
reactor. An established flow process is readily scaleable (in contrast to a batch 
process) by either extending product collection time, increasing the length of 
microchannel (thereby allowing for a higher flow rate), parallel operation of 
many identical channels (“numbering up principle”), or by a combination of 
these principles [3].  
We will present how continuous flow processing can be realized in meso-fluidic 
flow devices featuring stainless steel tubes, allowing for an exceptionally high 
operating window of up to 350 °C and 180 bar working pressure. Microwave 
reactors were advantageously used for rapid modification and optimization of 
the reactions conducted in flow reactors and directly transferred to continuous 
flow conditions. 
[1]  Damm M, Glasnov TN, Kappe CO. Translating High-Temperature Microwave Chemistry to Scalable 
Continuous Flow Processes. Org Process Res Dev. 2010; 14: 215–224. doi:10.1021/op900297e 
[2]  Razzaq T, Kappe CO. Continuous Flow Organic Synthesis under High-Temperature/Pressure 
Conditions. Chem Asian J. 2010; 5: 1274–1289. doi:10.1002/asia.201000010 
[3]  Razzaq T, Glasnov TN, Kappe CO. Accessing Novel Process Windows in a High-
Temperature/Pressure Capillary Flow Reactor. Chem Eng Technol. 2009; 32: 1702–1716. 
doi:10.1002/ceat.200900272 www.scipharm.at Scientia  Pharmaceutica  631 
Presented at the 8
th Central European Symposium on Pharmaceutical Technology, 
September 16
th–18
th 2010, Graz, Austria. 
Conference abstract PMS04 
Heterogeneous Hydrogenations  
in Continuous Flow 
M. IRFAN, T. N. GLASNOV, C. O. KAPPE 
Christian Doppler Laboratory for Microwave Chemistry (CDLMC) and Institute of Chemistry, Karl-Franzens-
University Graz, Heinrichstrasse 28, A-8010 Graz, Austria 
E-mail: muhammad.irfan@edu.uni-graz.at (M. Irfan) 
Sci Pharm. 2010; 78: 631        doi:10.3797/scipharm.cespt.8.PMS04 
Catalytic heterogeneous hydrogenation processes arguably belong to the most 
valuable synthetic transformations known. Current batch reactor technology is 
not only time consuming and difficult to set up but also catalyst addition and 
filtration is hazardous. Because of the aromatic character of many substrates, 
hydrogenation often requires the use of significant hydrogen pressures in 
combination with elevated temperatures and extended reaction times.  
In this context, continuous flow hydrogenation technology presents an attractive 
alternative to batch processing and the recent introduction of the H-Cube
TM – a 
continuous flow hydrogenation device incorporating in-situ hydrogen generation 
and pre-packed catalyst cartridges – has provided a safe and reliable method 
for performing hydrogenation reactions [1, 2]. 
In this poster we investigate the hydrogenations of olefins and heterocyclic 
aromatic rings. In general, the hydrogenations proceeded smoothly independent 
from the choice of the supported precious metal catalyst (Pd/C, Pt/C or Rh/C). 
Using 30–80 bar of hydrogen pressure at 60–80 °C full conversion was typically 
achieved in all cases at a flow rate of 0.5 mL min
−1 providing the corresponding 
piperidines in high yields. For disubstituted pyridines variations in stereoselec-
tivity were observed depending on both the metal catalyst and on the tempera-
ture/pressure in the reaction. For ethyl nicotinate the selectivity between partial 
and full hydrogenation could be tuned depending on hydrogen pressure and the 
choice of the supported metal catalyst. Changing the hydrogen source from 
H2O to D2O allowed the preparation of deuterated derivatives [3].  
N
R
N
H
R
N
H
CO2Et
for R = 3-CO2Et
Flow hydrogenation:
Pd/C, H2 (30 bar)
EtOH, r.t.
Flow hydrogenation:
Pt/C, H2 (100 bar)
AcOH, 100°C
Flow hydrogenation:
Pt/C, H2 (30–90 bar), AcOH, 60–80°C
 
[1]  Desai B, Kappe CO. Heterogeneous Hydrogenation Reactions Using a Continuous Flow High 
Pressure Device. J Comb Chem. 2005; 7: 641–643. doi:10.1021/cc050076x 
[2]  Desai B, Dallinger D, Kappe CO. Microwave-Assisted Solution Phase Synthesis of Dihydro- pyrimidine 
C5 Amides and Esters. Tetrahedron. 2006; 62: 4651–4664. doi:10.1016/j.tet.2005.12.061 
[3]  Irfan M, Petricci E, Glasnov TN, Taddei M, Kappe CO. Continuous Flow Hydrogenation of 
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Efficient and effective powder mixing is an essential part of pharmaceutical 
manufacture. Positron emitting isotopes enable particles to be followed singly or 
in groups during mixing processes, using Positron Emission Particle Tracking 
(PEPT) or Positron Emission Tomography (PET) respectively. This paper 
shows how the two techniques can be adapted to pharmaceutical mixing 
operations and describes their application to mixing in V-mixers and bin-
blenders. PEPT enables particle trajectories to be determined and methods of 
using trajectory information to quantify mixing are described. www.scipharm.at Scientia  Pharmaceutica  633 
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Solid particle mixing is an important unit operation in process industry. In 
pharmaceutical industry it is of particular importance because the Active 
Pharmaceutical Ingredient (API) has to be properly mixed which is normally in 
the quantity of few milligrams in the final dosage form, and if not mixed properly 
can have no or severe therapeutic effects depending on API quantity.  
Particle mixing is usually perceived as a simple unit operation because it does 
not involve any high-tech and complicated equipment but this operation is still 
under spotlight of latest research to understand complexity of the underlying 
physical phenomena. Mixing of solid particles depends on several parameters 
like nature of the material of the particles, their size, shape, number, and 
loading/unloading profile. It also depends on the size, shape, and material of the 
mixer container and likewise the size, shape, and material of the blades, fill 
level, position of the blade from bottom of the mixer, its speed, acceleration, any 
external surfaces/obstacles e. g. baffles present, phases involved, nature of the 
fluid (Newtonian or non-Newtonian) and its physical conditions like viscosity, 
surface tension, temperature, and pressure etc. Scale-up of powder flows and 
mixing is also a big issue because even small changes e.  g. in equipment 
material, may change the powder flow and hence the mixing. Because of the 
number of parameters involved, mixing processes become complicated and 
expensive to understand experimentally. 
In these mixing simulations of solid particles, DEM (Discrete Element Method) is 
used which treats every particle discretely and solves for each particle’s 
position, velocity, and all the forces acting on it including contact forces, body 
forces, hydrodynamic forces and cohesive forces. In this presentation, some 
physical parameters affecting mixing like blade rake angles, size of particles, 
and their loading profile will be studied by setting up a number of simulation 
cases for dry particles. First, velocity profiles for these mixing simulations will be 
analyzed and then the effects of blade rake angles, size of particles and their 
loading profile on mixing will be studied by calculating mixing index for each 
case. 
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Diffuse reflectance near-infrared (NIR) spectroscopy is a non-invasive and 
widely used technology with the potential for a wide range of applications in the 
pharmaceutical industry, ranging from raw material identification to final product 
qualification. Especially powder blending processes, as one of the key unit 
operations for solid dosage forms can be monitored in real-time for the blend 
quality and blending time until uniformity. Common NIR systems enable single 
point measurements at dedicated positions of the blender, based on the 
assumption, that the sampled position represents the whole blend. This is a 
problematic task as the mixing characteristics of powders significantly change 
(e. g., segregation, agglomeration, etc.) with the process parameters.  
Here we introduce, a new process analytical technology (PAT) setup for a 
spatially resolved quasi-simultaneous process monitoring for batch and 
continuous manufacturing processes. Therefore, an FT-NIR spectrometer was 
combined with an optical multiplexer, simultaneously switching the excitation 
and detection path of the bifurcated fibers, which can be connected to a blender 
via sapphire sampling ports at different positions. Different multi-component 
powder mixing processes were investigated and quantitatively analyzed with 
multivariate data analysis (MVDA) using software packages of CAMO and 
Umetrics, which also support real-time process monitoring. 
The new flexible PAT setup presented here, enables non-invasive in-line and 
real-time monitoring of dynamic processes, especially where spatial deviations 
can be expected e. g., segregation in solids (i. e., powder blends) and liquids 
(i. e., sedimentation).  
 
[1]  Balak N, Koller DM, Khinast JG. Spatially Resolved Real-time Monitoring of Pharmaceutical 
Processes with a Multiple NIR-Probe Setup; in preparation. www.scipharm.at Scientia  Pharmaceutica  635 
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The application of process analytical technology (PAT) has opened the 
possibility for continuous process monitoring and quality control in the 
pharmaceutical industry.  
Transporting and mixing of pharmaceutical powders is a challenging task and 
changes significantly with the mixer type and with the process scale up. 
Therefore knowledge about the critical process parameters (CPPs) with respect 
to the powder and their influence on the mixing behavior are essential. 
Traditional powder tests (e. g., shear cell, flow through a funnel, etc.) often lack 
reproducibility and depend strongly on the operator. In contrast to these powder 
characterization methods, here, an FT4 powder rheometer (Freeman 
Technology) was applied to determine standardized and repeatible results for 
powder properties, e.  g., shear properties, permeability, cohesion, 
compressibility, etc.  
Based on design of experiment (DoE), an experimental design was developed, 
testing a recent amount of parameters, which were evaluated for their 
responses on forming a uniform blend in a mixing process. Continuous process 
monitoring of the blending processes with near-infrared (NIR) spectroscopy 
allowed a non-destructive investigation of blend quality and mixing dynamics. 
Evaluation of the spectral data was performed with qualitative and quantitative 
multivariate data analysis (MVDA) methods, in order to look for correlations 
between FT4 parameters and blend quality. 
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Fluid mixing and dissolution processes are still an area of ongoing research. 
Numerical simulations have proven to be a valuable tool in understanding and 
optimizing industrial mixing problems [1]. Computational Fluid Dynamics (CFD) 
is a well-developed and validated method that is frequently applied in many 
different fields of applications. Nevertheless, for more complex applications 
(e. g. industrial mixing) there is still much work left to be done until CFD can be 
effectively applied as engineering tool providing reliable results in reasonably 
short calculation times. In this contribution we focus on mixing and dissolution of 
a bulk powder in a solution inside a stirred tank reactor.  
In our work the dissolution kinetics of solids in water were measured in a stirred 
tank reactor utilising inline Near Infrared (NIR) spectroscopy. The dissolution 
rate can thus be determined as a function of the powder and process properties 
such as particle size distribution, solution temperature, impeller speed, and 
concentrations of the solution. 
A dissolution model was derived from the analytical investigations and 
implemented in the CFD code AVL FIRE. The dissolution test mentioned above 
was simulated with the CFD method in order to validate the dissolution model.  
Due to the fact that real-time CFD simulations of mixing processes are very 
time–consuming, the dissolution rate of the particles was accelerated in the 
simulation process and the calculation time was thus reduced. The 
concentration of a passive scalar is used as a measure for the mass fraction of 
the dissolving solid particles. This approach allows an analysis of the variation 
of mixing parameters, and the respective effect on the mixing performance, 
respectively. 
Finally industrial mixing and dissolution processes can be investigated and 
optimized by applying CFD simulations. In addition, NIR inline measurement 
techniques enable real-time analysis of the mixing status. Industrial mixing 
process can thus be controlled by Process Analytical Technology (PAT). 
[1]  Marshall EM, Bakker A. 2002. Computational Fluid Mixing. Fluent Inc., Lebanon, New Hampshire, 
USA 
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In the pharmaceutical sciences, interfacial phenomena play an important role in 
the processing of a wide variety of formulations, such as in the blending of solid 
materials. The surface energies can be utilized in the formulation of wet 
granulation processes in order to select a suitable device and to predict the 
properties of the resulting granules. The success of granulation depends on the 
spreading of the liquid and/or solid over the solid. In the method of Wu [1], the 
surface free energy is taken as the sum of dispersive and polar components. 
The surface free energies of solid materials can be determined by means of 
contact angle measurements on two liquids with known polarities. If the surface 
free energies of the solid materials are known, the spreading coefficient may be 
computed and the interactions between the two materials may be predicted. 
The spreading coefficient is calculated as the difference between the work of 
adhesion and the work of cohesion. The spreading coefficient (S12) of a material 
(1) over the surface of another material (2) can be determined as [2]: 
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The purpose of this study was to investigate a device suitable for wet 
granulation via determination of the spreading coefficient. Contact angle 
measurements were carried out with an optical contact angle measuring 
instrument (OCA 20, DataPhysics Instruments GmbH, Filderstadt, Germany). 
The results were applied to calculate the surface free energy and the spreading 
coefficient according to the above-mentioned Wu method. 
Granules were produced in a high-shear granulator (Pro-C-epT 4M8, Zelzate, 
Belgium). A lower work of adhesion was found in a steel vessel as compared 
with a glass process vessel. 
This work was supported by Evonik Industries AG. 
[1]  Wu S. Calculation of interfacial tension in polymer systems. J Polym Sci. 1971; 34: 19–30. 
doi:10.1002/polc.5070340105 
[2]  Rowe RC. Binder–substrate interactions in granulation: a theoretical approach based on surface free 
energy and polarity. Int J Pharm. 1989; 52: 149–154. doi:10.1016/0378-5173(89)90289-5 
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Introduction: Hot-melt granulation techniques have received increasing attention 
due to the significant advantages compared to the conventional granulation 
methods. Fluidized hot melt granulation (FHMG) is recognized as promising 
technique, but there is still lack of information related to this topic [1]. The aim of 
the present study was to investigate the influence of process and formulation 
parameters on granule characteristics and paracetamol dissolution from tablets.  
Experimental methods: Granulation process was performed in Mycrolab fluid 
bed processor, OYSTAR Hüttlin. Precirol ATO 5 (Gattefossé, France) and PEG 
2000 (Fluka AG, Switzerland) were used as meltable binders that were initially 
present as discrete particles within fluidized bed. The effects of binder content, 
particle size of the binder, granulation time, and the inlet air speed on the 
granule flow properties (Carr index) and drug dissolution parameters (T40, T80) 
were investigated using factorial design.  
Results and discussion: Formulations with Precirol ATO 5 showed considerably 
slower drug release due to the forming of the lipid matrix. The binder content 
had significant influence on granule properties, as well as on drug release rate 
in the case of both formulations with Precirol ATO 5 and formulations with PEG 
2000. Concerning the paracetamol dissolution from tablets prepared with 
Precirol ATO 5, particle size and granulation were also found to be significant 
factors. Furthermore, two-factor interaction between the binder content and the 
particle size was identified.  
Conclusion: FHMG is simple and rapid granulation technique that enables a 
formulator to manipulate drug release rate depending on the nature and 
concentration of the meltable binder.  
[1]  Andrews GP. Advances in solid dosage form manufacturing technology. Philos Trans R Soc Lond A. 
2007; 365: 2935–2949. doi:10.1098/rsta.2007.0014 
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The Leistritz Micro Pelletizer (LMP) is a tool to cut extrudates from a twin-screw 
extruder to a defined shape and size. The purpose of this study was to evaluate 
the influence of the parameters to the granual properties in a wet granulation 
process. 3³ experimental design was applied. 
A formulation consisting of 40% microcrystalline cellulose (MCC M101, 
Pharmatrans Sanaq, Switzerland) and 60% lactose (Granulac 200, Meggle, 
Germany) was used. A preblend was transferred to the gravimetric powder 
feeder of the twin-screw extruder (18GL-40D, Leistritz, Germany). The extrusion 
took place at a constant powder feed rate of 25g/min and different liquid feed 
rates. Deionized water was used as granulation liquid. The Pelletizer (Leistritz 
Micro Pelletizer, Leistritz, Germany) cut the extrudates when emerging from the 
orifices of the die-head, using variable cutting blade speed. Image analysis was 
conducted by using the Camsizer (Retsch Technology, Germany). 
The study dealt with the effect of 3 different process parameters – screw speed, 
liquid feed rate and cutting blade speed – on the pellet shape and size. These 
parameters were varied systematically in a 3³ full factorial design. In addition, 3 
experiments were performed at the center point in order to approximate the 
reproducibility. 
The regression model was simplified by a backward regression. The pellet size 
and the pellet shape were characterized by equivalent diameter and aspect 
ratio, respectively. The most spherical pellets were obtained by using a liquid 
feed rate of 0.95kg/h and a cutting blade speed of 2500rpm. In the variance 
analysis, the cutting blade speed and the screw speed were insignificant, 
whereas the liquid feed rate had an effect to the pellet shape and size. 
One of 3 investigated process parameters affected the pellet properties. Neither 
the screw speed nor the cutting blade speed showed an influence on the pellet 
shape and size. The liquid feed rate was crucial in the used experimental setup. 
The continuous granulation process using the Leistritz Micro Pelletizer (LMP) in 
combination with the twin-screw Extruder (Leistritz 18GL-40D) was robust and 
reliable. 
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Pellet manufacturing by extrusion/spheronisation is quite common in the 
pharmaceutical field because the obtained product is characterized by a high 
spericity as well as a narrow particle size distribution. After extrusion of the bulk 
material, the cylindrically shaped extrudates are transferred to the spheronizer, 
where they are plastically deformed into spherical pellets. The established 
mechanisms [1, 2] only consider deformation of the initial particles but do not 
account for mass transfer between the particles as a factor in achieving 
spherical particles.  
This study investigates methods for visualizing and understanding the 
interparticle interactions and a possible mass transfer during the spheronisation 
step. Therefore, two common pelletization aids (Microcrystalline cellulose 
(MCC), kappa – carrageen) were used in combination with lactose as a filler. To 
visualize the interparticle exchanges of mass during the spheronization process, 
different colored extrudates were spheronized simultaneously, and the color 
change of the different particles was monitored. 
The data obtained indicated that mass transfer between particles must be 
considered in addition to plastic deformation in order to capture the 
spheronization mechanism. A material transfer between pellet particles was 
observed in all investigations (fig. 1). Moreover, the images show regional 
distinctions in the amount of mass transfer. There seems to be an equatorial 
zone with a higher probability for agglomeration than at the former edges of the 
extrudate.  
In conclusion, the commonly espoused pelletization mechanisms need to be 
extended to account for material transfer between pellet particles, which has not 
been considered before. 
 
Fig. 1. Images of samples taken during spheronization after different for a pure MCC 
formulation 
[1]  Rowe R.C. Spheronization: a novel pill-making pocess?. Pharm Int. 1985; 6: 119–123.  
[2]  Baert L. Vervaet C. Remon J.P. Extrusion-spheronisation A litrature review. Int J Pharm. 1995; 116: 
131–146. doi:10.1016/0378-5173(94)00311-R www.scipharm.at Scientia  Pharmaceutica  641 
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The problem emerging from particle coating is how to manufacture particles with 
just enough material deposited to achive the desired result [1]. Especially in 
case of functional coatings, the uniformity of coating thickness over the entire 
particle surface plays an important role. In our study the performance of two 
bottom spray coaters and the effect of the particle motion on the coating 
uniformity were evaluated for the pellets with wide size distribution. In the first 
case the traditional Wurster coater was employed, while in the second one the 
coater with a swirl flow generator was used. Pellets (Cellets
®, Syntapharm, 
Germany) of four different sieved fractions (300–400, 500–600, 700–800 and 
900–1000 µm) were used in each coating experiment. Fractions of pellets 
comprising the bed were separated after dye dispersion coating, using the same 
sieves as used in the preparation of starting cores. Spectrofotometric evaluation 
of the dye concentration on the population of pellets from each fraction of every 
experiment was done. Results confirmed the fact that pellets having smaller 
diameter receive significantly less coating material compared to the larger ones 
when using conventional bottom spray coater with Wurster insert [2]. The ratio 
of mass of coating deposited on the pellet to the pellet surface indicates the 
coating thickness to be much more evenly distributed over the pellets coated 
with the use of swirl flow generator equipped coating chamber. For example the 
values of dye per particle surface varied from 0.88 for smallest fraction to 
2.12 µg/mm
2 for largest fraction in case of conventional Wurster coating cham-
ber and only from 1.21 to 1.79 µg/mm
2 in case of application of swirling airflow 
generator. These results also indicate that the amount of dye deposited per 
particle is in a strong correlation with the particle diameter to the power of 2.36 
in case of coater with swirl airfow, compared to the value of 2.85 obtained by a 
conventional bottom spray coater. The amount of dye per pellet would ideally be 
in correlation with pellet surface (d
2,00), which makes swirl flow coater more 
suitable for coating particles with wide size distribution. The improvement in the 
yield of the process was also observed in the case of swirling airflow coater. 
[1]  Chan L, Tang ES, Heng PW. Comparative study of the fluid dynamics of bottom spray fluid bed 
coaters. AAPS PharmSciTech. 2006; 7: E37. doi:10.1208/pt070237 
[2]  Sudsakorn K, Turton R. Nonuniformity of particle coating on a size distribution of particles in a 
fluidized bed coater. Powder Technol. 2000; 110: 37–43. doi:10.1016/S0032-5910(99)00266-1 642 Scientia  Pharmaceutica  www.scipharm.at 
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Coated multiparticulate systems are increasingly popular on the market. Their 
manufacture in a fluid bed often requires polymer binders. Polymers have been 
widely studied as inhibitors of crystallization [1]. Migration of drugs into the 
coating layer has also been described [2] but the influence of the coating 
polymers on the crystallization of the drug is yet to be studied in more depth. 
In our experiments we studied the thermal behaviour of diltiazem hydrochloride-
layered pellets before and after coating. The multiparticulate pellet samples 
were prepared in a Strea-1 (Niro Aeromatic, Bubendorf, Switzerland) fluid bed 
Wurster chamber. Acryl-EZE dispersion (a fully formulated USP copolymer type 
C coating system) was prepared and applied following the guidelines provided 
by the manufacturer as a 20% aquous dispersion. The thermoanalytical 
examinations were carried out with a Mettler-Toledo 821
e instrument with a 
dynamic method in the interval of 0–400°C, at a heating rate of 10°C/minute. 
We found that the coated samples exhibited an exothermic peak between 90-
110°C that wasn’t characteristic of any of the used materials. Further examina-
tions suggested that the exothermic peak is the result of recrystallization; this 
theory was tested with XRD. Results showed that the uncoated drug-containing 
pellets contained only a relatively small amount of the crystalline drug. Coated 
samples behaved similarly. XRD examinations after heating the samples to 
120°C (above the range of the exothermic peak) showed a definite increase in 
the crystallinity of the drug. Thermal examinations showed a correlation 
between the thickness of the coating and the extent of recrystallization.  
One explanation of the above is that the water-soluable drug dissolves into the 
aqueous coating dispersion on the surface of the pellets during the coating and 
crystallizes only in a small extent as the film is dryed; most of the drug forms a 
molecular dispersion in the film. Crystallization is completed only on heating, as 
can also be proven by microscopic evidence. 
This work was supported by “Stiftung Aktion Österreich-Ungarn“. 
[1]  Bruce C, Fegely K A, Rajabi-Siahboomi A R, McGinity J W. Crystal growth formation in melt 
extrudates. Int J Pharm. 2007; 341: 162–172. doi:10.1016/j.ijpharm.2007.04.008  
[2]  Heinicke G, Schwartz J B. The Influence of Surfactants and Additives on Drug Release from a 
Cationic Eudragit Coated Multiparticulate Diltiazem Formulation. Pharm Dev Technol. 2007; 12: 381–
389. doi:10.1080/10837450701369170  
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  Flows encountered in processes involving turbulent bubbly flow are highly 
complex, especially when the gas holdup and gas-liquid interface mobility are 
such that coalescence and breakup of bubbles take place. These phenomena 
have an enormous impact on the performance and productivity of the 
processes. Attempts have been made by researchers to gain insight in the 
hydrodynamics of bubbly flows by detailed numerical simulation. However, 
resolving coalescence and breakup has often been ignored due to their large 
computational requirements.  
The goal of this presentation is to assess the feasibility of using computational 
fluid dynamics (CFD) modeling as an engineering tool for analyzing, designing 
and scale-up of processes involving bubbly flow with coalescence and breakup 
of bubbles. The parallel and highly efficient modeling technique for bubbly flows 
described in the work of Sungkorn et al. [1] was extended to incorporate 
coalescence and breakup phenomena. The continuous liquid phase is 
simulated using the lattice Boltzmann (LB) scheme originally developed by 
Derksen and Van den Akker [2]. The trajectory of the individual bubbles is 
tracked by solving their equations of motion including the effect of the fluid 
fluctuation along the bubble trajectory. Bubble-bubble collisions as well as 
coalescences are described based on the stochastic inter-particle collision 
model according to kinetic theory. The breakup of bubbles is considered using a 
model based on the local size of turbulent eddies.  
Simulations of gas-liquid flow in a bubble column have been performed. The 
simulations provide detailed insight for the liquid flow field as well as the gas 
dispersion pattern. The accuracy of the simulations is demonstrated by 
comparing the predictions with experimental data. Additionally, excellent 
speedup and scalability on parallel computing platforms demonstrate the 
capability of the present modeling technique for simulations of large-scale 
reactors. 
[1]  Sungkorn R, Derksen JJ, Khinast JG. Modeling of turbulent gas-liquid bubbly flows. To be submitted 
to AIChE J. 
[2]  Derksen JJ, Van den Akker HEA. Large eddy simulations on the flow driven by a Rushton turbine. 
AIChE J. 1999; 45: 209–221. doi:10.1002/aic.690450202 644 Scientia  Pharmaceutica  www.scipharm.at 
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Granular flows are extremely important for the pharmaceutical and chemical 
industry, as well as for other scientific branches dealing with granular media. 
Thus, the understanding of the impact of particle size and related effects on the 
mean as well as on the fluctuating flow field in granular flows is critical for 
design and optimization of powder processing. 
We use a specialized simulation tool written in C and CUDA, a massive 
parallelization technique which runs on the Graphics Processing Unit (GPU). It 
was chosen to be able to simulate significantly higher amounts of particles in 
acceptable runtime. 
We focus on flow fields and wet-mixing properties obtained in the lower million 
particle range. In our talk, we present simulation results of a pitched blade mixer 
on a laboratory scale. Particles with a medium particle size of 365 micrometers 
are blended at 30–60 rpm for several turns (> 10 revolutions). The GPU 
implementation enable the DEM simulation of quartz powders in the real 
geometric resolution. In order to investigate the mixing process during the 
continuous spraying of a liquid, the DEM code was extended suitable. Liquid 
films and bridges implement the spread of the fluid in the aggregates. 
Depending on the wetness level on particle surfaces, capillary forces account 
for cohesion and agglomeration. The simulations will shed light on the optimum 
location and the type of fluid entry, and allow predictions about the time until a 
homogeneous moisture distribution in a blended bulk can be achieved. 
 Complex process engineering like drying of fluidized particles in hot air streams 
is a huge challenge for numerical simulations. Highly resolved two-phase flow of 
one million particles will be investigated. Here we focus on both, a gas-phase 
simulated using the Lattice Boltzmann Method (LBM) and a coupled solid-phase 
of discrete particles, simulated by using Discrete Element method (DEM). 
Subgrid scale two-way coupling of liquid and solid flow allows the investigation 
of residence time as well as other important process parameters and the 
prediction of an optimum operation regime. 
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Particle coating using fluid bed technology such as Wurster chamber is a 
common process in pharmaceutical technology. Coatings are used to achieve 
variety of functions, such as: taste masking, controlled release, increase of 
stability and others. Coating uniformity is one of the most important parameters 
of coated particles and can play an important role in the release of the active 
ingredient and is a result of number of process settings and material properties 
[1,  2]. One of the material parameter that effects particle movement and 
consequent coating is coefficient of restitution, which is defined as the ratio of 
particle velocity before and after the impact [3]. 
We have analysed the effect of coefficient of restitution on particle distribution 
and their velocity in the Wurster process chamber. Simulations were performed 
on a 2D axisymetric model using Ansys Fluent. Euler-Euler approach was used 
for simulation of gas and solid phase. The particle size was set at 1 mm and the 
coefficient of restitution was set from 0,1 to 1,0 in 0,1 steps. All other process 
parameters such as fluidizing and atomizing air flow were kept constant.10 s of 
two-phase flow was calculated in each simulation using timestep of 2.5*10
−5 s, 
starting from the same initial condition. 
The analysis of the simulation has established that in most cases higher values 
of coefficient of restitution increase the particle volume fraction in the coating 
region of the chamber. The lowest value of volume fraction of particles in the 
coating region was 6.82% and the highest was 9.41%. It was established that 
coefficient of restitution has effect on particle velocity and flow rate through the 
coating region, however far less pronounced as in the case of volume fraction, 
which is one of the main factors that affects uniformity of coating. Therefore, 
according to our findings elastic properties of the particles can affect the 
outcome of the coating process i. e. coating functionality, even when using the 
same process chamber and process parameters. 
[1]  Cheng X, Turton R. The prediction of variability occurring in fluidized bed coating equipment. I. The 
measurement of particle circulation rates in a bottom-spray fluidized bed coater. Pharm Dev Technol. 
2000; 5: 311–322. doi:10.1081/pdt-100100546 
[2]  Dreu R, Perpar B, Zun I, Srcic S. Influence of hydrodynamic conditions in Wurster chamber on 
uniformity of the pellet film coating thickness. Eur J Pharm Sci. 2005; 25: S92–S94. 
doi:10.1016/j.ejps.2005.04.007 
[3]  Du W, Bao X, Xu J, Wei W. Computational fluid dynamics (CFD) modeling of spouted bed: Influence 
of frictional stress, maximum packing limit and coefficient of restitution of particles. Chem Eng Sci. 
2006; 61: 4558–4570. doi:10.1016/j.ces.2006.02.028 646 Scientia  Pharmaceutica  www.scipharm.at 
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Purpose: The aim of this study was to investigate the possibility of using 
Polyox® as the binding and/or coating agent for paracetamol sustained release 
formulation development. 
Methods: Paracetamol granules were prepared in fluidized-bed apparatus, 
using different ratios of Polyox® as binding agent. Granules were coated with 
Polyox® solution by applying the bottom spray fluidized-bed technique. Tablets 
were prepared by compressing coated granulates with an excenter tablet press. 
For comparison purposes, sample tablets were also prepared by direct 
compression of the homogeneous mixture of paracetamol, Polyox® and 
microcrystalline cellulose. In vitro release studies were performed in the paddle 
dissolution apparatus, using USP phosphate buffer pH 5.8.  
Results: The rate of drug release from Polyox® based formulations was 
determined by swelling and diffusion through the gel layer formed. Dissolution 
study results of coated granules show that an increased Polyox® level in the 
formulation resulted in a markedly decreased drug release rate. Similarly, 
tablets made from coated granules exhibited slower and additionally decreased 
drug release compared to uncompressed granules [1, 2]. The in vitro dissolution 
rate of all the investigated granules and tablets was slower than drug release 
from the corresponding physical mixtures of the drug and polymer. Also, the 
results of dissolution studies show certain difference among the tablets made 
from coated and/or uncoated granulates. 
Conclusion: The results obtained indicate the potential use of Polyox® polymer 
as the binding and coating agent in the sustained release tablet formulation.  
Acknowledgement:  This work was supported by the Ministry of Science and 
Technological Development, Republic of Serbia project TR23015. 
[1]  Maggi L, Bruni R, Conte U. High molecular weight polyethylene oxides (PEOs) as an alternative to 
HPMC in controlled release dosage forms. Int J Pharm. 2000; 195: 229–238. doi:10.1016/S0378-
5173(99)00402-0 
[2]  Sentry®Polyox®-Products Regulatory Data Sheet, The Dow Chemical Company, US www.scipharm.at Scientia  Pharmaceutica  647 
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In recent years, the interest in melt granulation has increased due to the 
advantages of this technique respect to traditional wet granulation; utilizable 
equipments for melt granulation are high-shear mixer and fluidised bed [1].  
The aim of the study was to evaluate, by asymmetrical factorial design [2], the 
contribution of some variables on the in situ melt granulation process performed 
in fluidised bed in order to identify the critical parameters that influence the 
granule properties and the process.  
The experiments have been performed in a lab scale apparatus (Mini-Glatt), 
employing spray dried lactose monohydrate as filler. Six factors were studied at 
different levels: the binder type was evaluated at 2 levels (Lutrol F68 and Lutrol 
F127), while the percentage of the binder, the size of the binder particles, the 
inlet air temperature, the inlet air rate and the granulation time were studied at 3 
levels. The 16 experiments were run randomly in duplicate. Five variables were 
selected as experimental responses: the total process time, the yield, the 
particle size (d50), the friability and the flowability of the produced granules. 
The analysis of the results showed that the percentage of the binder, the inlet 
air temperature and the inlet air rate significantly influenced all the experimental 
responses, while the binder type, the size of the binder and the granulation time 
had minor “weight” on the entire process. Five additional tests allowed to 
assess the validity of the screening.  
In conclusion the factorial design results permitted to identify the most important 
variables of the in situ melt granulation process in fluidised bed. These findings 
result crucial for the ongoing further optimisation phase of the process. 
[1]  Passerini N, Calogerà G, Albertini B, Rodriguez L. Melt granulation of pharmaceutical powders: A 
comparison of high-shear mixer and fluidised bed process. Int J Pharm. 2010; 391: 177–186. 
doi:10.1016/j.ijpharm.2010.03.013  
[2]  Voinovich D, Campisi B, Moneghini M, Vincenzi C, Phan-Tan-Luu R. Screening of high shear mixer 
melt granulation process variables using an asymmetrical factorial design. Int J Pharm. 1999; 190: 73–
81. doi:10.1016/S0378-5173(99)00278-1 648 Scientia  Pharmaceutica  www.scipharm.at 
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One of several different ways to quantify the compactibility of pharmaceutical 
powders is the calculation of Pr [1], where tensile strength (σx) is normalized 
with the specific work (Wspec) of tablet compression (Equation 1): 
Eq. 1. 
m E
σ
W
σ X
spec
X
/
Pr
2
= =  
in which Wspec is expressed as effective work (E2) invested in the compression 
of the unit mass of substance (m). E2 represents the area of hysteresis between 
compression and decompression curves in force-displacement measurements 
during tablet compression cycle. 
In our previous experiments [2] we have noticed that the Pr is dependent on the 
maximum compression pressure used to produce the tablet, where Pr increases 
with compression pressure until a plateau is reached. This phenomenon is 
unwanted from a practical point of view, because it makes the comparison of 
results very difficult. It has been established, that both tensile strength and 
specific work yield a linear relationship with compression pressure, so Pr can be 
described as a quotient between two linear functions and is expected to be a 
constant value. However, the two linear functions do not go through origin of the 
co-ordinate system. Both functions have a negative y-intercept, which is the 
mathematical reason for apparent Pr dependence on compression pressure. 
We propose a modification, indexed as Pr’  (Equation 2), based on the limit 
value of Pr: 
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where SLOPEs are the slopes of the two linear functions; P1 and P2 are two 
different compression pressures. In the compression pressure range from 68 to 
211 MPa the Pr’ represents asymptotic value of Pr in plateau region, validating 
the equation. This modification enables the comparison of compactibility 
independently from the compression pressure.  
[1]  Révész P, Hódi K, Miseta M, Selmeczi B. Production of tablets by direct compressing, Compressibility 
of active ingredients and auxiliary materials. Gyógyszerészet. 1991; 35: 215–218. 
[2] Ilić I, Kása P, Dreu R, Pintye-Hódi K, Srčič S. The compressibiltiy and compactibility of different types 
of lactose. Drug Dev Ind Pharm. 2009; 35: 1271–1280. doi:10.1080/03639040902932945 
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The formulation of solid oral dosage forms significantly determines the release 
rate of active pharmaceutical ingredients (APIs). The release characteristics of 
the API are controled by the excipients in the tablet and the tablet 
microstructure. Computational simulation of tablet dissolution enables tablet 
designs and formulations to be tested quickly without resorting to many 
experiments. Crucially, the model offers a method of mapping the available 
design space with respect to both tablet composition and tablet geometry 
enabling parametric sensitivity studies to be carried out. This also enables the 
inverse problem to be solved i. e. for a desired API release rate, the model 
calculates the tablet composition and/or tablet geometry which achieves this. 
The presented model discretises tablets using a grid of volume elements (for 
non swelling polymers) or discrete element method (DEM) (for swelling 
polymers), enabling the tablet microstructure to be explicitly defined. Mass 
transfer between volume elements is carried out using Fick's law with per-
component porosity dependent diffusion coefficients. A concentration boundary 
layer is situated around the tablet whose thickness is defined by the Sherwood 
number based on flow conditions. Material diffusing across the boundary is 
considered released and plotted over time to form component release curves. 
Optimisation minimises the difference between the simulated API release curve 
and the target release curve using the mean squared error and the downhill 
simplex method. This method can be used to find pure component parameters 
from dissolution experiments or can be used to optimise tablet formulations by 
adjusting one or more parameters. In this work, the method was applied to 
optimise a tablet formulation such that it meets a specified API release time. 
The tablet formulation contained a disintegrant whose fraction was varied in 
order to change this time. Two release times were specified (fast and slow) and 
the resulting formulations were then tested with dissolution experiments to 
validate the simulation. 
The model demonstrates that optimisation can be applied to tablet formulation, 
leading to better Quality by Design (QbD) and faster realisation of custom 
formulations.  
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Aim: The “Drill&Fill”-Method is a suitable method to radiolabel compact dosage 
forms, such as tablets, and further to investigate their comportment in the 
human organism. Therefore, a hole is drilled into the tablet and filled with 
radioactive liquid. The hole is sealed with antiabsorbable glue. Hence, the 
radioactivity labels the tablet and allows its visualisation in the body using 
scintigraphy. The aim of the study was the evaluation and validation of a 
“Drill&Fill”-method for enteric coated tablets for a clinical study of dosage 
modification. Thereby the mandatory conditions were:  
–  The drill loss must be ≤3.0% and ≤32mg, respectively.  
–  No damaging of the coating through the drilling and filling.  
–  A uniform radiolabelling should be warranted.  
–  The labelled tablets must not differ from the not labelled tablets in the 
dissolution test. 
–  A suitable amount of radioactivity had to be determined to allow the 
visualisation of the tablet in the human body over 36 hours (study design: 3 
tablet/day, max. radiation dosage/day: 10MBq) 
Material & Methods: The tablet’s dimension was 18x 9x 5mm and it had a 
weight of approximately 1 gram. Drill: The hole was drilled using an electric drill 
(Proxxon
®). Fill: The drill hole was filled with 99m-Tc-DTPA using a Hamilton 
syringe. Subsequently the drill hole was sealed with cyanacrylate glue (Pattex
® 
Blitz Sekundenkleber) and air-dried. Thereafter, the activity of the tablet was 
assessed in a PTW Curiementor 2. The method was validated on the basis of 
80 tablets.  
Results: For ideal filling conditions the drill hole had to be 12mm deep with a 
diameter of 1.5mm. The drill loss was 28.78mg  ±0.4 and 2.64%  ±0.04, 
respectively. The volume of 99m-Tc-DTPA in the hole was 21.92µl ±2.1. The 
glue was air dried for 90 minutes in order to assure a complete drying-out of the 
glue. The activity after drying was 2.77MBq ±0.4. The dissolution test showed 
no difference between drilled and intact tablets. 
Conclusion: All required conditions could be achieved. The “Drill&Fill”-Method is 
a fast and easy method for labelling tablets. It is suitable for showing the 
residence and disintegration of the tablet. 
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Coated dosage forms in which the active pharmaceutical ingredient (API) is 
incorporated in the film layer in order to achieve rapid release have become 
very common in recent years. Our present aim was to develop a matrix pellet 
containing an API in the coated layer. The presence of insoluble particles in the 
coating liquid is a critical parameter in the preparation of films as such particles 
can modify the properties of the film formed [1, 2]. The film surface is required 
to be smooth, resistant against mechanical effects, heat and light. The 
excipients and APIs incorporated in a film layer influence the structure of the 
film significantly. 
In this work, films were prepared on a teflon surface. The coating liquid was 
prepared as reported previously [3]. Eudragit
® L 30 D-55 dispersion was used 
as polymer, and Diclofenac sodium as API. The samples contained 0, 1 and 5% 
of the API. Measurements were made on the mechanical properties, surface 
properties and glass transitions of the free films, and on the free volume holes 
in the films. 
The mechanical strength and the degree of deformation of the films were 
determined by the recording of deformation curves. Contact angles were 
measured to evaluate the surface free energy, solid surface free energy, liquid 
surface tension and polarity. Glass transition temperatures were detected by 
means of DSC. Positron annihilation spectroscopy was applied to study the free 
volume and track interactions between the polymer and the active ingredient. 
The size distributions of free volume holes were calculated from positron 
lifetime data for films of different compositions. The long-term stability of films 
was also studied. 
[1]  Petereit HU, Weisbrod W. Formulation and process considerations affecting the stability of solid 
dosage forms formulated with methacrylate copolymers. Eur J Pharm. 1999; 47: 15–25. 
doi:10.1016/S0939-6411(98)00083-6  
[2]  [Felton LA, McGinity JW. Influence of insolusble excipients on film coating systems. Drug Dev Ind 
Pharm. 2002; 28: 225–243. doi:10.1081/DDC-120002839 
[3]  Bajdik J, Bölcskei É, Kelemen A, Pintye-Hódi K. Rapid method to study the sedimentation of a 
pigment suspension prepared for coating fluids. J Pharm Biomed Anal. 2007; 44: 1159–1162. 
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An essential step for the development of probiotic products is the stabilisation 
(drying) of the microorganisms. The aim of this study was to compare the 
efficiency of drying cells by lyophilisation, a classical method for cell stabilisation 
[1], with fluid bed technology, which is an approved method for gentle drying as 
well as for mixing, granulation and coating processes [2]. For this purpose the 
probiotic microorganism Enterococcus faecium M74 was dried by lyophilisation 
as well as by fluid bed drying. A further aim was to investigate the protective 
impact of excipients in different concentrations on microorganisms during the 
drying processes. 
Both methods were studied regarding their effect on the culturability and the 
cellular activity of E. faecium M74. The culturability was determined by 
spreading the rehydrated cells onto kanamycin esculin azide agar plates and 
calculating the number of colony forming units (CFU). In order to investigate the 
cell membrane damage, the esterase activity, and the change in superoxide 
production of cells, the rehydrated cells were stained with the fluorescent dyes 
propidium iodide (PI), fluorescein diacetate (FDA), and dihydrorhodamine 123 
(DHR 123), respectively, and measured with fluorimetry. 
The addition of 50% skim milk, based on the wet mass of cells, had the best 
protective impact on E. faecium M74 during lyophilisation, whereas the best 
results for fluid bed drying were obtained by adding 100% skim milk. 
Remarkably, adding 50% or 100% skim milk were the only settings which 
significantly protected the cells during lyophilisation, contrary to the results of 
fluid bed drying, where nearly all of the used excipients had a significant 
protective impact on the cell culturability and the cellular activity of E. faecium 
M74. Furthermore the investigations showed that fluid bed drying is a capable 
method for the stabilisation of microorganisms. However, the selection of 
suitable protectants is important for the reliable application of both methods for 
drying probiotic microorganisms. 
[1]  Meng XC, Stanton C, Fitzgerald GF, Daly C, Ross RP. Anhydrobiotics: The challenges of drying 
probiotic cultures. Food Chem. 2006; 106: 1406–1416. doi:10.1016/j.foodchem.2007.04.076 
[2]  Morgen CA, Hermann N, White PA, Vesey G. Preservation of micro-organisms by drying: A review. J 
Microbiol Methods. 2006; 66: 183–193. doi:10.1016/j.mimet.2006.02.017 www.scipharm.at Scientia  Pharmaceutica  653 
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Ballistic powder injection is an emerging needle-free technology. Powder 
particles are accelerated towards the skin and penetrate the superficial layers. 
Biopharmaceuticals like vaccines can be placed into the epidermal layer of the 
skin, widely known to be an attractive site for immunization [1]. Beneath 
avoiding hazards associated with needle-stick injuries using conventional 
needles and syringes, the use of dried sugar powders provides an enhanced 
stability for biopharmaceuticals [1]. In the literature the use of spray freeze 
drying to generate sugar particles for ballistic powder injection has been 
evaluated [2]. A ternary mixture of trehalose, mannitol and dextran was found to 
be appropriate to generate high density particles attributing appropriate 
characteristics for ballistic injection [2]. Dextran has an antiplasticizing effect on 
the formulation and leads to a partially collapsed, highly wrinkled morphology of 
the spray freeze dried particles. Nevertheless, the stabilising effect of this matrix 
for proteins still needs to be improved. A polymer like dextran is vital for the 
partial collapse of the spray freeze dried particles, but it is also responsible for 
the reduced stabilizing effect on the protein [2]. Our approach is to apply an 
aggressive freeze drying cycle as performed by Schersch et al. to evoke a 
collapse of the sugar matrix and generate a high density structure of the freeze 
dried cake [3]. Characteristics like high density and low specific surface area of 
the lyophilizates can provide protein stability and appropriate properties for 
ballistic powder injection. We investigated different sugar formulations with and 
without dextran and evaluated the effect of collapse freeze drying on particle 
morphology and protein stability. With this more in-depth information about 
particle morphology and protein stability we can introduce an improved 
formulation strategy for biopharmaceutics entrapped in a high density sugar 
matrix intended for ballistic powder injection. 
[1]  Chen D, Maa Y -F, Haynes J R. Needle-free epidermal powder immunization. Expert Rev Vaccines. 
2002; 1: 265–267. doi:10.1586/14760584.1.3.265 
[2]  Rochelle C, Lee G. Dextran or Hydroxyethyl Starch in Spray-Freeze-Dried Trehalose/Mannitol 
Microparticles Intended as Ballistic Particulate Carriers for Proteins. J Pharm Sci. 2007; 96: 2296–
2309. doi:10.1002/jps.20861 
[3]  Schersch K, Betz O, Garidel P, Muehlau S, Bassarab S, Winter G. Systematic investigation of the 
effect of lyophilizate collapse on pharmaceutically relevant proteins I: Stability after freeze-drying. J 
Pharm Sci. 2010; 99: 2256–2278. doi:10.1002/jps.22000 654 Scientia  Pharmaceutica  www.scipharm.at 
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We considered poly(esteramide) hyperbranched polymers (trade names: 
Hybrane S1200 and Hybrane HA1690) as enhancers of glimepiride solubility 
and therewith associated dissolution rate. We prepared solid dispersions (SD) 
of glimepiride with hyperbranched polymers (HB) and compared their solubility 
with those of crystalline and amorphous glimepiride as well as with the solubility 
of SD of glimepridie with conventional linear polymers, i.ie. Poly(ethylene glycol) 
and Gelucire (stearoyl macroglyceride)s. 
Since the solubility and dissolution rate depend also on glimepiride crystallinity 
we characterized the morphology of solid dispersions by X-ray powder 
diffraction (XRD) analysis. The nature of molecular interactions involved in 
complexation of glimepiride with HB was studied by infrared spectroscopy 
(FTIR). 
The comparison of the results of in-vitro dissolution studies show that SD based 
on poly(ester amide) HB polymers showed significantly enhanced aqueous 
solubility of glimepiride and its dissolution rate as compared to glimepiride in 
crystalline or amorphous form as well as its SD with conventional linear 
polymers. We also calculated the amount of glimepiride complexed with 
particular HB polymer (loading capacity) in SD using dissolution results. The 
loading capacity for both HB polymers was estimated to be around 5 %, w/w of 
glimepiride. SD containing higher amounts of glimepiride appear to be 
oversaturated, so that non-complexed glimepiride crystallizes as a separate 
solid phase during the solvent evaporation. X-ray diffraction studies confirmed 
calculated loading capacity.  
IR results indicated that glimepiride forms complexes with HB polymers through 
hydrogen bonds between the NH groups of glimepiride and carbonyls of ester 
(O)-C=O and amide (N)-C=O groups of HB polymers. Therefore, the improved 
glimepiride solubility was ascribed to complex formation between glimepiride 
and HB polymers. 
[1]  Froehling P. Development of DSM’s Hybrane (®) hyperbranched polyesteramides. J Polym Sci A1. 
2004; 42: 3110–3115. doi:10.1002/pola.20113 
[2]  Gillies E, Frechet J M J, Dendrimers and dendritic polymers in drug delivery. Drug Discov Today. 
2005; 10: 35–43. doi:10.1016/S1359-6446(04)03276-3 www.scipharm.at Scientia  Pharmaceutica  655 
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The study demonstrates two approaches in formulation of solid self-emulsifying 
drug delivery systems (SSEDDS) of gliclazide (BCS class II drug). Self-
emulsifying (SE) formulations can improve oral bioavaiability of poorly water-
soluble and lipophilic drugs. Traditional SE formulations are liquids, having 
some disadvantages such as high production cost, low stability, low drug 
loading and few choices of dosage forms. To address these problems solid 
SEDDS are being investigated [1].  
The aim of the study was formulation of solid oral self-emulsifying gliclazide 
preparations - hard capsules and tablets. 
Twelve formulations have been prepared with varying type of solubilizer 
(Labrafil® M2130CS, Cremophor® RH40, Labrafil® M 1944CSCG, Labrafil® 
M2125CS), ratio gliclazide:solubilizer (1:1 to 1:20), presence of adsorbent 
(Neusilin® UFL2), as well as the ratio of gliclazide solution:adsorbent (1:1 and 
2:1) and presence of disintegrator (Ludiflash®) in concentration of 10–50%. 
Formulations have been filled in hard capsules or compressed into tablets using 
excenter tablet press. Determination of gliclazide release from prepared 
capsules or tablets has been conducted in rotating basket apparatus (Erweka 
DT600, pH=7.5, 100 rpm, 900 ml, 45 minutes). 
It has been demonstrated that gliclazide has the highest solubility in 
Cremophor® RH40, at ratio 1:20. Gliclazide release studies have demonstrated 
that capsules filled with gliclazide solution adsorbed on adsorbent, with ratio 
solution:adsorbent 1:1, show the fastest gliclazide release rate. Addition of 
disintegrator in formulations having ratio of solution:adsorbent 1:1, slows down 
gliclazide release rate. On the other hand, disintegrator enhances gliclazide 
release in formulations having ratio of solution:adsorbent 2:1. Gliclazide release 
studies from tablet formulations containing adsorbed solution (in ratios 1:1 and 
2:1) and Ludiflash® demonstrate faster onset of drug release in first minutes 
followed by more sustained gliclazide release, in comparison to capsules.  
Obtained results demonstrate the possibility to formulate solid self-emulsifyng 
gliclazide formulations, once appropriate emulsifier, adsorbent and disintigator, 
in adequate ratio, are selected. 
[1]  Tang B, Cheng G, Gu JC, Xu CH. Development of solid self-emulsifying drug delivery systems: 
preparation techniques and dosage forms. Drug Discov Today. 2008; 13: 606–612. 
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The study demonstrates two approaches in formulation of solid oral lipid-based 
diazepam preparations (BCS class II drug). The aim of the study was to 
formulate tablets and hard capsules, using emulsifier and adsorbent. Lipid-
based preparations improve drug solubility and permeability, i. e. bioavailability. 
Solid silicate carriers are able to adsorb liquid lipid formulations, resulting in 
freely flowable and compressible powders [1]. 
Twelve formulations have been prepared, using emulsifier Labrafil
®M2125CS 
(linoleoyl macrogolglycerides) to solubilize diazepam, Neusilin
®UFL2 
(magnesium aluminium silicate) as adsorbent, with the varying ratio of 
diazepam solution:adsorbent (1:1 to 4:1), and disintegrators Ac-Di-Sol
®  and 
Ludiflash
® (with the ratio varying from 0–90 %). Formulations have been filled in 
hard capsules or compressed into tablets using excenter tablet press. 
Diazepam release study from prepared capsules or tablets has been conducted 
in rotating basket apparatus (ErwekaDT600, 0.1 M HCl, 100 rpm, 500 ml, 45 
minutes). 
Diazepam release studies have demonstrated that it is possible to formulate 
lipid-based solid oral preparations with immediate diazepam release. Capsules 
filled with diazepam solution adsorbed on adsorbent, with the ratio of 
solution:adsorbent 1:1, show the fastest diazepam release rate. Addition of 10% 
of disintegrator in capsule formulation enhanced diazepam release rate, but 
when the ratio of disintegrator is increased furthermore, diazepam release is 
sustained. It was observed that compression of powders in tablets also led to 
decrease in diazepam release rate. Addition of disintegrators further sustained 
diazepam release leading to conclusion that a physical interaction occurs 
between adsorbent and disintegrators. When adsorbent was excluded from the 
tablet formulations diazepam release rate was enhanced, but tableting 
properties of such powders were compromised.  
Obtained results demonstrate the possibility to formulate diazepam immediate 
release formulations, with the necessity of careful selection of excipients and 
dosage forms.  
[1]  Jannin V, Musakhanian J, Marchaud D. Approaches for the development of solid and semi-solid lipid 
based formulations. Adv Drug Deliver Rev. 2008; 60: 734–746. doi:10.1016/j.addr.2007.09.006 www.scipharm.at Scientia  Pharmaceutica  657 
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Adsorption onto silica-based high surface area carriers is a long known method 
of improvement drug dissolution rate, which has been described in early 1970s 
[1]. Porous silica has many silanol groups on its surface and can be used as 
pharmaceutical excipient, since it is regarded nontoxic after oral application. 
Due to its porous structure and large specific surface area, porous silica has a 
great capacity to adsorb organic compounds into its nano-sized pores and can 
improve physical stability of amorphous drug [2].  
Solid dispersions of carvedilol in porous silica (Sylysia 350) were prepared by 
solvent evaporation in a vacuum evaporator which ensures efficient pore filling 
procedure [3]. Two sets with different concentrations of carvedilol in solid dis-
persions were prepared, which differ in pore filling process. Set a) was prepared 
by one-step filling and set b) by multiple filling of smaller portions of dissolved 
carvedilol into porous silica. Solid dispersions were characterized by thermal 
analysis (DSC), X-ray diffraction and nitrogen adsoprtion experiments. Specific 
surface area and porosity parameters of solid dispersion samples confirm 
different mechanism of drug loading within silica pores in each experimental set. 
Results showed that carvedilol is more efficiently “packed” inside porous matrix 
when multiple drug filling procedure of smaller amounts is used as suggested 
by absence of crystalline state of a drug and greatly reduced porosity, while at 
the same time physical stability of amorphous carvedilol was most improved. 
Due to space restriction carvedilol can not crystallize when it is entrapped in a 
region of pores of smaller diameters than the minimum size of crystalline nucle-
us. Once the amorphous form of drug is stabilized inside porous silica it remains 
physically stable against crystallization and water sorption, while pure amor-
phous drug partially crystallized and adsorbed a detectable amount of moisture.  
The authors acknowledge to KRKA, d.d., Novo mesto for support in the study. 
Present work was partly financed by the European Union, European Social 
Fund. 
[1]  Rupprecht H, Biersack MJ, Kindl G. Freigabe schwer löslicher Substanzen von den Oberflächen 
partiell belegter Kieselsäuren. Colloid Polym Sci. 1974; 252: 415–416. doi:10.1007/BF01387967 
[2]  Takeuchi H, Nagira S, Yamamoto H, Tanimura S, Kawashima Y. Tabletting of solid dispersion 
particles consisting of indomethacin and porous silica particles. Int J Pharm. 2005; 293: 155–164. 
doi:10.1248/cpb.53.487 
[3]  Ohta KM, Fuji M, Takei T, Chikazawa M. Development of a simple method for the preparation of a 
silica gel based controlled delivery system with a high drug content. Eur J Pharm Sci. 2005; 26: 87–
96. doi:10.1016/j.ejps.2005.05.002 658 Scientia  Pharmaceutica  www.scipharm.at 
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Taste-masking technologies are important for obtaining high-patient compliance 
and drug therapy efficiency, since many oral-delivery drugs have unpleasant 
qualities such as bitterness, sourness or saltiness.  
Taste-masking technology includes two aspects: selection of appropriate taste-
masking substances (polymers, flavourings, sweeteners, amino acids, etc.) and 
selection of appropriate taste-masking technique. Such taste-masked 
multiparticulate systems (granules, powders, dry syrups, or suspensions) 
represent further base for preparation of peroral formulations, such as 
dispersible tablets and oral liquids. 
Selection of appropriate taste masking technique can strongly impact both, 
quality of taste masking and the process efficiency. There are many available 
techniques for taste masking developed today, including conventional granu-
lation and polymer coating, but also more sophisticated is taste masking by 
encapsulation with lipids or cyclodextrins or by making multiple emulsions [1].  
The aim of this study was to reduce or completely inhibit bitterness of model 
drug of defined physical-chemical characteristics.  Fluid bed technology was 
used as the suitable method for taste masking. Drug particles were coated with 
the polymeric material, which ensured masking the bitter taste of the drug 
substance. Two different polymers, amino methacrylate copolymer (Eudragit
® E 
PO) and ethylcellulose (Aquacoat ECD) were used. Influence of spray position 
and process parametrs on quality of coating of drug particles was studied. 
Physico-chemical properties of formed granules were characterised and 
compared in terms to ensure proper masking of drug bitterness and process 
efficiency [2]. 
This work was supported by scientifically assistance and knowledge share of 
Gordana Matijašević and Ivan Simčić in performing analytical tests.  
[1]  Lieberman HA, Lachman L, Schwartz BJ. Pharmaceutical dosage forms, Chewable tablets. Second 
edition (1989); Volume 1, 8: 367–415. 
[2]  Rambali B, Baert L, Massart DL. Scaling up of the fluidized bed granulation process. Int J Pharm. 
2003; 252: 197–206. doi:10.1016/S0378-5173(02)00646-4 
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The dispersion and emulsification in micro channels by high pressure have 
several characteristics which recommend these methods especially for 
pharmaceutical applications, e.  g. the possibility to use very small educt 
batches, a narrow residence time distribution and a relatively accurate 
adjustment of the induced stresses with a good reproducibility. Due to the small 
dimensions “Cleaning In Place” (CIP) is easy to realize without a large loss of 
product or time and for high hygienic requirements even the possibility of 
disposable devices exists. Nevertheless deposits, which can lead to blockages, 
and the abrasion of the micro systems with the associated product 
contamination pose big challenges. 
In order to determine the dispersion efficiency of different micro channel 
geometries, experiments with nanoparticle agglomerates were carried out. The 
results show that the dimensions as well as the geometries of the micro 
channels influence the dispersion efficiency, the appearance of blockages and 
the amount of abrasion. Especially areas with low velocities as behind rough 
edges or oversized in- and outlets run the risk of depositions. With 
computational fluid dynamics calculations (CFD) and flow measurements (µPIV) 
areas of low velocities or backflow which run the risk of depositions and the 
occurence of cavitation are identified and subsequently eliminated or minimized 
in optimized channel designs. 
The CFD calculations are also conducted to get a better understanding of the 
stress field which leads to the dispersion or emulsification. The turbulent flow 
fields of the different micro channels were solved and used for a stationary 
particle tracking. Based on these particle pathes the impressed elongential, 
shear and turbulent stresses are calculated. The agglomerate size distribution 
measured after the dispersion experiments are compared to the calculated 
stresses to determine the mechanisms involved in the dispersion or 
emulsification. 
The authors gratefully acknowledge the DFG for financial support within the 
DFG research group 856 “Mikrosysteme für partikuläre Life-Science-Produkte“ 
(mikroPART). 660 Scientia  Pharmaceutica  www.scipharm.at 
Presented at the 8
th Central European Symposium on Pharmaceutical Technology, 
September 16
th–18
th 2010, Graz, Austria. 
Conference abstract PMS33 
Oxazoline-Based Hydro-, Amphi- and Lipogels 
from Microwave-Assisted Synthesis 
F. WIESBROCK 
1, A. HECKE 
2, B. WIRNSBERGER 
1, A. M. KELLY 
2, F. STELZER 
1 
1 Graz University of Technology, Institute for Chemistry and Technology of Materials, Stremayrgasse 16,  
AT-8010 Graz, Austria. 
2 Polymer Competence Center Leoben GmbH (PCCL), Roseggerstrasse 12, AT-8700 Leoben, Austria. 
E-mail: f.wiesbrock@tugraz.at (F.Wiesbrock) 
Sci Pharm. 2010; 78: 660        doi:10.3797/scipharm.cespt.8.PMS33 
The group of poly(2-oxazoline)s has scarcely been considered as scaffold for 
hydrogels [1,  2], despite of the FDA approval for two prominent congeners, 
namely poly(2-ethyl-2-oxazoline) and poly(2-phenyl-2-oxazoline) (21 CFR 
175.105). The polymerization of 2-oxazolines has significantly benefited from 
the advent of microwave reactors specially designed for chemical syntheses by 
a remarkable decrease of reaction times with a factor of 60, maintaining the 
livingness of the polymerization [3, 4]. These accelerations have paved the way 
to the synthesis of hydro-, amphi-, and 
lipogel libraries.  
In this presentation, the influence of the 
ratio of poly(2-ethyl-2-oxazoline) vs. 
poly(2-phenyl-2-oxazoline), the degree 
of cross-linking and the type of cross-
linker on the swelling degree and the 
proton-mediated degradation of the gels 
will be shown, and the potential of 2-
oxazoline-based gels as toolbox for 
tailor-made hydro-, lipo- and amphigels 
will be discussed [5]. 
[1]  Chujo Y, Sada K, Matsumoto K, Saegusa T. Synthesis of nonionic hydrogel, lipogel, and amphigel by 
copolymerization of 2-oxazolines and a bisoxazoline. Macromolecules. 1990; 23: 1234–1237. 
doi:10.1021/ma00207a002 
[2]  Puskas JE, Chen Y. Biomedical Application of Commercial Polymers and Novel Polyisobutylene-
Based Thermoplastic Elastomers for Soft Tissue Replacement. Biomacromolecules. 2004; 5: 1141–
1152. doi:10.1021/bm034513k 
[3]  Wiesbrock F, Hoogenboom R, Schubert US. Microwave-Assisted Polymer Synthesis: State-of-the-Art 
and Future Perspectives. Macromol Rapid Commun. 2004; 25: 1739–1764. 
doi:10.1002/marc.200400313 
[4]  Wiesbrock F, Hoogenboom R, Leenen MAM, Meier MAR, Schubert US. Investigation of the Living 
Cationic Ring-Opening Polymerization of 2-Methyl-, 2-Ethyl-, 2-Nonyl-, and 2-Phenyl-2-oxazoline in a 
Single-Mode Microwave Reactor. Macromolecules. 2005; 38: 5025–5034. doi:10.1021/ma0474170 
[5]  Hecke A, Wirnsberger B, Kelly AM, Stelzer F, Wiesbrock F; submitted. www.scipharm.at Scientia  Pharmaceutica  661 
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Shrinkage cracking during the deliquoring of compressible filter cakes by means 
of differential gas pressure is an undesired phenomenon of great practical 
importance for the pharmaceutical industry amongst others. Cracks are 
detrimental to the deliquoring process as they can lead to a channelling effect 
whereby the gas flows preferentially through the network of cracks rather than 
displacing the interstitial liquid, reducing the effectiveness of the deliquoring 
process. This has economic consequences of increased gas consumption, as 
well as higher residual moisture content, which would lead to an increased 
energy input in the later thermal drying stages. 
The precise mechanism of crack formation is not fully understood at present. 
Crack formation is usually preceded by shrinkage of the filter cake, the driving 
potential for this shrinkage being the action of the capillary forces on particles 
forming the cake. When the stresses generated by the capillary forces exceed 
the tensile strength of the filter cake, the formation and propagation of cracks 
can be observed [1]. The tensile strength can be significantly reduced by local 
cake inhomogeneities. 
In this contribution we will present the results of an experimental parametric 
study on cake cracking. The cracking probability was investigated for a model 
system of calcium carbonate-water on a laboratory-scale pressure filtration rig. 
The effects of the following parameters on crack formation were studied in 
detail: particle size distribution, filtration and deliquoring pressure, cake height, 
concentration of slurry and filter medium. The results will be presented in the 
form of graphs and correlations allowing the estimation of both the probability 
and severity (expressed by an increase in cake permeability) of cracking. For 
selected cases the crack network structure will be characterised by digital 
image analysis and three-dimensional techniques such as x-ray 
microtomography.  
This work was supported by the UK Engineering and Physical Sciences 
Research Council (CASE grant number 0900052) and by GlaxoSmithKline Ltd. 
[1]  Wiedemann T, Stahl W. Experimental investigation of the shrinkage and cracking behaviour of fine 
particulate filter cakes. Chem Eng Process. 1996; 35: 35–42. doi:10.1016/0255-2701(95)04105-2 662 Scientia  Pharmaceutica  www.scipharm.at 
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Metoprolol is a cardioselective β-blocker that is classified as a class I substance 
according to the Biopharmaceutics Classification Scheme BCS, meaning that it 
is highly soluble and highly permeable. Dissolution test was carried out 
according to EP 2.9.3. in medium 0.1N HCl, 900 ml, 100 r/min, sampling time 5 
minutes. Quantification was spectrophotometric measurement on 275 nm. 
The results of dissolution analysis are summarized in Table 1, sample 1 
hardness 123–137  N, disintegration 5.21–9.17 min, sample 2 hardness   
157–168 N, disintegration 8.38–14.10 min and sample 3 hardness 132–151 N, 
disintegration 12.23–14.23 min.  
Tab. 1. 
Min  5  10 15 20 25  30  f2 
Sample 1 
% dissolution   24,29 47,88 68,32 86,01 98,99 100,35 
SD   1,29   3,31   3,99   4,44   3,54    1,39 
RSD   5,33   6,91   5,84   5,17   3,58    1,39  75.21 
Sample 2                    
% dissolution  21,42 43,00 62,35 78,86 91,72   97,85 
SD   2,57   4,07   5,07   5,69   4,95    1,99 
RSD  11,98   9,46   8,13   7,22   5,40    2,04  78,22 
Sample3 
% dissolution  22,18 44,78 65,45 82,85 95,47   98,47 
SD   3,60   5,78   6,65   6,38   4,20    1,02 
RSD  16,21  12,90  10,15   7,70   4,40    1,04  99.18 
Reference drug 
% dissolution  22,28 44,96 65,41 82,66 94,84   98,52  
SD   4,00   8,20   9,90  12,10  11,10    6,41   
RSD  17,95 18,25 15,13 14,64 11,70     6,51  
Sample 3 has the highest f2 compared to reference drug, Samples 2 and 1 
have values significantly different from the reference drug results. This study 
helps in revealing the effect of formulation processing variables on tablet 
properties. 
[1]  Yang Y, Yu LX. Oral Drug Absorption, Evaluation and Prediction. In: Qiu Y, Chen Y, Zhang GGZ, Liu 
L, Porter WR (editors). Developing Solid Oral Dosage Forms. Elsevier Inc. 2009; p. 289–318. 
doi:10.1016/B978-0-444-53242-8.00012-6 www.scipharm.at Scientia  Pharmaceutica  663 
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The application of a coating layer on a tablet is a commonly used technique to 
selectively control tablet characteristics. Among the most important functions of 
the coating is the regulation of the release of active ingredient. 
In the course of a typical coating process, the tablet passes a spray zone 
multiple times. Each time, a partial coating layer is applied. For each tablet, this 
is repeated numerous times until a film of desired thickness is achieved. The 
number of repetitions needed as well as the quality of the final coating depends 
strongly on the quality of the partial coating. Therefore, it is of great interest to 
study the outcome of a single coating event in detail.  
 
Fig. 1. Film formation on a single vertical tablet after 0.3 s in the spray zone. 
In this work, we show the application of numerical simulations to the 
investigation of film formation on a tablet (see fig. 1). External parameters 
entering the simulation were taken from measurements of an industrial coating 
process. Adapted computational fluid dynamics (CFD) models are applied to 
study the influence of central process characteristics (e.  g. temperature, 
residence time, tablet rotation or droplet diameter distribution) on the quality of 
partial coating. As a result, a deeper understanding on the influence of each 
parameter is gained, helping to optimize the tablet coating process. 
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Particle shape and size have an influence on the solubility of an API-particle 
and hence on the bioavailability of the substance. Thus, bulk properties such as 
the crystal size distribution (CSD) are important quality attributes of powders. 
Furthermore, downstream processes (e. g., filtering, washing, drying etc.) and 
the handling abilities (e. g., flowability, tabletability) of the particles are positively 
affected by narrow CSDs. In order to obtain product crystals with desired 
features it is important to control numerous parameters during a crystallization 
process. 
We present a versatile, continuously operated tubular crystallizer system, which 
is based on the growth of seeds to product particles in a tube. Due to the 
tubular appearance and the small inner dimensions of the crystallizer in the few 
millimeter range, it is possible to adjust the temperatures along the tubing 
according to the needs of the crystallization. Thus, the product can be 
manipulated under controlled conditions [1–3]. Parameters that can be altered 
in the crystallization process include seed loadings, temperatures, solution 
concentrations, and flow rates of the suspension in the tubing. As a model 
system we have chosen the crystallization of acetylsalicylic acid (ASA) in 
ethanol (EtOH). 
The effects of various process parameters on product characteristics have been 
investigated. All experiments resulted in significant crystal growth despite short 
residence times in the few minute range. Moreover, crystal masses increased 
by a few g/min and steady-state conditions were obtained in less than 5 
minutes. Suppression of nucleation events by avoiding rapid cooling, thus high 
levels of supersaturation allowed successful achievement of narrow CSDs. 
Additionally, simulations regarding the temperature gradients and the crystal 
growth have been performed and compared to the experimental results. 
[1]  Eder R, Radl S, Schmitt E, Innerhofer S, Maier M, Gruber-Woelfler H, Khinast J. Continuously 
Seeded, Continuously Operated Tubular Crystallizer for the Production of Active Pharmaceutical 
Ingredients. Cryst Growth Des. 2010; 10: 2247–2257. doi:10.1021/cg9015788 
[2]  Eder R, Gruber-Wölfler H, Khinast J. Kontinuierliche Kristallisation in einem Rohrkristallisator. Chem 
Ing Tech. 2009; 81: 1171. doi:10.1002/cite.200950372 
[3]  Schiewe J, Zierenberg B. Process and apparatus for producing inhalable medicaments. US-Patent 
Pub. No.: 2003/00151594 A1. 2003. www.scipharm.at Scientia  Pharmaceutica  665 
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The aim of this work is to investigate image processing and process monitoring 
technologies which can provide a systematic, robust and sensitive solution for 
nucleation detection using bulk video imaging (BVI). The external BVI method is 
based on a video camera and a capture hardware, which captures 25 frames of 
the crystallization bulk per second [1]. Another set of experimental data is 
generated using in-situ endoscopy and a small scale crystallization calorimeter 
[2]. In this work the images are converted into time series and these are 
monitored using Shewhart and exponentially moving average (EWMA) 
statistical process control (SPC) charts; nucleation is detected when the signals 
exceed the control limits. A second approach to nucleation detection is 
histogram matching. Histograms of the images are generated and similarity 
measures are applied to detect significant changes indicating the beginning of 
nucleation; the current study evaluates the use of Kolmogorov-Smirnof and Chi
2 
statistics to determine the statistically significant change between the observed 
and the reference histograms for a 95% confidence interval.  
The third approach relies on the advantages offered by the multivariate image 
analysis [3]. According to this, multiway principal component analysis (PCA) is 
performed on the color images to obtain the first score, which is also an image. 
Furthermore, the PCA model residual monitoring performance was investigated. 
The image analysis techniques are applied for the crystallization of caffeine as a 
model for active pharmaceutical ingredients, both externally and in-situ.  
[1]  Simon LL, Nagy ZK, Hungerbuhler K. Comparison of external bulk video imaging with focused beam 
reflectance and ultra violet-visible spectroscopy for crystallization nucleation detection and metastable 
zone identification. Chem Eng Sci. 2009; 64: 3344–3351. doi:10.1016/j.ces.2009.04.016 
[2]  Simon LL, Nagy ZK, Hungerbuhler K. Endoscopy-Based in Situ Bulk Video Imaging of Batch 
Crystallization Processes. Org Process Res Dev. 2009; 13: 1254–1261. doi:10.1021/op900019b 
[3]  Simon LL, Abbou Oucherif K, Nagy ZK, Hungerbuhler K. Bulk video imaging based multivariate image 
analysis, process control chart and acoustic signal assisted nucleation detection. Chem Eng Sci. 
2010;65:4983–4995. doi:10.1016/j.ces.2010.05.045 666 Scientia  Pharmaceutica  www.scipharm.at 
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The compression during tabletting is a complex and irreversible dynamic 
process and the study of it with instrumented tablet presses is beneficial for 
process and formulation optimization. The compaction and ejection cycle 
provides us suitable signals about the tabletting process. Instrumented presses 
used in tabletting research and development are normally equipped to measure 
punch force and displacement [1]. By measuring the compression force both of 
the upper and the lower punch and the displacement of the upper punch force 
as a function of time and as a function of displacement can be analyzed. 
Moreover, several energy parameters, such as the lubrication of the tablets and 
the occurred friction during the compaction can be calculated from these data 
concerning for example to the binding characteristics of the applied excipients 
[2, 3]. 
The aim of our work was to investigate the effect of pharmaceutical excipients 
and process parameters on the tabletting properties of poorly compactable 
drugs analyzing the force-displacement profile of drug-excipient systems 
recorded by tablet press instrumentation. Furthermore with matching the forces 
measured on the upper and lower punches various parameters of the 
compaction – lubrication, friction coming up during tabletting – were calculated 
as well. A 3
2-type face centered full factorial design was applied to study the 
energy parameters as response variables (Y) and surface plot was made which 
is to describe with the following equation: 
2 1
2
2
2
1 2 1 X X f X e X d X c X b a Y + + + + + =  
where according to the polynomial terms the effect of each independent 
variables (b, c), their linearity (d, e) and the interaction between them (f) are 
described. The force-time curves are useful indicators of the compaction 
behavior regarding elasticity and plasticity. In addition, studies on compression 
profiles may serve as fingerprints for tablet compositions.
 
[1]  Doelker E, Massuelle D. Benefits of die-wall instrumentation for research and development in 
tabletting. Eur J Pharm Biopharm. 2004; 58: 427–444. doi:10.1016/j.ejpb.2004.03.011 
[2]  Antikainen OK, Yliruusi JK. Determining the compression behaviour of pharmaceutical powders from 
the force-distance compression profile. Int J Pharm. 2003; 252: 253–261.  
doi:10.1016/S0378-5173(02)00665-8 
[3]  Yliruusi JK, Antikainen OK. New parameters derived from tablet compression curves. Part I. force-time 
curve. Drug Dev Ind Pharm. 1997; 23: 69–79. doi:10.3109/03639049709148483 www.scipharm.at Scientia  Pharmaceutica  667 
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This paper presents results of the simulation of unsteady mixing processes 
using a unique, mesh-less particle approach. Similar simulations, performed by 
Hörmann et.al [1] using common Computational Fluid Dynamics (CFD) have 
already been published in the past. The new method applied offers 
computational possibilities for problems involving transient dynamics, free 
surface analysis, moving boundaries or fluid-structure interaction. The 
simulations performed within the framework of this project are based on the 
Navier Stokes Equations using Large Eddy or Detached Eddy approaches. 
Turbulent energy dissipation models are used to resolve scales which are not 
captured by the particle resolution. 
The investigations presented focus on the reproduction flow phenomena in a 
mixing tank, including viscosity adaption due to particle dissolution and analysis 
of particle concentration using a Discrete Phase Model (DPM). Applying CFD 
packages, problems including moving boundaries require time consuming work-
arounds, which often lead to errors or divergence of the simulation. Due to the 
used mesh-less method, only the physical and mechanical properties of the 
problem, like number of revolutions, filling height or initial fluid viscosity need to 
be defined. 
The results of the simulation are compared with Particle Image Velocimetry 
(PIV) measurements, showing good agreement.  
[1]  Hörmann Th, Redlinger-Pohn J, Schaffer M, Suzzi D, Radl S, Khinast JG. Simulation of mixing 
processes for the manufacture of pharmaceutical products. International Graz Congress for 
Pharmaceutical Enginering 2009. 668 Scientia  Pharmaceutica  www.scipharm.at 
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Process performance in the synthesis of API and its intermediates can be 
reached through new technologies and methods. Significant development time 
reduction, operating cost reduction by yield improvement, energy savings and a 
fundamental improvement of plant safety are some of the main results of 
process intensification concepts. The activities can be divided into 4 phases: 1. 
evaluation, 2. verification, 3. development and 4. realization. A riskbased 
approach according to ICH Q9 is used during the whole project. 
First of all the identification of reaction performance potential of existing 
chemical plants needs to be analyzed ending with the formulation of a target for 
the verification (basic feasibility). The evaluation starts with a process capability 
check, followed by the generation of a cost flow analysis and ends with a 
technology evaluation and comparison. Microinnova compares the needs for a 
chemical reaction with technology profiles to find out the most suitable solution 
for a process.  
In the second phase the intensification potential of the reaction needs to be 
verified. Typically a continuous plant setup is developed and modified according 
to the needs of the chemical process. An operating procedure will be generated 
and optimized. Finally, a rough parameter scan of a few key parameters will 
deliver a relevant overview for the verification.  
Once the potential is proven the process development needs to be done, where 
the basic feasibility delivers a good basis for the work (phase 3). The reaction 
process will be optimized. New process options are used as well as new 
technology concepts like microreactors and flow chemistry to find the best 
possible process. A knowledge based approach according to ICH Q8 will be 
used for the development by applying methods like the critical parameter 
concept and cause effect chains. Engineering data necessary for the scale up 
will be generated in this part of the work.  
Finally in the fourth phase the observed performance needs to be realized. The 
deep specific knowledge in process intensification equipment needs to be 
combined with process experience and competence. The best possible 
equipment solution needs to be selected and calculated under considerations 
regarding the common standards like ATEX or cGMP. The gap between 
continuous processing and multi-purpose flexibility can be bridged by 
modularization of continuous plants. www.scipharm.at Scientia  Pharmaceutica  669 
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Freeze dried products form a special group of sterile medications because of 
the unique manufacturing process. Their importance is ever growing due to the 
appearance of a number of unstable active pharmaceutical ingredients and 
nanosystems. This instability can be overcome with the formulation of a freeze 
dried product in most cases, thus ensuring a pharmaceutically acceptable shelf-
life. On the other hand, in a number of compositions which comprise low 
concentrations of active ingredients the addition of a bulking agent is necessary 
to produce an optimal product [1].  
Isomalt is a disaccharide sugar alcohol, which offers several important health 
benefits. The most important is its suitability for diabetics as it does not raise 
blood glucose or insulin levels. Its glycaemic index is very low [2]. 
The aim of our work was to assess isomalt as a new bulking agent. 
Furthermore, our purpose was to determine and optimize the parameters for 
freeze drying and to compare important properties (e. g. water content, water 
uptake) of freeze dried isomalt to conventionally used excipients (lactose).  
Our experiment led us to the elaboration of the optimal parameters for freeze 
drying. We determined the acceptable rate of freezing and the time of primary 
sublimation during lyophilisation using statistical analysis of data. Latter was 
performed using the TableCurve
®3D v4.0 (Systat Software Inc., London, UK). 
The effect of the independent variables on response y was modelled by the 
following polynomial equation: 
2 1 12
2
2 22
2
1 11 2 2 1 1 0 0 x x b x b x b x b x b x b y + + + + + =  
where x1 and x2 are the factors (x1: time, x2: temperature) and b parameters 
mark the coefficients characterizing the main (b1, b2), the quadratic (b11, b22), 
and the interaction effects (b12). These equations were used in a two factorial, 
three level study to determine the water content of the product. 
Furthermore we determined the water uptake of freeze dried isomalt over time 
and compared it to lactose lyophilised under the same process parameters. 
[1]  Herman BD, Sinclair BD, Milton N, Nail SL.The Effect of Bulking Agent on the Solid-State Stability of 
Freeze-Dried Methylprednisolone Sodium Succinate. Pharm Res. 1994; 10: 1467–1473. 
doi:10.1023/A:1018908326074 
[2]  Liversey G. Health potential of polyols as sugar replacers, with emphasis on low glycaemic properties. 
Nut Res. 2003; 16: 163–191. doi:10.1079/NRR200371 670 Scientia  Pharmaceutica  www.scipharm.at 
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Nowadays, a considerable range of industrial applications (pharmaceutics, 
cosmetics, foods agriculture products) relies on microencapsulation of solids or 
liquids by polymer coating and entrapment into polymer matrices. 
Production of these micro-systems doubtless represents one of the most 
important improvements in the development of functional and therapeutic 
products belonging to the industrial fields above reported. 
Generally, microencapsulation is widely used in pharmaceutical and 
nutraceutical fields, mainly to improve stability or to modify active principles 
release. Smart micro-systems release active molecules in fuction of external 
stimuli (pH, temperature). Preparation of the microparticles is achieved by both 
physico-chemical and mechanical processes. Feasibility studies about a 
process of microencapsulation are achieved by manual procedures in a lab-
scale. The path toward commercialization of micro-particles needs plants or 
automated equipments on lab- or pilot-scale first, eventually on industrial scale. 
However, the state-of-art about microencapsulation techniques displays several 
processes based on manual operations that often don’t find an applicative 
realization in industrial field. Moreover, equipments reported in literature, 
especially in lab-scale systems, are not versatile devices and are penalized by a 
high consumption of resources. This work is focused on the development of 
techniques able to overcome such limitations. A promising new technique with 
low energy consumption consists in the 
coupling between ultrasonic atomization 
and microwave drying to produce 
micro-systems through an intensified 
process. The variation of 
energy/frequency of ultrasounds gives 
the dimensional distribution more 
suitable for the final applications. The 
microwave drying modifies materials 
structure giving unique properties to the 
micro-particles. 
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The propylene glycol Liquorice, Marigold and Yarrow extracts (LE, ME, YE- 
respectively) were obtained by the repercolation method, in the plant:extract 
ratio 1:2. Its appearance, relative density, index of refraction, pH values and dry 
materials content were evaluated. The extracts were encapsulated into the 
instant liposome (Natipide
® II, Nattermann Phospholipids, Germany). Liposomal 
encapsulation of LE, ME and YE extracts was done by mixing of instant 
liposomes and the extract (2:1) in an ultrasound bath for 10 min. The obtained 
dispersions were diluted with purified water, in the ratio 1:1 and homogenised 
during 15 min to get final dispersion LD, MD and YD, respectively. Average 
radius of the liposoms size in dispersions was determined spectrofotometrically. 
For obtaining the O/W emulsion-type creams-vehicle, applying the cold-cold 
method, we used 5%w/w Emulgin
®VL75 emulsifier [Lauryl Glycoside (and) 
Polyglyceryl-2 Dipolyhydroxystearate (and) Glycerine] (Cognis, Germany). The 
composition of vehicle is the same as described previously [1]. The extracts LE, 
ME and YE (5% w/w) were incorporated in the vehicle (LC, MC and YC creams 
obtained). The liposomal dispersions LD, MD and YD were incorporated (30%) 
in the vehicle to obtain LLC, MLC and YLC creams, respectively. Liposomal 
creams (LLC, MLC, YLC) and nonliposomal creams (LC, MC, YC) were 
inspected simultanously: stability under storage: at room temperature (22°C±2), 
in hot air at 45°C±2 and at 5°C±2; centrifuge test: centrifuged in two 15-minutes 
runs, each at 3000 rpm; organoleptic properties inspected both visually and by 
smear tests on glass slabs: appearance, colour, odour and homogeneity of the 
samples; pH values of the creams were obtained by direct potentiometric 
method; rheological characterization of creams: Rotovisko RV 12 with coaxial 
sensor cylinder systems SVst, Svdin, was used (measurements carried out at 
20±0,1°C with shearing rates continuously changing within the ratio from 0 to 
110s
−1). The results indicate that emulsifier mentioned in the text above is 
suitable excipient for preparation of stable o/w creams-vehicles for incorporation 
of LE, ME and YE as well as liposomes filled with extracts. 
This work was supported by Serbian Ministry of Science and Technological 
Development, project number TR 20137. 
[1]  Cupara S, Arsic I, Homsek I, Tadic V, Jankovic S, Djordjevic S. Moisturizing effect of o/w oleosom 
structure creams containing sea buckthorn fatty oil and olive oil. Book of Abstract, No 35, 6
th World 
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In order to reach the deep lung API (active pharmaceutical ingredient) particles 
must have an aerodynamic diameter of 1 µm to 5 µm. Powders of this size are 
rather cohesive and exhibit poor flowing properties. Due to the fact that dosing 
is done volumetrically sufficient flowability is crucial. One solution to cope with 
cohesivity is to mix the API with coarser carrier particles of sufficient flowability. 
On the one hand interparticular forces of such interactive mixtures must be high 
enough to guarantee powder uniformity during mixing and powder handling and 
on the other hand low enough to allow API detachement form the carrier upon 
inhalation. Since interparticular forces depend on the contact area between API 
and carrier particles and consequently surface morphology the variation of the 
carrier surface may lead to optimized dry powder inhaler (DPI) formulations. 
Experiments of Maas [1] showed that spray drying aqueous mannitol samples 
at different outlet temperatures lead to varying morphologies. However these 
particles which had been prepared at a lab scale spray dryer were too small 
(d50,3=12 µm) as to be used as carriers in DPIs.  
The aim of this work was to prepare spray dried mannitol carrier particles of 
variable surface roughness. Intended particle size was between 50  µm and 
100 µm. Interactive mixtures of carrier particles with salbutamol were prepared 
and the respirable fraction was determined according to the European 
Pharmacopoeia using the next generation impactor (NGI). 
[1]  Maas SG. Optimierung trägerbasierter Pulverinhalate durch Modifikation der Trägeroberfläche mittels 
Sprühtrocknung. PhD Thesis, Heinrich-Heine-University Duesseldorf. 2009 
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The lipophilicity of a drug plays a key role for its distribution and accumulation in 
the human organism. The analysis of the distribution behaviour between buffer 
and a model membrane is most suitable to ascertain the partition coefficient 
between hydrophilic and biological membranes. Liposomes are common 
membrane models and ideal systems to characterize drug-membrane 
interactions [1].  
We verified an indirect screening method to investigate the liposome-buffer 
partition coefficient using the fluorescent dye 6-Lauryl-2-dimethylamino-
naphtalene (Laurdan). Laurdan offers a distinctive emission spectrum which is 
characterized by a shoulder at 434 nm and a maximum at 486 nm. The ratio of 
the fluorescence intensities at these two wavelengths is termed as the 
membrane state parameter (MSP). MSP changes depend on the polarity of the 
dye’s enviroment. After insertion of drug molecules into the liposomal 
membrane, the MSP value decreases as a function of the amount of inserted 
drug. The calculation of the MSP for different drug concentrations and various 
lipid amounts enables the determination of the drug’s partition coefficient [2, 3].  
This indirect method offers the possibility to analyze the partition behaviour of a 
broad range of different drug classes without requiring further operations like 
separation steps or specific drug detection.  
In an initial study, we determined the membran partition behavior of bile salts as 
amphiphilic model drugs. 
[1]  Plemper v. Balen G, Marca Martinet C, Caron G, Bouchard G, Reist M, Carrupt PA, Fruttero R, Gasco 
A, Testa B. Liposome/water lipophilicity: methods, information content, and pharmaceutical 
applications. Med Res Review. 2004; 24: 299–324. doi:10.1002/med.10063 
[2]  Paternostre M, Meyer O, Grabielle-Madelmont C, Lesieur S, Ghanam M, Ollivon M. Partition 
coefficient of a surfactant between aggregates and solution: application to the micelle-vesicle 
transition of Egg-phosphatidylcholine and Octyl-β-D-glucopyranosid. Biophys J. 1995; 69: 2476–2488. 
doi:10.1016/S0006-3495(95)80118-9 
[3]  Theobald A, Thesis, 2009; University of Freiburg. 
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Rhabdomyosarcoma is the most common soft tissue sarcoma of childhood. 
Especially the alveolar rhabdomyosarcoma (ARMS) shows poor prognosis 
when metastases have developed.  
The aim of this project is to downregulate the expression of several genes that 
are involved in the aggressive behaviour of ARMS by means of siRNA. 
Therefore, a liposomal delivery system, which is able to transport siRNA 
selectively to the ARMS cells, is being developed. 
For enhancing the interaction of the delivery systems with the target cells and 
thus the effectivity, active targeting is intended. Therefore, the surfaces of the 
liposomes were modified with ligands binding to receptors expressed on the 
ARMS. Two different kinds of targeting devices were utilized: a RGD-peptide 
(arginine-glycine-aspartic acid tripeptide) recognizing integrins on ARMS as well 
as an antibody binding to the IGF1-receptor (insulin-like growth factor 1 
receptor).  
siRNA was encapsulated into the liposomes during liposome preparation by 
speedmixing (dual asymmetric centrifugation). This method is well suitable for 
efficient siRNA entrapment [1]. 
To modify liposomes for active targeting the ligands were coupled to the 
liposomal surface using the sterol-based post-insertion technique (SPIT) [2].  
For optimization of the delivery systems, cellular interaction of fluorescently 
labeled liposomes with the ARMS cell line RH-30 and gene silencing of siRNA-
loaded (anti-GFP siRNA) liposomes in stably GFP-transfected RH-30 cells were 
determined by flow cytometry. 
RGD-peptide as well as anti-IGF1-receptor antibody modified liposomes 
showed significant interaction with RH-30 cells. Furthermore, specificity and 
extend of gene silencing was analyzed. 
[1]  Hirsch M, Ziroli V, Helm M, Massing U. Preparation of small amounts of sterile siRNA-liposomes with 
high entrapping efficiency by dual asymmetric centrifugation (DAC). J Control Release. 2009; 135: 80–
88. doi:10.1016/j.jconrel.2008.11.029 
[2]  Gantert M, Lewrick F, Adrian JE, Rössler J, Steenpaß T, Schubert R, Peschka-Süss R. Receptor-
Specific Targeting with Liposomes In Vitro Based on Sterol-PEG1300 Anchors. Pharm Res. 2009; 26: 
529–538. doi:10.1007/s11095-008-9768-z www.scipharm.at Scientia  Pharmaceutica  675 
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Blood vessel diseases like antherosclerosis lead to formation of blood clots with 
severe consequences like acute ischemic stroke or myocardial infarction [1]. 
A well-directed treatment of thrombotic events implies fast localization of the 
blood clot as well as fast and effective destruction with low doses of lytic agents 
to prevent the patient from severe damage. Standard procedure is application of 
high doses of thrombolytic agents with bleeding complications as negative side 
effects. Daffertshofer et al. investigated clot lysis efficiency of thrombolytic drugs 
alone, in combination with ultrasosund and ultrasound alone and proofed that 
even ultrasound alone is able to burst clots [2]. The well known fact that blood 
clots are fibrin rich areas can be used for the development of a site specific drug 
vehicle for diagnostic and therapeutic applications.  
The aim of this study was to proof the concept that ultrasound active liposomes, 
surface modified with antifibrin antibodies, can act as drug carriers. We focused 
our work on the development of novel ultrasound active liposomes which are 
stable under similar conditions as in human body like blood pressure, 
physiological pH and body temperature. They are composed of DPPC/PEG40-
stearate or DSPC/PEG40-stearate and show a small diameter between 100-
200 nm with a sharp polydispersity. In order to develop long-circulating 
immunoliposomes, which combine sterical stabilization with a superior 
targetability, we attached fibrin antibodies directly onto the distal ends of s 
synthesized DPPE-PEG derivative, which had been endgroup-functionalized 
with cyanuric chloride [3]. The binding efficiency of the antibody, the ultrasound 
activity and the binding ability to fibrin under streaming conditions was 
investigated. 
The authors would like to thank the DFG “Forschergruppe Nanohale 695” for 
support. 
[1]  Hennerici M. The unstable plaque. Cerebrovasc Dis. 2004; 17 (Suppl 3): 17–22. 
doi:10.1159/000075300 
[2]  Daffertshofer M, Hennerici M. Ultrasound in the treatment of ischaemic stroke. Lancet Neurol. 2003; 2: 
283–90. doi:10.1016/S1474-4422(03)00380-6 
[3]  Bakowsky H, Richter T, Kneuer C, Hoekstra D, Rothe U, Bendas G, Ehrhardt C, Bakowsky U. 
Adhesion characteristics and stability assessment of lectin-modified liposomes for site-specific drug 
delivery. Biochim Biophys Acta. 2008; 1778: 242–249. doi:10.1016/j.bbamem.2007.09.033 
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Recently, increasing attention has been paid to lecithin/chitosan nanoparticles 
as colloidal drug delivery system showing the great potential to improve the 
permeation of encapsulated drug across various biological barriers [1,  2]. 
However, the overall poor stability of colloidal nanoparticles in an aqueous 
medium is a significant drawback in their development perspective. Therefore, 
the aim of this study was to set up a freeze-drying process of melatonin-loaded 
lecithin/chitosan nanoparticles in order to improve their physico-chemical 
stability. Suspensions of nanoparticles were freeze-dried in the presence of 
glucose or trehalose as cryoprotectants. Nanoparticles were characterised in 
terms of size, polydispersity, zeta-potential and melatonin content before and 
after the lyophilisation process.  
Before the lyophilisation process, lecithin/chitosan nanoparticles obtained were 
characterised by mean diameters ranging between 117.4 ± 3.9 and 328.5 ± 3.1 
nm, and were significantly larger than comparable lecithin nanoparticles. The 
zeta potential was inverted from negative values for lecithin nanoparticles to 
positive values for lecithin/chitosan nanoparticles (up to 30.2 mV).The size and 
the surface charge of the nanoparticles increased with the increase in the 
chitosan content and the negative charge of lecithin used in the preparation. 
Compared to lecithin nanoparticles, lecithin/chitosan nanoparticles were 
characterised by significantly higher melatonin loadings (up to 7.1 %, w/w). 
In the lyophilisation process it was shown that a minimal concentration of 2.5 % 
(w/v) of trehalose or glucose was needed for a suitable reconstitution of 
nanoparticles lyophilised at particle concentration of 2 mg/ml. No significant 
difference in the mean particle size, size distribution or zeta-potential of 
nanoparticles in suspension before and after freeze-drying and reconstitution 
were observed. No significant melatonin leakage caused by the stress of 
freezing and dehydration in the presence of cryoprotectants occurred.  
This work was supported by Grant 006-0061117-1244 of the Ministry of 
Science, Education and Sports of the Republic of Croatia. 
[1]  Hafner A, Lovrić J, Voinovich D, Filipović-Grčić J. Melatonin-loaded lecithin/chitosan nanoparticles: 
Physicochemical characterisation and permeability through Caco-2 cell monolayers. Int J Pharm. 
2009; 381: 205–213. doi:10.1016/j.ijpharm.2009.07.001 
[2]  Şenyiğit T, Sonvico F, Barbieri S, Özer Ö, Santi P, Colombo P. Lecithin/chitosan nanoparticles of 
clobetasol-17-propionate capable of accumulation in pig skin. J Control Release 2010; 142: 368–373. 
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Atherosclerosis is the major cause of mortality in the western world today. The 
main objective for the use of nanotechnology is to address prospects of imaging 
atherosclerotic (AS) plaques, which lead to clinical endpoints. Today various 
biomarkers are known to be involved in the pathophysiologic scenario of AS-
plaques. For the targeting the biomarker globular Adiponectin (gAd) [1] was 
coupled to two different nanoparticles (NP). The gAd-targeted NPs were 
investigated towards their potency to characterize critical scenarios within early 
and advanced AS-plaque lesions applying an AS-mouse model. Aortas of wt 
and ApoE-deficient mice, fed a high fat diet, were dissected and first stained 
with fluorescence-labelled gAd. Ex vivo imaging was performed using confocal 
laser-scanning microscopy (CLSM). Second, gAd was coupled to fluorescence-
labelled protamine-oligonucleotide nanoparticles (proticles), respectively flu-
labelled Stealth
®-liposomes to enhance the imaging performance. The gAd-
proticle constructs were characterized using scanning electron microscopy. 
Modified native gel electrophoresis was used for the characterization of the 
gAd-targeted Stealth
®-liposomes. Successful fluorescence labelling of gAd was 
achieved. According to WB analysis no critical structural changes occurred. Ex 
vivo CLSM imaging showed that flu-gAd binds to the AS-plaque but not to the 
lesser injured aortic surface. Both, successful coupling of gAd to proticles, 
respectively to the reactive PEGylated lipids exposed on the liposomal surface 
of Stealth
®-liposomes, was achieved. Compared to the plaque-staining using 
only flu-labelled gAd, the gAd targeted, flu-labelled Stealth
®-liposomes showed 
a strong signal enhancement in CLSM imaging, while the gAd targeted, flu-
labelled proticles generated a different, more spotty-like staining on the surface 
of the AS-plaques. Results by now suggest a promising role of the applied gAd-
targeted NPs for enhanced AS-imaging in vivo and their potential use for new 
targeted therapeutic strategies in cardiovascular medicine. 
[1]  Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, Uchida S, Ito Y, Takakuwa K, Matsui J, 
Takata M, Eto K, Terauchi Y, Komeda K, Tsunoda M, Murakami K, Ohnishi Y, Naitoh T, Yamamura K, 
Ueyama Y, Froguel P, Kimura S, Nagai R, Kadowaki T. Globular adiponectin protected ob/ob mice 
from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem. 2003; 278: 2461–2468. 
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Introduction: The eye provides a variety of defense mechanisms, which protect 
the organ against numerous different substances. These mechanisms include 
the bony orbit, the eyelids and cilia, the tear film and nasolacrimal drainage, 
corneal and conjunctival epithelium, and a submucosal secretory immune 
defense. In order to overcome the strong physiological barriers, new drug 
delivery systems have been established, including the development of nano-
carriers. However, it is known that nanostructured materials are able to invade 
cellular structures and trigger toxic reactions. Methods: For the establishment of 
an in vitro system, fluorescence-labelled carboxyl polystyrene particles (CPP 
20  nm and 200  nm) were characterized in terms of their physico-chemical 
properties (size, distribution, agglomeration, surface charge) in different 
biological media (i. e. MQ-water, 0.9% NaCl and tear fluid) using a ZetaSizer 
Nano-ZS (Malvern). Ex vivo permeability studies were performed with static 
Franz diffusion cells. Donor and receiver compartment were separated by 
insertion of three weeks cultured excised human corneae. CPP (20 nm) were 
suspended in physiological NaCl, applied in concentrations of 100 µg/ml and 
250 µg/ml and incubated for 6 hours. Samples were withdrawn from the 
sampling port of each cell and fluorimetrically analyzed. After 6 hours the tissue 
was fixed, frozen, sliced into 10 µm thin slides and observed with a 
fluorescence microscope. Results:  Size and surface charge of the particles 
differed according to the medium. Particles suspended in tear fluid showed 
reduced surface charges and diameters three times higher, compared to those, 
suspended in MQ-water and 0.9% NaCl. This increase in particle size can not 
only be explained by partial aggregation of the particles but also by the fact that 
in biological fluids, proteins attach to the nanoparticle surface, which leads to 
the so called ‘protein corona‘. Histopathological Analysis showed that corneal 
epithelium and endothelium detached during prolonged storage and incubation. 
Fluorescent particles were seen in the entire corneal stroma. Conclusion: 20 nm 
CPP can penetrate through Bowman´s and Descement membrane and the 
entire corneal stroma. Corneae with shorter culturing times will be used for the 
assessment of the epithelial barrier function.  
[1]  Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: An emerging discipline evolving from 
studies of ultrafine particles. Environ Health Perspect. 2005; 113: 823–39. doi:10.1289/ehp.7339 www.scipharm.at Scientia  Pharmaceutica  679 
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In studying in vitro drug release from nanoparticles (NPs) an important issue to 
consider is the method that can be used to measure drug release [1]. The 
characterization of the in vitro drug release from a colloidal carrier is technically 
difficult to achive. This can be attributed to the inability of effective and rapid 
separation of the particles from the dissolved or released drug in the 
surrounding medium owing to the very small size of nanocarriers [2]. 
The aim of our study was to compare in vitro release profiles of budesonide 
from NPs, which were obtained using four different methods for the assessment 
of drug release: membrane diffusion technique (dialysis or reverse dialysis) and 
sample and separate technique (filtration or ultracentrifugation). 
Budesonid as a hydrophobic drug was incorporated into poly(lactic acid) NPs, 
which were prepared by the nanoprecipitation method using vibrating nozzle 
device [3]. The mean size of NPs was 260 nm, the entrapment efficiency of 
budesonid 70 % and drug content 5,6 %. Our results show that in vitro drug 
release profiles from NPs obtained by four methods were different. In vitro 
release profiles obtained by filtration, centrifugation and reverse dialysis 
exhibited a typical biphasic release phenomenon namely initial burst release 
and consequently sustained release. The critical points in filtration are the pore 
size and adsorption of dissolved drug on filter membrane. The problem with 
centrifugation is that smallest particles are very slow to sediment and further 
dissolution can occur over this time. The fastest burst release phase was 
obtained after centrifugation following by filtration and reverse dialysis. The 
release of budesonide from NPs determined by dialysis was much slower and 
showed no burst release. In this method the transport across the membrane 
was rate limiting, and therefore the true release rate was not measured. 
No clear agreement exists on the suitability of the techniques reported to date 
for drug release determination from particles in the nanometer size range. Our 
results show that the comparison of in vitro release results obtaned by different 
methods is not reasonable. 
[1]  D'Souza S.S, DeLuca P.P. Methods to assess in vitro drug release from injectable polymeric 
particulate systems. Pharm Res. 2006; 23: 460–474. doi:10.1007/s11095-005-9397-8 
[2]  Dolenc A, Kristl J, Baumgartner S, Planinsek O. Advantages of celecoxib nanosuspension formulation 
and transformation into tablets. Int J Parm. 2009; 376: 204–212. doi:10.1016/j.ijpharm.2009.04.038 
[3]  Zvonar A, Kristl J, Kerč J, Ahlin Grabnar P. High celecoxib-loaded nanoparticles prepared by a 
vibrating nozzle device. J Microencaps. 2009; 26: 748–759. doi:10.3109/02652040802584402 680 Scientia  Pharmaceutica  www.scipharm.at 
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Ketoprofen is a potent non-steroidal anti-inflammatory drug and an excellent 
candidate for transdermal/dermal delivery because of its adverse side effects 
and short elimination half-time after oral administration [1, 2]. It is previously 
reported that drug loaded nanoparticles may provide a number of advantages 
compared to free drug such as increasing of bioavailability and drug skin 
penetration, ensuring controlled drug delivery, delayed and prolonged drug 
action in the application site [3,  4]. Therefore, the aim of our work was to 
prepare poly-D,L-lactide nanospheres of ketoprofen by modified precipitation 
method and to characterize them [5,  6]. The size and morphology of the 
obtained particles have been determined by field-emission scanning electron 
microscopy (FESEM) and laser light diffraction. Span value and mean diameter 
were about 1,3 and 65 nm, respectively. The encapsulation of ketoprofen into 
the PDLLA nanospheres was confirmed by X-ray diffraction (XRD) and infrared 
spectroscopy (FT-IR). Nanoparticles of ketoprofen were obtained with high 
encapsulation efficiency.  
[1]  Fujii M, Hori N, Shiozawa K, Wakabayashi K, Kawahara E, Matsumoto M. Effect of fatty acid Esters on 
permeation of ketoprofen through hairless rat skin. Int J Pharm. 2000; 205: 117–125. 
doi:10.1016/S0378-5173(00)00496-8 
[2]  Kim B.S, Won M, Yang, Lee K.M, Kim C.S. In Vitro Permeation Studies of Nanoemulsions Containing 
Ketoprofen as a Model Drug. Drug Deliv. 2008; 15: 465–469. doi:10.1080/10717540802328599 
[3]  Luengo J, Weiss B, Schneider M, Ehlers A, Stracke F, König K, Kostka K.H, Lehr C.M, Schaefer U.F. 
Influence of nanoincapsulation on human skin transport of flufenamic acid. Skin Pharmacol Physiol. 
2006; 19: 190–197. doi:10.1159/000093114 
[4]  Rancan F, Papakostas D, Hadam S, Hackbarth S, Delair T, Primard C, Verrier B, Sterry W, Peytavi 
U.B, Vogt A. Investigation of Polylactic Acid (PLA) Nanoparticles as Drug Delivery Systems for Local 
Dermatotherapy. Pharm Res. 2009; 26: 2027–2036. doi:10.1007/s11095-009-9919-x 
[5] Stevanović M, Ignjatović N, Jordović B, Uskoković D. Stereological analysis of the poly(D, L-lactide-co-
glycolide) submicron sphere prepared by solvent/non-solvent chemical methods and centrifugal 
processing. J Mater Sci: Mater Med. 2007; 18: 1339–1344. doi:10.1007/s10856-007-0156-8 
[6] Jovanović I, Jordović B, PetkovićM, Ignjatović N, Uskoković D. Preparation of smallest microparticles 
of poly-D, L-lactide by modified precipitation method: Influence of the process parameters. Microsc 
Res Tech. 2008; 71: 86–92. doi:10.1002/jemt.20529 www.scipharm.at Scientia  Pharmaceutica  681 
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Formulation development of nanostructured lipid carriers (NLC) aims physical 
stability in both particle size and crystalline state. Besides production 
parameters, the selection of appropriate stabilizers is the most crucial 
parameter in the development. Very often the influence of different stabilizers 
on the size and the physical stability is investigated. However, little is known 
about the influence of stabilizers on the crystalline state of lipid nanoparticles 
(LN). Thus, two surfactants of polyglycerol fatty acid ester type were screened 
for their ability to form physically stable NLC and for their influence on the 
crystalline state of the lipid matrix. The investigated surfactants are polyglycerol 
6-distearate (PD) and polyglycerol 6-isostearate (Pl). Physical stability study 
was performed using light microscopy, dynamic and low angle static light 
scattering. DSC study was used to analyze the crystalline status of LN. Both 
surfactants in the concentration of 1.0 % (w/w) led to almost similar LN with a 
mean diameter between 180–200 nm. LN were stable over the period of 90 
days. The absence of large particles was also confirmed by light microscopy 
and low angle static light scattering. In contrast to this significant differences 
were found within DSC thermograms. LN stabilized with PD show a melting 
event, whereas LN stabilized with PI show no melting event. Hence, PI inhibited 
the crystallization of the lipid matrix, leading to a non-crystalline LN instead of 
NLC. A possible explanation is that PD which has a solid lipid tail leads to a 
different interaction with lipid matrix, than the liquid lipid tail surfactant (PI). 
These interactions can lead either to an initiated crystallization or to the 
circumvention of crystallization. In conclusion: Stabilizers can influence the 
crystalline state of the lipid matrix of LN. Thus, for a successful development, 
this parameter needs to be investigated. Furthermore, it might be a helpful tool 
to develop NLC with a “tailor-made” crystalline state and release profile in the 
future. 
The authors would like to acknowledge the financial support obtained from 
DAAD (Deutscher Akademischer Austauschdienst) for the present research. 
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Solid lipid nanoparticles (SLN) represent rapidly growing class of colloidal 
transport system, particularly interesting for pharmaceutical applications [1]. 
Various physical methods can be used for characterization of nanoparticles 
(NPs), but evidently, their imaging and monitoring, especially in biological 
system, are of primary importance.  Fluorescence microscopy may provide 
valuable information regarding interactions between nanoparticulate carriers 
and target cells as well as their intracellular fate. For this purpose, good 
fluorescent labels are needed. Since numerous different dyes with affinity to 
particular target object in the cell are available, for colloidal carriers only few are 
frequently used (e.  g. derivatives of cyanine, fluorescein, rhodamine and 
coumarin), which are not design for particular nanosized system and often 
make comprehension difficult [2].  
The advantages of the in vitro imaging of SLN by using novel fluorescent dye 
(SPP-189) was investigated in comparison with frequently used dye 6-coumarin 
(C). SPP-189 is derivative of coumarin with long lipophilic chain [3] which 
enables its stronger integration into lipid matrix of SLN than 6-coumarin, what 
was proved by release study. SPP-189 shows overall brightness in the pictures 
of long lasting monitoring of SLN-SPP-189 internalization and intracellular 
localization comparing to the dye 6-coumarin (Figure 1).  
Accordingly, we present an extremely sensitive tool to monitor the location of 
fluorescently labelled NPs by SPP-189 within respective organelles that should 
find a wide application in drug study.  
SLN-SPP SLN-C
A B
 
Fig. 1. Imaging of internalized SLN (marked with 
arrows) located next to the nuclei (rounded 
structure). A - SLN-SPP are seen distinctly as 
(blue) dots, while B - SLN-C are hardly re-
cognized due to the broadly distributed 
fluorescence from 6-coumarin (green). Bar is 
10 μm. 
 
[1]  Teskac K, Kristl J.The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int J 
Pharm. 2010; 390: 61–69. doi:10.1016/j.ijpharm.2009.10.011 
[2]  Watson P, Jones AT, Stephens DJ. Intracellular trafficking pathways and drug delivery: fluorescence 
imaging of living and fixed cells. Adv Drug Deliv Rev. 2005; 57: 43–61. doi:10.1016/j.addr.2004.05.003 
[3]  Pajk S, Pecar S. Synthesis of novel amphiphilic spin probes with the paramagnetic doxyl group in the 
polar region. Tetrahedron. 2009; 65: 659–665. doi:10.1016/j.tet.2008.11.016 
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Nanoparticles composed of silica and its derivatives are currently in use both in 
basic scientific research and applied enginnering development. Precursor silica 
particles have been investigated for applications in microeletronics, chemical, 
biological sensors, as targeting devices and in drug delivery [1]. The efficacy 
and quality of these products is highly dependent on the size and polydispersity 
of the silica nanoparticles [2]. The aim of this work was to compare two mixing 
modes, i.  e. ultrasonication vs magnetic stirring, in the synthesis of silica 
nanoparticles. These nanoparticles were produced applying the aqueous sol-gel 
method [3] at room temperature via hydrolysis and condensation of tetraethyl 
orthosilicate (TEOS) using HCl as catalytic agent. Particle size was measure by 
dynamic light scattering (DLS) and the morphology of nanoparticles was 
assessed by transmission electron microscopy (TEM). Ultrasonication and 
magnetic stirring allowed the production of particles with mean average size of 
485.9  nm and 81.8  nm, respectively. TEM micrographs showed that particle 
aggregation is stronger under ultrasonication process in comparison to 
magnetic stirring. This result was attributed to the nanoparticles collision 
enhanced by the higher input of energy of sonication which is minimized under 
magnetic stirring. Furthermore, the latter provides a more uniform energy 
distribution in the dispersion contributing to better assembling of these particles. 
The formation of homogenous, monodispersed nanometer silica particles 
depends on the reaction conditions and parameters e. g. TEOS concentration, 
pH, temperature and H2O/TEOS ratio. 
Acknolowledgements: This work was supported by FCT, SFRH/BD/60640/2009 
to T. Andreani and by Capes to A.L.R. Souza. Whe are thankyfull to Dr. L. 
Fernandes for TEM assistance. 
[1]  Amglin EJ, Cheng L, Freeman WR, Sailor MJ. Porous silicon in drug delivery devices and materials. 
Adv Drug Deliv Rev. 2008; 60: 1266–1277. doi:10.1016/j.addr.2008.03.017 
[2]  Park SK, Kim KD, Kim HT. Preparation of silica nanoparticles: determination of the optimal synthesis 
conditions for small and uniform particles. Colloids Surf A Physicochem Eng Asp. 2002; 197: 7–17. 
doi:10.1016/S0927-7757(01)00683-5  
[3]  Ferrer ML, Del Monte F, Levy D. A novel and simple alcohol-free sol-gel route for encapsulation of 
labile proteins. Chem Mater. 2002; 14: 3619–3621. doi:10.1021/cm025562r 684 Scientia  Pharmaceutica  www.scipharm.at 
Presented at the 8
th Central European Symposium on Pharmaceutical Technology, 
September 16
th–18
th 2010, Graz, Austria. 
Conference abstract PNM14 
Itraconazol-Loaded Nanostructured Lipid 
Carriers (NLC) for Pulmonary Application 
J. PARDEIKE 
1, S. WEBER 
1, H. P. ZARFL 
2, A. ZIMMER 
1 
1 Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology, Karl-Franzens Universität 
Graz, Universitätsplatz 1, 8010 Graz, Austria 
2 Private Veterinary Sugery, Auen 23, 9400 Wolfsberg, Austria 
E-mails: jana.pardeike@uni-graz.at (J. Pardeike), h.p.zarfl@gmail.com (H.P. Zarfl) 
Sci Pharm. 2010; 78: 684        doi:10.3797/scipharm.cespt.8.PNM14 
Introduction: Aspergillosis is a common fungal infection in falcons. Standard 
treatment, systemic application of Itraconazol, is limited due to hepatotoxicity. 
The aim of the present study was to develop Itraconazol-loaded Nanostructured 
Lipid Carriers (NLC) for pulmonary application. NLC are a nanoparticulate 
carrier system composed of a blend of solid lipid and liquid lipid, with a particle 
matrix being solid at body temperature. NLC have shown many advantages for 
pulmonary application such as deep lung deposition due to the small particle 
size, adhersive properties leading to an accumulation in the lung, prolonged 
release properties leading to a reduction of dosing frequency and low toxicity 
due to the use of well tolerated excipients.  
Material & Methods: NLC composed of 0.02% Itraconazol (Jai Rhades Sales, 
India), 4.5% Precirol ATO 5 (Gattefossé, Germany), 0.5% oleic acid (Croda, 
Germany), 2% Tween 20 (Cognis, Germany) and 92.81% Milli-Q water were 
prepared by hot-high pressure homogenization method (Panda K2, GEA Niro 
Soavi, Germany). The particle size of NLC was determined using a NanoSizer 
ZS (Malvern Instruments, UK). The melting point of NLC was assassed by 
differential scanning calorimetry using a DSC 204 F1 Phoenix (Netzsch, 
Germany). NLC dispersion was nebulized using a Nanonebulizer (Medic Activ, 
Germany). The particle size of the aerosol was analysed using a wide range 
aerosolspectrometer (Grimm Aerosol Technik, Germany). 
Results & Discussion: Itraconazol-loaded NLC with an average particle size of 
119 nm and a polydispersity index (PI) of 0.254 were obtained applying 5 
homogenisation cycles at 500 bar. NLC showed a melting point of 45.1°C 
proving the solid state of the particle matrix of the carrier system. Nebulizing the 
NLC dispersion using a Nanonebulizer led to an aerosol with an average 
particle size of 265 ± 1.78 nm. The particle size of NLC in the aerosol was found 
to be of the same order of magnitude as before nebulization, which shows that 
after nebulization the favorable characteristics of the delivery system are 
maintained. 
Conculusion: Nebulization of Itraconazol-loaded NLC using a Nanonebuizer by 
MedicActiv leads to an aerosol with favorable characteristics for pulmunar 
treatment of aspergilosis in falcons. 
This work was supported by MedicActiv Vertriebs-GmbH (www.medicactiv.de). www.scipharm.at Scientia  Pharmaceutica  685 
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In order to use API (active pharmaceutical ingredient) particles in a dry powder 
formulation, they have to exhibit an aerodynamic diameter of 1 µm – 5 µm. Only 
this order of magnitude guarantees a penetration to the deeper parts of the 
lungs. Particles of this scale are very cohesive and possess rather poor flow 
properties [1], which lead to difficulties concerning volumetrically dosing. To 
handle cohesivity, the drug particles may be coated with particles in the 
nanometer range. Nanoparticles will act as spacers between the contacting API 
particles and may cause a reduction of the interparticle forces. Already 
implemented experiments showed that Aerosil® particles can enormously alter 
the particles´ flow characteristics. [2–4]. Due to the fact that Aerosil® is not 
approved in DPI formulations, there is a rising demand for substances, which 
can be used as an alternative. 
The aim of this work is to create nanoparticles via a novel spray drying 
technique. With the help of this apparatus, it is feasible to produce API particles 
in the nanometer range. The intended benefit is the absence of any excipient, 
because both, the drug itself (1 µm – 5 µm) and the nanoparticles, acting as 
flowability enhancers, are made of the same API substance. During a mixing 
process [5] the nanoparticles are attached on the microparticles` surface. This 
alternative DPI formulation should facilitate a reproducible dosing, which is a 
quite important requirement for using DPI's. 
[1]  Daniher DI, Zhu J. Dry powder platform for pulmonary drug delivery. Particuology. 2008; 6: 225–238. 
doi:10.1016/j.partic.2008.04.004 
[2]  Mykhaylova V. Developent of microparticle - nanoparticle powder mixtures for the use in dry powder 
inhalers. PhD Thesis. Heinrich-Heine-Universiät Düsseldorf, 2009. 
[3]  Huber G, Wirth KE. Electrostatically supported surface coating of solid particles in liquid nitrogen for 
use in Dry-Powder-Inhalers. Powder Technol. 2003; 134: 181–192. doi:10.1016/S0032-
5910(03)00128-1 
[4]  Linsenbühler M, Wirth KE. An innovative dry powder coating process in non-polar liquids producing 
tailor-made micro-particles. Powder Technol. 2005; 158: 3–20. doi:10.1016/j.powtec.2005.04.035 
[5]  Wirth KE, Linsenbühler M. Electrostatically supported mixing of fine grained particles. Chem Eng 
Technol. 2004; 27: 729–732. doi:10.1002/ceat.200403219 
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The major limitations for the use of small interfering RNA (siRNA) in vivo and in 
vitro are the relatively high molecular weight, the negative charge, and the 
susceptibility to nuclease degradation  [1]. Therefore it is imperative to use 
suitable carrier systems to ensure internalization and intracellular separation of 
the components to subsequently induce RNA interference. The aim of this study 
was to silence a specific protein expression with a nanoparticulate system by 
RNA interference and analyze the consequences on tumor cell growth, 
proliferation and protein expression. Fluorescence microscopy was used for 
intracellular detection and localization of the components. This study was 
performed to determine differences between intracellular siRNA delivery after 
the application of different developed protamine-based nanoparticle systems 
and their effect on human glioma cells. Therefore two particulate systems 
composed of i) siRNA and protamine (binary particls) and ii) siRNA, protamine 
and human serum albumin (ternary particles) were assembled and analysed by 
size and surface charge before applying on cells. Our study has yielded the 
following results: fluorescence microscopy showed differences in intracellular 
particle separation. Binary particles could not be separated after internalization. 
Protamine-rhodamine B was colocalized with siRNA-FAM dye in the cytoplasm 
while in case of ternary particles no intracellular protamine signal could be 
detected. In this case siRNA-FAM was uniformly distributed in the cytoplasm. 
Furthermore PCR studies showed a protein expression of 76% for ternary 
particles and 112% for the binary system referring to control (100%). 
Proliferation of the cells after transfection was 85% for ternary particles and 
106% for binary particles. This data verified the necessarity of intracellular 
separation of siRNA from the nanoparticle complex to induce RNA interference.  
The authors would like to acknowledge the financial support of the study by 
FFG, Bridge-program: P810994.  
[1]  Meade BR, Dowdy SF. Enhancing the cellular uptake of siRNA duplexes following noncovalent 
packaging with protein transduction domain peptides. Adv Drug Deliv Rev. 2008; 60: 530–536. 
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Pharmaceutical drug formulations in the nanometer scale received significant 
interest during the last years as they provide the possibility to stabilize drugs 
and to transport them directly to their target. Biodegradable self-assembled 
nanoparticles consisting of protamine and oligonucleotides, so-called “proticles”, 
have already been successfully developed for different applications [1, 2]. 
However, the production could only be performed at the milliliter scale due to 
the sensibility with respect to parameter changes at larger volumes. For further 
investigations, such as in-vivo or clinical studies, it is essential to scale-up the 
production process to achieve larger amounts of proticles. As the introduction of 
a microreactor has been shown to have many advantages for the scale-up of 
nanoparticle formation processes, this approach is investigated for the 
production of proticles. The advantages of microreactors include the ability for 
continuous mixing of small volumes and the precise control of the operating 
parameters [3]. Because of the high costs of oligonucleotides, alternative 
nanoparticles comprising protamine and polyacrylic acid were developed for the 
first scale-up experiments. The characterization of these nanoparticles 
produced at the milliliter scale, included size and zeta potential measurements 
which were performed by Dynamic Light Scattering and Laser Doppler 
Electrophoresis. Protamine binding efficiency was determined by fluorimetry. 
After optimization of the process, particles of about 150 nm and a zeta potential 
of around 30 mV were produced exhibiting a suspension stability of at least 5 
days. First experiments with a microreactor can now be started. This 
presentation will highlight some details of the microreactor, its advantages in the 
scale-up and the latest results concerning the nanoparticle production. 
The project is supported by one-A engineering austria, Prager Elektronik and 
the Austrian NANO Initiative (Nano-HEALTH). 
[1]  Junghans M, Kreuter J, Zimmer A. Antisense delivery using protamine-oligonucleotide particles. 
Nucleic Acids Res. 2000; 28: E45. doi:10.1093/nar/28.10.e45 
[2]  Wernig K, Griesbacher M, Andreae F, Hajos F, Wagner J, Mosgoeller W, Zimmer A. Depot formulation 
of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles. J Control Release. 
2008; 130: 192–198. doi:10.1016/j.jconrel.2008.06.005 
[3]  Chang C, Paul B, Remcho V, Atre S, Hutchison J. Synthesis and post-processing of nanomaterials 
using microreaction technology. J Nanopart Res. 2008; 10: 965–980. doi:10.1007/s11051-007-9355-y 
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Ischemic stroke results from a cerebral vessel occlusion by a blood clot. 
Treatments are intended to restore the cerebral blood flow as soon as possible 
to avoid major brain damage. Intravenous administration of recombinant tissue 
plasminogen activator (rtPA) is the only thrombolytic drug approved for 
treatment of acute ischemic stroke [1]. 
In vitro and in vivo studies have shown that rtPA in combination with ultrasound 
and microbubbles can improve clot lysis [2]. However, the exact mechanisms 
involved in this sonothrombolysis process remain unknown. Additionnally, the 
optimal conditions for clot lysis are not mastered. 
The aim of the present work was to set up a robust in vitro human clot model 
and to evaluate the thrombolytic effect of rtPA and microbubbles while varying 
various acoustic parameters. 
Practically, fresh whole human blood clots were formed after three hours at 
37°C in 200 µL glass micropipettes through which a silk suture had been 
threaded. The clots were characterized by their diameter, by scanning electron 
microscopy (SEM) and by immunostaining. The clots were placed in a cell 
mounted with transparent Mylar® films, and filled with human plasma. The cell 
was then placed in a thermostated water bath (37°C) and the clot was exposed 
to different experimental conditions of ultrasound (0.65MHz), rtPA and 
microbubble suspensions in a continuous infusion. Every five minutes during 60 
minutes photographs were taken and analysed to determine the mean diameter 
decrease of the clot. 
The clots had an initial diameter of 0.89 ± 0.06 mm (mean diameter ± sd). In the 
presence of rtPA at 3 µg/mL, microbubbles and ultrasound, the mean clot 
diameter dropped by more than 0.5 mm in 60 min. Under SEM and with the 
immunostaining, sonothrombolysis effects were clearly observed. 
These preliminary experiments are encouraging and will enable a thorough 
evaluation of the synergetic effects of microbubbles, ultrasound and rtPA. 
[1]  Adams H P, Del Zoppo G, Alberts M J, Bhatt D L, Brass L, Furlan A, Grubb R L, Higashida R T, Jauch 
E C, Kidwell C, Lyden P D, Morgenstern L B, Qureshi A I, Rosenwasser R H, Scott P A, Wijdicks E F 
M. Guidelines for the Early Management of Adults With Ischemic Stroke. Stroke. 2007; 38: 1655–
1711. doi:10.1161/STROKEAHA.107.181486 
[2]  Meairs S, Culp W. Microbubbles for Thrombolysis of Acute Ischemic Stroke. Cerebrovasc Dis. 2009; 
27 (Suppl 2): 55–65. doi:10.1159/000203127 www.scipharm.at Scientia  Pharmaceutica  689 
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The majority of topical ocular preparations available today are in the form of 
aqueous eye drops. This might be due to existing problems related to ocular 
drug delivery systems such as cost, bulk manufacturing, and patient 
compliance. Commercial eye drops are commonly used by patients, due to their 
ease in usage and low interference with vision. A homogenous dosage solution 
form offers many industrial advantages including the simplicity of large-scale 
manufacturing. At the ame time, commercial eye drops are often ineffective and 
require frequent application. Only 1–5% of the applied drug penetrates the 
cornea and goes into intraocular tissues [1, 2]. Therefore, the aim of this study 
was to formulate a polyelectrolyte/surfactant mixture that can maintain the 
advantage of commercial eye drops while enhancing biopharmaceutical 
properties i.e., enhanced ocular bioavailability. 
Micelle systems composed of the polyoxyethylated nonionic surfactant 
Pluronic
® F127 (F127) and cationic polyelectrolyte chitosan (CH) were prepared 
with dexamethasone (DEX) as a hydrophobic model drug. The F127/CH 
micelles were characterised by their hydrodynamic diameter and a zeta-
potential ranging between 25.4 and 28.9 nm and +9.3 and +17.6 mV, respec-
tively. The DEX loading was between 0.48% and 0.56%, and no significant 
influence of CH on DEX loading was observed. 
This colloidal carrier was well tolerated in rabbit eyes, and no clinically abnormal 
signs in various ocular structures were observed. The increase in intraocular 
pressure (IOP) in rabbits was used to evaluate DEX ocular bioavailability. The 
AUC values showed a 1.7- and 2.4-fold increase in bioavailability with F127 and 
F127/0.015 w/v % CH micelle systems, respectively, as compared to a standard 
DEX suspension. These data indicate improved intraocular DEX absorption 
from the micelle systems, which can be ascribed to both F127 and CH corneal 
permeability enhancement. 
This work was supported by Grant 006-0061117-1244 of the Ministry of 
Science, Education and Sports of the Republic of Croatia 
[1]  Ali Y, Lehmussaari K. Industrial perspective in ocular drug delivery. Adv Drug Deliv Rev. 2006; 58: 
1258–1268. doi:10.1016/j.addr.2006.07.022  
[2]  Sánchez A, Alonso MJ. Nanoparticular carriers for ocular drug delivery. In Torchilin V, editor 
Nanoparticulates as drug carriers. 2006, London: World Scientific-Imperial College Press. p 649–673. 690 Scientia  Pharmaceutica  www.scipharm.at 
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Aim:  Different promising colloidal delivery systems including microemulsions 
and liquid crystals could be obtained with suitable combination of oil, 
surfactants/cosurfactants and water. However, the main problem from a 
formulation point of view has been to choose the surfactants capable of forming 
such systems and be physiologically acceptable in the same time. To overcome 
the later shortcoming the use of less toxic non ionic or biocompatible naturally 
obtained surfactant is proposed [1]. 
The aim of this study was to develop and characterize colloidal systems for 
dermal delivery based on nontoxic components, i. e. lecithin and Tween 80 as 
surfactant mixture, isopropyl myristate as oily phase and water. 
Experimental: Pseudoternary phase diagrams were constructed using 
conventional titration technique with 1:1 and 2:1 mass ratios of Tween 80 to 
lecithin, respectively, isopropyl myristate and water. Clear samples of high 
viscosity were deemed to be lyotropic liquid crystals. Representative samples 
were further evaluated for their physical stability and rheological characteristics, 
while the structure of the samples was examined with a polarization 
microscope. 
Results and discussion: The region of clear and highly viscous mixtures was 
detected at higher concentrations of Tween 80/lecithin (at both mass ratios) that 
were further on confirmed as lamellar lyotropic liquid crystals with polarization 
microscopy due to characteristic “Maltese cross” textures The samples were 
physically stable at room temperature during 2 months and after centrifuge test. 
Determination of viscosity and flow curves showed shear-thinning 
characteristics and thixotropic behaviour of samples containing more than 35% 
of water, while samples with less than 30% of water revealed rheopectic 
properties. Additionally, the viscosity was decreasing with increasing 
temperature, and was affected by composition of surfactant mixture (higher 
content of Tween 80 induced higher viscosity) and water content (up to 40% 
water content increased viscosity due to hydration of lecithin polar head 
groups).  
Conclusion:  Lamellar lyotropic liquid systems were identified from phase 
diagrams at higher surfactant concentration. They show great potential for 
dermal application due to nontoxicity of surfactants, physical stability and 
moreover, convenient rheological properties. 
[1]  Moreno MA, Ballesteros MP, Frutos P. Lecithin-Based Oil-inWater Microemulsions for Parenteral Use: 
Pseudoternary Phase Diagrams, Characterization and Toxicity Studies. J Pharm Sci. 2003; 7: 1428–
1437. doi:10.1002/jps.10412 www.scipharm.at Scientia  Pharmaceutica  691 
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Solid dispersions of active pharmaceutical ingredients (APIs) in freely water 
soluble carriers are often used in order to improve dissolution rate and/or 
solubility of poorly water soluble drugs [1] in the aqueous gastro intestinal fluids. 
Depending on the dispersion of the drug in the carrier one may distinguish 
between solid solutions, in which the drug is molecularly dispersed within the 
carrier and solid suspensions, which is a dispersion of either amorphous or 
crystalline drug particles in the carrier. Whether a solid solution or a solid 
suspension is obtained, depends on the preparation conditions of the solid 
dispersion. Moreover, storage may lead to changes in the dispersion of the drug 
in the carrier, for example leading to the recrystallisation of initially dissolved 
API in the carrier. These changes may substantially alter the dissolution 
profile/solubility of the drug in the aqueous dissolution media. 
There are several techniques that are used in order to either determine the 
state of dispersion of the drug in the carrier or to monitor storage induced 
changes. Conventional techniques include thermal analysis and wide angle X-
ray diffraction, although the detection of very fine drug crystals in the carrier or 
the transition of an initial solid solution to a solid suspension at a very early 
stage is almost impossible. 
We apply simultaneous small and wide-angle X-ray scattering, which is 
becoming more important for solid-state pharmaceutical analytics [2], in order to 
gain information of solid nano-structure and dispersions stability. The study 
presents examples consisting of nimodipine and polyethylene glycol and/or 
polyvinylpyrrolidone, characterized by SWAXS analytical parameters. 
[1]  Chiou WL, Riegelmann S. Pharmaceutical Applications of Solid Dispersion Systems. J Pharm Sci. 
1971; 60: 1505–1510. doi:10.1002/jps.2600600902 
[2]  Hodzic A, Kriechbaum M, Laggner P. Laboratory SWAXS for application in the pharmaceutical 
technology. Acta Cryst A. 2009; A65: S120. 692 Scientia  Pharmaceutica  www.scipharm.at 
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In order to fulfill the qualtity requirements introduced by regulatory authorities for 
pharmaceutical products, sure and adequate methods are needed for the 
product qualification. A considerable portion of process analytical technology 
(PAT) tools exists, which satisfy many expected requirements, as non-
destructive and sensitive examination of material properties. Recently 
continuous manufacturing (e.  g. mixing, extruding, etc.) became a big issue, 
which has the need for fast process monitoring systems with the capability for 
real-time and in-line measurements. 
Here, a near-infrared (NIR) spectral imaging system (Helios Core from EVK DI 
KERSCHHAGGL) with an InGaAs detector (240x316 Pixel) was tested for its 
applicability in the pharmaceutical industry. The system characterization was 
performed in order to examine detection limits for low active pharmaceutical 
ingredient (API) content or powder blends, impurities in powder mixtures and 
the coating thickness of tablets. Multivariate data analysis (MVDA) was applied 
for qualitative and quantitative evaluation. 
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Spray coating is an important unit operation in the pharmaceutical industry. The 
ultimate goal is to produce uniformly coated products with the desired amount of 
coating material, to guarantee controlled active pharmaceutical ingredient (API) 
release. The coating thickness and homogeneity can be determined with 
spectroscopic process analytical technology (PAT) tools, like near-infrared 
(NIR) and Raman spectroscopy.  
Here, both spectroscopic techniques were applied for the analysis and 
characterization of tablet coatings. Due to the relatively small coating thickness 
with respect to the penetration depth of the excitation, both laser light and 
Raman scattering penetrate through the coated layer. Hence, Raman chemical 
mapping can also be used to analyse qualitatively the chemical composition 
(i.  e. the distribution of (active) components) in tablets. A quantitative 
multivariate data analysis (MVDA) based model for the tablet coating thickness 
was developed on basis of tablets sampled from different stages of a coating 
process [1, 2]. Calibration was carried out by monitoring weight gain, which is 
also used in industrial quality control. A comparison between calibration models 
for four different sampling modes (Mapping,  Line,  Super Macro and  Single 
Point) was performed. The root mean squared error of prediction (RMSEP) of 
the different sampling methods showed 1.25, 1.33, 2.1 and 2.05  mg for 
Mapping,  Line,  Super Macro and Single Point measurement respectively. In 
accordance, NIR measurements with a fiber optical reflectance probe showed a 
RMSEP of 1.07 mg, representing a good correlation between the two methods.  
Although the RMSEP of the mapping mode is the smallest, it does not 
compensate for the much longer measurement time. Raman chemical mapping 
is conditionally applicable for the determination of coating thickness, but it is not 
a rapid standard method. 
[1]  Heigl N, Koller DM, Hörl G, Khinast JG. Assessing the Component Distribution Homogeneity of 
Tablets by Raman Chemical Mapping and Determining the Coating Thickness by FT-NIR and varying 
Raman Spectroscopic Sampling Approaches by means of Multivatiate Calibration; in preparation 
[2]  Kauffman JF, Dellibovi M, Cunningham CR. Raman spectroscopy of coated pharmaceutical tablets 
and physical models for multivariate calibration to tablet coating thickness. J Pharm Biomed Anal. 
2007; 43: 39–48. doi:10.1016/j.jpba.2006.06.017  694 Scientia  Pharmaceutica  www.scipharm.at 
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We investigate the compaction behavior of the most usual pharmaceutical 
excipients mixture (placebo) contained lactose monohydrate (LmH), 
microcrystalline cellulose (MCC), silicum dioxyd (SiO2) and magnesium stearate 
(MgSt)  with combined small- and wide-angle X-ray scattering (SWAXS). In 
general, the method is becoming an increasingly important technique in 
pharmaceutical solid-state characterization [1, 2]. Highly relevant questions of 
polymorphism in crystalline materials, stability and nanostructure of amorphous 
states, total inner surface in controlled-release formulations, stability and ageing 
formulations can be addressed by this technique. The information to be gained 
by SAXS expands largely the scope of conventional powder diffraction 
techniques. A particular advantage lies in the simultaneous observation of 
nano-scale (SAXS) and atomic scale (WAXS). With the development of high-
brilliance laboratory SWAXS systems (Hecus S3MICROpix) the times for 
analysis have been greatly reduced, and hence the method can be applied to 
quality screening and process analytical technology (PAT). Furthermore, 
examples will be presented for technologically relevant systems, such as 
polymorphic forms of active ingredient carbamazepine, compactness of 
granulate, amorphous formulations of their coating lack, and dissolution 
behavior of pentoxifylline after process granulation. The results show, that an 
analysis in terms of robust SAXS parameters, such as total inner surface, 
scattering power intensity, Porod exponent and average correlations length, can 
provide highly valuable technological information about granulate compactness 
and dissolution behavior in correlation with tablets hardness. 
[1]  Hodzic A, Kriechbaum M, Laggner P. Laboratory SWAXS for application in the pharmaceutical 
technology. Acta Cryst A. 2009; A65: S120. 
[2]  Laggner P, Kriechbaum M, Rappolt M, Pabst G, Amenitsch H, Johs A, Lohner K, Zweytick D, 
Koschuch R, Abuja P. Pharmaceutical solid-state characterization by small-and wide-angle X ray 
scattering, In: Solid State Characterization of Pharmaceuticals. Eds. A. and M. Zakrzewski. Assa 
International, 2005. Danbury, chapter 12.  www.scipharm.at Scientia  Pharmaceutica  695 
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Protein aggregation represents probably the most common and troubling 
manifestation of protein instability. Shelf life of therapeutic proteins is 
particularly impaired by aggregation, which can occur almost in all phases of 
protein drug development. Administration of protein aggregates may lead to 
reduced pharmacological activity and adverse drug reactions. Thus, prediction 
of protein aggregation is of major interest for pharmaceutical industry. Existing 
sequence based bioinformatic tools are barely able to predict the aggregation 
behavior of therapeutic proteins. To implement new approaches for this, 
detailed analysis of protein aggregation, its underlying mechanisms and its 
kinetics is necessary. 
In our study we simulate process conditions for induction of aggregation of a 
common therapeutic protein (granulocyte colony stimulating factor, G-CSF). 
Size exclusion HPLC is performed to quantify protein aggregates and to enable 
kinetic pathway analysis by identification of different aggregation intermediates 
under certain process and formulation conditions over time. Further 
characterization is accomplished using intrinsic fluorescence, polyacrylamid gel 
electrophoresis and mass spectrometry. 
This work was supported by FFG, Land Steiermark and Steirische 
Wirktschaftsförderung (SFG). 
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Introduction: 
To investigate the nonlinear kinetics of in vitro hepatic uptake the OATP 
substrate, Pitivastatin, was used as a probe. Experiments were conducted using 
freshly isolated rat hepatocytes, utilising the ‘oil spin’ methodology described by 
Hassen et al [1]. Briefly, freshly isolated rat hepatocytes were incubated with 
Pitvastatin (5–300µM). At 10 s, 30 s, 50 s and 70 s aliquots were spun through 
a silicone oil layer to separate the hepatocytes from the media. 
[Pitivastatin]hepatocyte was detemined using LCMSMS. 
Results: 
Uptake to rat hepatocytes was saturable and progressed according to 
Michaelis-Menten kinetics. The Km  and Vmax of Pitvastatin were 2050 
pmols/min/10
6 cells and 33 µM respectively, which was in in good agreement 
with other literature reports [2]. 
Mathematical Modelling: 
A nonlinear pharmacokinetic model has been derived to characterise the uptake 
process. A structural identifiablity analysis was performed on the model to 
establish that all unknown parameters could be identified from the experimental 
observations available. The model was then subsequently used for parameter 
estimation and model validation using the data collected. Sensitivity analysis 
and model robustness analyses were also performed. Once fully validated the 
model has the potential to perform robust, predictive simulations to ascertain 
optimal levels of uptake and the effects of the use of appropriate inhibitors.  
This work was supported by AZ & TG was supported by AZ and the MRC 
Capacity Building initiative. 
[1]  Hassen AM, Lam D, Chiba M, Tan E, Geng W, Pang KS. Uptake of sulfate conjugates by isolated rat 
hepatocytes. Drug Metab Pharmacokin. 1996; 24: 792–798. PMid:8818578 
[2]  Shimada S, Fujino H, Morikawa T, Moriyasu M, Kojima J. Uptake mechanism of pitavastatin, a new 
inhibitor of HMG-CoA Reductase, in rat hepatocytes. Drug Metab Pharmacokin. 2003; 18: 245–251. 
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Stressful life style of modern human societies leads to many diseases and one 
of the growing indispositions related to this fact is hypertension. Thus, there is a 
strong need for novel effective drugs. One of the new categories of 
antihypertensive drugs consists of AT1 antagonists (SARTANs), whose action is 
based on blocking of the active site of the AT1 receptor. The aim of the present 
study is to contribute to a basic understanding of the their molecular mode of 
action on membranes. We studied influences on the binary mixtures of 
DMPC/cholesterol and POPC/cholesterol. Losartan led to a complete loss of 
positional correlations between adjacent bilayers for all single component model 
membranes. This can be explained by the negative surface charged conferred 
to the bilayers upon losartan insertion. The effect was however, counter-
balanced upon the addition of cholesterol. Both, POPC and DMPC bilayers 
exhibited no positional correlations up to 5 mol% cholesterol, respectively. 
However, only POPC remained uncorrelated at 20 mol% and above, while 
DMPC/cholesterol bilayers exhibited multilamellar vesicles, i.  e. a reentrant 
transition of the positionally uncorrelated bilayers into correlated ones. Our 
results may be understood in view of the different hydrocarbon chain packing 
densities in saturated versus unsaturated bilayers and their respective affinities 
to interaction with cholesterol. This shows that the insertion of losartan into the 
membrane may be overridden by a tighter bilayer interface and emphasizes the 
role of hydrocarbon chain composition in its mode of action. Additionally, we 
also the influence of the SARTANs (e.  g. losartan, candesartan-cilexiril and 
valsartan) on the global structure of phospholipid bilayers composed of pure 
dimyristoyl phosphatidylcholine (DMPC), palmitoyl oleoyl phosphatidylcholine 
(POPC) and dipalmitoil phosphatidylcholine (DPPC) applying synchrotron small-
angle x-ray scattering. Valsartan is the only one which shows a disruption of the 
neutral DPPC bilayer, more visible at higher drug concentrations. This could be 
attributed to the valsartan chemical structure, which poses a carbonyl acid 
(carboxyl) group providing higher polarity compared to the other two drugs in 
the neutral environment.  698 Scientia  Pharmaceutica  www.scipharm.at 
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The interaction of active pharmaceutical ingredients with various surfaces and 
solutions are of high interest in pharmaceutical industry in particular with 
respect to development of new formulations, new packaging material [1] and 
cleaning validation of production plants [2]. Experimental adsorption/absorption 
studies as well as the performance of cleaning validations provide valuable data 
for these research fields; however appropiate analytical methods are needed for 
the drug of interest. In the case of diisopropylphenol – a small lipophilic drug 
which is typically formulated as lipid emulsion for intravenous injection – the 
main analytical challenge is a highly sensitive method (in the ng/ml range) 
suitable to be applied to a variety of different sample matrices (lipid emulsions, 
aqueous solutions, organic solvents as well as various surfaces). In particular, 
the analysis of diisopropylphenol in complex matrices such as lipid formulations 
requires efficient samplecleanup methods. We here report the development and 
evaluation of a new headspace-solid phase microextraction (HS-SPME) 
methodology for GC-MS as a cleanup procedure for the moderately volatile 
drug diisopropylphenol in various matrices. Optimization of the HS-SPME 
procedure with respect to temperature, incubation times and matrix was carried 
out and linear calibration curves in the range of 2–200 ng/ml could be achieved 
for various matrices including lipid emulsions.  
This work was supported by the RCPE K1 Competence Center – Initiated by 
the Federal Ministry of Transport, Innovation & Technology (MMVIT) and the 
Federal Ministry of Economics & Labour (BMWA). Funded by FFG, Land 
Steiermark and Steirische Wirtschaftsförderung (SFG).  
[1]  FDA Guidance for Industry Container Closure Systems for Packaging Human Drugs and Biologics, 
May 1999. 
[2]  United States, Code of Federal Regulation, Titel 21 Food and Drugs, Part 211 CURRENT GOOD 
MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS, § 211.67 equipment cleaning 
and maintenance. 
 www.scipharm.at Scientia  Pharmaceutica  699 
Presented at the 8
th Central European Symposium on Pharmaceutical Technology, 
September 16
th–18
th 2010, Graz, Austria. 
Conference abstract PPAT10 
Use of Forced Degradation Studies on  
S-(−)-Amlodipine Besylate to Generate 
Information on the Degradation Products 
Š. HADŽIDEDIĆ 
1, A. UZUNOVIĆ 
1, S. PILIPOVIĆ 
1, S. KOCOVA EL-ARINO 
2 
1 Agency for Medicinal Products and Medical Devices of B&H, 71000 Sarajevo, Bosnia and Herzegovina 
2 National Research Centre, Tahrir Street, Cairo, Egypt 
E-mail: s.hadzidedic@alims.gov.ba (S. Hadžidedić) 
Sci Pharm. 2010; 78: 699        doi:10.3797/scipharm.cespt.8.PPAT10 
Amlodipine is a long-acting calcium channel blocker used in the treatment of 
hypertension and angina pectoris. S-(−)-amlodipine besylate is a safer and 
longer-acting alternative to the existing racemate [1]. Although several products 
based on the active enantiomer have reached the market, information on its 
chemical, physical and thermal stability during storage is lacking [2,  3]. The 
objective of the present study was to evaluate the critical properties of the 
S-enantiomer and to obtain information on the degradation pathways during 
storage of the bulk drug. The degradation products formed upon subjecting 
S-(−)-amlodipine besylate to different conditions (hydrolysis, oxidation, high and 
low pH, dry heat and photolysis) were resolved on a Lichrospher RP-18 column 
using 237  nm as detection wavelength [4, 5].  A good understanding of the 
chemical and physical stability of the drug was gained based on the results of 
the forced degradation study. 
Acknowledgements: This work was supported by ALIMS B&H. 
[1]  Hutt AJ, Valentova J. The Chiral Switch:The Development of Single Enantiomer Drugs from 
Racemates. Acta Facultatis Pharmaceuticae Universitatis Comenianae. 2003; 50: 7–23. 
[2]  EMEA Guideline, Guideline on Impurities in New Medical Products, (CPMP/ICH/282/95), 1995, 1/14. 
[3]  Li ZJ, Zell MT, Munson EJ, Grant DJ. Characterization of racemic species of chiral drugs using 
thermal analysis, thermodynamic calculation, and structural studies. J Pharm Sci. 1999; 88: 337–346. 
doi:10.1021/js980205u 
[4]  Abdoh A, Al-Omari MM, Badwan AA, Jaber AMY. Amlodipine Besylate-Excipients Interaction in Solid 
Dosage Form. Pharm Dev Technol. 2004; 9: 1–10. PMid:15000463 
[5]  Giron D. Characterization of salts of drug substances. J Therm Anal Calorim. 2003; 73: 441–457. 
doi:10.1023/A:1025461625782 
 700 Scientia  Pharmaceutica  www.scipharm.at 
Presented at the 8
th Central European Symposium on Pharmaceutical Technology, 
September 16
th–18
th 2010, Graz, Austria. 
Conference abstract PPAT11 
Quality-by-Design Based Characterization of 
Pharmaceutical Processes by Means of 
Numerical Simulations 
S. ADAM 
1, D. SUZZI 
1, S. RADL 
1,2, G. TOSCHKOFF 
1, C. RADEKE 
1,  
T. HÖRMANN 
1, M. IANNUCCELLI 
1, J. G. KHINAST 
1,2 
1 Research Center Pharmaceutical Engineering GmbH, Graz, Austria 
2 Graz University of Technology, Institute for Process and Particle Engineering, Graz, Austria 
E-mails: siegfried.adam@rcpe.at (S. Adam), khinast@tugraz.at (J. G. Khinast),  
Sci Pharm. 2010; 78: 700        doi:10.3797/scipharm.cespt.8.PPAT11 
Fundamental scientific knowledge is required to develop and optimize 
pharmaceutical manufacturing processes that yield constantly high quality 
products and provide most cost efficient manufacturing strategies. In our work 
we present combined Quality-by-Design and computer simulation approaches 
(Discrete Element Method, DEM, and Computational Fluid Dynamics, CFD) to 
characterize three key unit operations of solid and liquid dosage form 
manufacturing, namely powder blending [1], tablet coating [2] and fluid mixing. 
The aim is to evaluate the impact of formulation parameters and process 
variables on process and product quality.  
Understanding the variability of both material attributes and process 
parameters, as well as their overall impact on the unit operations are critical 
elements for QbD. In a first step, the QbD-methodology is systematically used 
to (1) establish the critical quality attributes representative for the selected 
dosage forms, (2) identify potentially critical input factors that may affect 
process and product quality and (3) risk-rank these factors to define activities 
for process characterization. Subsequently, computer simulation-based 
characterizations of the three unit operations are performed. For the blending 
process the concentration of the active pharmaceutical ingredient, as well as 
the mixing time are related to the blending uniformity. The film homogeneity on 
a single tablet is then analyzed as critical quality attribute for the coating unit 
operation. Finally, a functional design space (engineering design space) for a 
mixing tank is established. The computational data are used to map out three-
dimensional knowledge spaces, leading finally to the definition of design spaces 
as subset of them. Based on these results, appropriate strategies for process 
control are presented as well. 
[1]  Adam S, Suzzi D, Radeke C, Khinast JG. An Integrated Quality by Design (QbD) Approach towards 
Design Space Definition of a Blending Unit Operation by Discrete Element Method (DEM) Simulation. 
Submitted to Eur J Pharm Sci, 2010. 
[2]  Suzzi D, Radl S, Khinast JG. Local Analysis of the Tablet Coating Process: Impact of Operation 
Conditions on Film Quality. Submitted to Chem Eng Sci, 2010. www.scipharm.at Scientia  Pharmaceutica  701 
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The aim  of the study  was to present an example of experimental design 
application to set up the dissolution test conditions for the two immediate-
release products of levothyroxine sodium (L-Na) with proven bioequivalence: 
the generic product A and the reference product B [1, 2]. The description of the 
dissolution profiles by using model-independent methods included the 
calculation of mean dissolution time (MDT) from the in vitro data for both 
formulations. MDT for the products were compared one to each other as well as 
with mean absorption time (MAT), calculated from the in vivo data [3]. The 
experimental factorial design 2
3 was applied with following independent 
variables: concentration of surfactant used (X1), volume of dissolution medium 
(X2), and paddle stirring speed (X3). Dependent variables were set up as a 
difference between the MDT observed under various experimental conditions 
for the investigated products (Y1), as well as the difference between MDT and 
MAT for each product (Y2 = MDTprod. A − MATprod. A; Y3 =MDTprod. B − MATprod. B). 
The obtained results showed that the paddle rotation speed was the most 
significant drug release factor. The medium volume had very small effect on 
responses Y1 and Y2 but its impact could not be regarded as negligible in the 
case of response Y3. The surfactant used for dissolution testing showed 
significant effect on the tested parameters, but the observed effects were 
contradictory and general conclusion could not be made. This study showed the 
limited applicability of experimental design in the optimization of the dissolution 
conditions for two different L-Na formulations. The significant differences among 
in vitro release profiles were obtained and there was not unique dissolution test 
model applicable to both investigated products. 
[1]  Lundstedt T, Seiferth E, Abramo L, Thelin B, Nystrom A, Pettersen J, Bergman R. Experimental 
design and optimization. Chemom Intell Lab Syst. 1998; 42: 3–40.  
doi:10.1016/S0169-7439(98)00065-3 
[2]  Malinowski HJ, Smith WE. Use of factorial design to evaluate granulations prepared by 
spheronization. J Pharm Sci. 2006; 64: 1688–1692. doi:10.1002/jps.2600641023 
[3]  Podczeck F. Comparison of in vitro dissolution profiles by calculating mean dissolution time (MDT) or 
mean residence time (MRT). Int J Pharm. 1993; 97: 93–100. doi:10.1016/0378-5173(93)90129-4 
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Introduction: 
The most commonly used drug physicochemical property to access its in vivo 
performance is in vitro dissolution of a drug product. It is, therefore, important to 
define drug release methodology that would be predictive of its bioperformance 
and to establish quantitative in vitro-in vivo correlation (IVIVC). 
The objective of this study was to: i) to develop drug-specific absorption models 
for the selected BCS Class II model compounds (nimesulide, glimepiride, 
gliclazide) using gastrointestinal simulation technology (GST), ii) to use the 
generated absorption models to provide the target in vivo dissolution profiles for 
IVIVC, iii) to identify biorelevant dissolution specifications for IR tablet forms of 
the tested model drugs. 
Experimental: 
GST [1] was used for in silico prediction of oral drug absorption. The input 
parameters required for the simulation were experimentally determined, in silico 
predicted and/or taken from the literature. Parameter Sensitivity Analysis (PSA) 
was used to assess the sensitivity of the predicted rate and extent of drug 
absorption to the selected input parameters. A set of experimentally observed 
and virtual in vitro data were used for correlation purposes. Level A IVIVC was 
applied to assess the relationship between the in vitro and in vivo data.  
Results: 
The results obtained indicate that: i) PSA can aid to identify critical parameters 
affecting the rate and extent of drug absorption, ii) GST can be successfully 
used to predict drugs absorption profiles, iii) IVIVC in conjunction with GST can 
aid to identify biorelevant dissolution specifications for the in vitro assessment of 
the tested model compounds. 
This work was done under the project Biopharmaceutical Characterization of 
the selected BCS Class II and III drugs: In Vitro and In Silico Methods 
Evaluation (TR-23015) supported by the Ministry of Science and Technological 
Development, Republic of Serbia. 
[1]  Agoram B, Woltosz W, Bolger M. Predicting the impact of physiological and biochemical processes on 
oral drug bioavailability. Adv Drug Deliv Rev. 2001; 50: S41–S67.  
doi:10.1016/S0169-409X(01)00179-X 
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Highly purified organic materials are essential in various fields, including the 
fine-chemical, pharmaceutical and food industry. A method widely used to 
purify, e. g., active pharmaceutical ingredients (APIs), is preparative chroma-
tography. In this context, continuous processing is becoming increasingly 
important. The development of a novel prototype for continuous annular electro-
chromatography (CAEC) is the goal of a project which was established by an 
international consortium of industrial and academic research partners. The 
CAEC process combines the principles of electrophoresis and chromatography, 
thus leading to an increase of throughput, whilst maintaining high separation 
efficiency. An online detection system enables advanced automation and quality 
control, so that the process accords to the PAT (Process Analytical Technology) 
guidelines specified by the FDA.  
We present the development of stationary phases for this CAEC process. Our 
approaches include functionalized silica-based monolithic materials [1], which 
were implemented in different devices, such as capillaries for capillary 
electrochromatography (CEC) as well as planar test cells that can be 
continuously operated. The functional groups attached to the monolithic silica 
backbone can be easily adapted to different separation problems. Alternativly, 
the functionalization was achieved by implementation of functionalized silica 
particles in the precursor mixture of the monolithic material. Using these 
approaches, we succeeded in the preparation of reversed phase as well as 
amino-, cyano- and thiol-functionalized materials. In addition to these inorganic 
materials, organic monoliths [2] were successfully implemented in CEC 
capillaries and planar glass plates. Preliminary results show that the 
implementation of the stationary phases in the continuous operation set-ups 
leads to improved feasibility to gain high-value added products. 
This work is supported by the 7th Research Framework Programme of the 
European Commission (Grant agreement number: NMP2-SL-2008-206707).  
[1]  Ding G, Da Z, Yuan R, Bao JJ. Reversed-phase and weak anion-exchange mixed-mode silica-based 
monolithic column for capillary electrochromatography. Electrophoresis. 2006; 27: 3363–3372. 
doi:10.1002/elps.200500931 
[2]  Schmid MG, Koidl J, Wank P, Kargl G, Zöhrer H, Gübitz G. Enantioseparation by ligand-exchange 
using particle-loaded monoliths: Capillary-LC versus capillary electrochromatography. J Biochem 
Biophys Methods. 2007; 70: 77–85. doi:10.1016/j.jbbm.2006.06.004 704 Scientia  Pharmaceutica  www.scipharm.at 
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Pregabalin is a structural analogue of γ-aminobutyric acid approved for 
treatment of neuropathic pain, as adjunctive therapy for partial seizures, and in 
generalized anxiety disorder. It has no significant UV or visible absorption, 
therefore most often derivatization methods have to be employed for its 
determination. Previusly published methods for pregabalin determination in 
pharmaceutical dosage forms are either time-consuming [1] or use 
chromatographic separation [2]. Herein, we propose a novel high-throughput 
method utilizing a simple derivatization with fluorescamine and fluorescence 
detection with a microplate reader. The derivatization process is fast (5 min), 
proceeds at a room temperature in borate buffer at pH 9.5. Using fluorescent 
detection (λex 395 nm, λem 476 nm), the method was linear (r
2 > 0.997) over 
the concentration range (0.75–30 µg/ml). The intraday and interday precision of 
quality control samples was <  4.5%, and accuracy was 97.3–105.3%. 
Evaluation of the method robustness revealed that the emission wavelength 
and fluorescamine concentration are the most influential parameter. The 
method was applied to the analysis of pregabalin in 25  mg capsules. The 
content of pregabalin did not differ from the declared amount by more than 
3.7%. Additionally, the method was applied to dissolution studies using USP 29 
Apparatus 2 and FDA recommendation for dissolution testing of pregabalin 
capsules. It was demonstarted that more than 80% of pregabaline released in 
10 min and more than 99.7% in 45 min. Finally, the universality of the method 
was proven by analyzing the content and dissolution profiles of pregabalin 
structural analogues vigabatrin, and gabapentin in pharmaceutical dosage 
forms. 
[1]  Onal A, Sagirli O. Spectrophotometric and spectrofluorimetric methods for the determination of 
pregabalin in bulk and pharmaceutical preparation. Spectrochim Acta A Mol Biomol Spectrosc. 2009; 
72: 68–71. doi:10.1016/j.saa.2008.08.009 
[2]  Jadhav AS, Pathare DB, Shingare MS. Validated Enantioselective LC Method, with Precolumn 
Derivatization with Marfey’s Reagent, for Analysis of the Antiepileptic Drug Pregabalin in Bulk Drug 
Samples. Chromatographia. 2007; 65: 253–256. doi:10.1365/s10337-006-0152-z www.scipharm.at Scientia  Pharmaceutica  705 
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Sodium naproxen (SN) exists in an anhydrous form and in four different 
hydrated forms: one monohydrate (MSN), two dehydrates (DSN and CSN) and 
one tetrahydrate (TSN). Mechanisms of dehydration have been previously 
determined by an isothermal method [1, 2]. In this study, their dehydration was 
followed by an isoconvertional analysis (ICA), which is based on a non-
isothermal method.  
Materials and Methods: 
SN (B.P.) was kindly supplied by A.C.R.A.F. (Italy). 
Thermogravimetric analysis (TGA) was performed by a Simultaneous Thermal 
Analyzer (STA 6000, Perkin Elmer, Inc., Waltham, MA, USA), under nitrogen 
atmosphere (20 mL/min) in a 0.07 ml open aluminium oxide pans. After 
calibration, samples (approximately 10 mg) were tested in quadruplicate by 
heating from 293 to 413 K at four different heating rates (5, 10, 20, 40 K/min). 
Results: 
For each hydrate form, the degre of conversion (% dehydration) was plotted 
versus temperature at any heating rate. The temperature relative to each 
conversion degree was then determined and plotted versus temperature. The 
slope of the regression lines permitted the calculation of the activation energy 
(Eatt). The Eatt ranged approximately from 60 to 80 kJ*mol
-1 for the MSN, from 
70 to 90 kJ*mol
-1 for the DSN, from 28 to 50 kJ*mol
-1 for the CSN and from 30 
to 70 kJ*mol
-1 for the TSN. A dehydration occurring by one-step mechanism has 
been revealed for the MSN and DSN, while a multi-step mechanism explains 
the dehydration of CSN and TSN. The results of this study showed a good 
correlation with those previously determined by applying an isothermal method 
[1]. In conclusion, the isoconversional analysis may be considered as a simple 
and fast method to predict the conversional behaviour of pharmaceutical 
substances and it may be applied to predict the phase transition of complex 
systems.  
[1]  Malaj L, Censi R, Di Martino P. Mechanism for dehydration of three sodium naproxen hydrates. Cryst 
Growth Des. 2009; 9: 2128–2136. doi:10.1021/cg800684v 
[2]  Kim Y, Rousseau RW. Characterization and solid-state transformations of the pseudopolymorphic 
forms of sodium naproxen. Cryst Growth Des. 2004; 4: 1211–1216. doi:10.1021/cg049917q 706 Scientia  Pharmaceutica  www.scipharm.at 
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The poorly-soluble Vinpocetine was successfully coground with micronized 
crospovidone in a planetary mill, which allowed an enhancement of 
bioavailability through a solid-state activation. Drug-to-polymer weight ratio and 
milling time variables led to statistically significant effects on the 
activation/amorphysation of the product. An ad hoc software was then used to 
calulate the dimensions of the drug crystallites in the samples on the basis of 
the calorimetric data [1]. The thermal analyses were then accompanied by a 
multisciplinary characterization of the samples, by means of X-ray diffraction, 
Raman imaging/spectroscopy, DRIFT and SS-NMR spectroscopy, laser light 
scattering and solubilization kinetics tests. All the analyses attested the 
progressive loosing of crystalline structure of the drug when increasing milling 
time and amount of polymer in the formulations. Further, the analyses revealed 
the perturbation of the VIN carbonyl environment as a result of the disruption of 
the crystalline lattice, the absence of hydrogen bonding between components 
and the insurgence of hydrophobic interaction between components. The 
activated status of the drug, that resulted to be homogeneously distributed on 
the coground sample and stable for at least 1 year, was reflected on favorable 
solubilization kinetics. Finally, the in vivo studies on rats revealed that coground 
systems promoted a five-fold higher oral bioavailability enhancement in 
comparison to a marketed oral formulation (Vimpocetin
® 5 mg C, Pharma). The 
authors thank Linnea for the kind gift of Vinpocetine and Fondazione CRTrieste 
for funding. 
[1]  Coceani N, Magarotto L, Ceschia D, Colombo I, Grassi M. Melting temperature, enthalpy and solubility 
dependence on crystal radius. The case of co-ground Nimesulide. submitted to J Phys Chem C, 2010.  
 www.scipharm.at Scientia  Pharmaceutica  707 
Presented at the 8
th Central European Symposium on Pharmaceutical Technology, 
September 16
th–18
th 2010, Graz, Austria. 
Conference abstract PPAT18 
Enzyme-Catalyzed Synthesis of  
2-Azido-2-deoxy-D-glucose under Catalysis by 
Recombinant Cellobiose Phosphorylase (CeP) 
B. LUBURA 
1, N. GABRA 
1, P. STARKL 
2, H. VIERNSTEIN 
1, F. M. UNGER 
1 
1 Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Althanstrasse 14, 
1090 Vienna, Austria 
2 Department of Pathophysiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, 
Austria  
E-mail: borjana.lubura@univie.ac.at (B. Lubura) 
Sci Pharm. 2010; 78: 707        doi:10.3797/scipharm.cespt.8.PPAT18 
The use of enzyme-catalyzed reactions for the synthesis of sugar substrates 
represents a more desirable approach in terms of “green chemistry”. As the 
azidonitratization reaction of cellobial furnishes the 2-azido-2-deoxycellobiose 
stereospecifically, we have prepared 2-azido-2-deoxyglucose from 2-azido-
2-deoxycellobiose using recombinant cellobiose phosphorylase (CeP) from 
Clostridium thermocellum NCIMB 10682 [1]. This enzyme catalyzes the 
reversible phosphorolysis of cellobiose to form α-D-glucose and α-D-Glucose-
1-phosphate with inversion of the anomeric configuration (Scheme 1) [2]. 
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2-Azido-2-deoxycellobiose is cleaved quantitatively by the action of cellobiose 
phosphorylase and is separated from glucose 1-phosphate by filtration through 
DEAE-cellulose. In this manner, we have demonstrated that the substitution of 
the hydroxyl group by an azido group in position 2 of the reducing cellobiose 
moiety is tolerated by the recombinant CeP. 
[1]  Wong CH, Koeller KM. Enzymes for chemical synthesis. Nature. 2001; 409: 232–240. 
doi:10.1038/35051706 
[2]  David BG, Fairbanks AJ. Carbohydrate Chemistry. Oxford University Press, 2002 
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The knowledge of surface charge and the isoelectric point is important for many 
biomedical applications. The zeta potential, formally defined as the electrical 
potential at the electrokinetic plane of shear, is an important property of charged 
solid/liquid interfaces and a descriptor of the actual surface charge of a solid 
immersed in a dielectric. For macroscopic solid surfaces, the zeta potential is 
commonly determined by the measurement of streaming potential and 
streaming current. The versatility of the streaming potential method allows 
handling of planar surfaces, cylindrical capillaries, and packed beds of granular 
or fibrous materials. 
Besides the evaluation of the charging behavior of solid surfaces, the zeta 
potential is a valuable indicator for surface stability in the presence of various 
liquids, and for the adsorption of proteins, polypeptides, and other 
biomacromolecules on biomedical and biomaterial surfaces. 
In this paper the application of the streaming potential method in the field of 
biomedical surface characterization is presented with different case studies. www.scipharm.at Scientia  Pharmaceutica  709 
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The aim of the presented study is to propose the utilization of dynamic neural 
networks and fuzzy algorithms as in silico tools for prediction of drug release 
rate from hydrophilic and lipid matrix tablets. Dynamic neural networks are 
neural networks used for analysis of nonlinear, time dependent processes, 
having the ability of multiple presentations of inputs to the network. Fuzzy 
algorithms, on the other hand, enable creation of set of rules defining desired 
formulation properties. Compositions of matrix tablets were as follows: (a) 
hydrophilic: polyethylene oxide (Polyox
® WSR Coagulant), diclofenac sodium, 
microcrystalline cellulose (Avicel
® PH 102); (b) lipid: glyceryl palmitostearate 
(Precirol
® ATO 5), caffeine, mannitol; and magnesium stearate. Matrix tablets, 
prepared using compression simulator (Zwick 1478), were evaluated on 
porosity, tensile strength and drug release rate. Commercially available 
software Peltarion
® has been used to construct dynamic neural networks and 
fuzzy algorithms. Modeling of drug release rate has been conducted taking into 
account formulation factors and manufacturing method (formulations 
composition, compression force used for tableting, porosity and tensile strength 
of manufactured tablets). Focused, Elman’s dynamic network was employed to 
model drug release rate from both hydrophilic and lipid matrix tablets, optimizing 
the number of neurons in hidden layers as well as signal time delay with genetic 
algorithms. Separate sets of rules were generated using fuzzy algorithms for 
hydrophilic and lipid matrix tablets. Testing of the developed dynamic networks 
and fuzzy algorithms has demonstrated that dissolution profiles for matrix 
tablets of known composition and mechanical properties can be predicted in 
silico with great accuracy. In the case of diclofenac sodium release modeling, 
obtained values for similarity and difference factors for test formulations release 
profiles were f2 = 79,08 and f1 = 4,36 i. e. f2 = 75,23 and f1 = 6,69. On the other 
hand, in the case of caffeine release modeling obtained values were f2 = 87,61 
and f1 = 1,58 i. e. f2 = 72,30 and f1 = 5,24. For all predicted drug release profiles 
the correlation coefficient among predicted and true values was higher than 
0,9950. This study demonstrates the feasibility of application of dynamic 
networks and fuzzy algorithms for modeling of drug release rate from 
hydrophilic and lipid matrix tablets. 710 Scientia  Pharmaceutica  www.scipharm.at 
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Existing concepts for personnel locks in clean rooms are characterized by cost 
and time consuming procedures. Clean room personnel have to change their 
clean room garment in personnel locks when moving from one clean room class 
to another. The changing process of clothes is a source of contamination due to 
human imperfection.  
It is a fact that the major source for airborne microbes is the human body. The 
results of confocal laser scanning microscopy show that the microstructure of 
synthetic fibers is very complex and offers many niches for the attachment of 
microbes to the fiber. These niches drastically reduce the point of action for 
example of UV sterilization.  
Clean room clothing is intended to hinder particles from the wearer’s body to 
contaminate the environment. There is a demand of the industries for the 
design of new textiles with new features and new concepts for innovative 
personnel lock systems. Innovation will take place either in the modification of 
the textile as well in the design of new cleaning systems for personnel locks. To 
overcome this huge challenge an interdisciplinary team will completely 
reconsider common processes to create new standards in clean room 
technology. This will be achieved by the screening for new bio-based 
antimicrobials, the usage of light-activated disinfection and the modeling of the 
behavior of particles on the textile as well as in clean room environment. The 
great challenge is to create an innovative concept with the basic requirement of 
maximum safety for the wearer’s body as well for the subsequent processes.  
This work was supported by the FFG, SFG, Das Land Steiermark, Ortner Clean 
Rooms Unlimited and Dastex.  
[1]  Berg G, Hartenberger K, Liebminger S. Methods and compositions for biologically controlling microbial 
growth on clean room equipment. EP 09180492.2 – 2113, 2009. 
[2]  Liebminger S, Cardinale M, Hartenberger K, Berg G. Survival of human-associated bacteria on clean 
room clothing. - In: International Graz Congress for Pharmaceutical Engineering. Graz, Austria, 
17.09.2009. 
[3]  Hartenberger, K, Müller H, Zachow C, Berg G. Mistletoes: which microbes do they share with their 
host plants?. - In: Bageco10 Bacterial genetics and ecology – coexisting on a changing planet. 
Uppsala, Schweden, 15.06.2009. www.scipharm.at Scientia  Pharmaceutica  711 
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Mechanical stress caused by gastrointestinal motility might have a great impact 
on drug release from oral dosage forms. In our experiments different 
mechanical influences on the tablet during dissolution experiments were tested 
using extended release tablets containing diclofenac. Dissolution experiments 
were performed on the flow-through apparatus, developed on Faculty of 
Pharmacy, University of Ljubljana [1]. The novel peristaltic movement simulating 
stirring device contains a working vessel with a certain amount of small glass 
beads that are stirred by a magnetic stirrer. Tablets were kept in simulated 
gastric fluid (pH 1.2) for 2 hours and in simulated intestinal fluid (pH 6.8) 
afterwards. The intensity of mechanical stress on the tablet was modified by 
varying the amount of glass beads, stirring speed, and by using different 
barriers in the working beaker in a different position for 5 or 20 minutes. 
Our experiments showed that mechanical stress induced by increasing stirring 
rate or decreasing the amount of glass beads resulted in increased diclofenac 
release. The insertion of different types of barriers into the working vessel 
increased the release rate, however, some crushing of tablets appeared. Thus, 
no subsequent decrease of release was observed when the barrier was 
removed. Namely, such dissolution kinetics was desired as we wanted to 
develop a dissolution test to predict double peaks in plasma profiles after oral 
administration of diclofenac extended release tablets. It seems that only 
squeezing the tablet and not other types of mechanical influences, simulates 
well in vivo situation [2]. Additionally, tablets were more sensitive to mechanical 
stress in intestinal than in gastric medium which is a consequence of different 
diclofenac solubility in both media. Thus, greater mechanical sensitivity of the 
tablet might also be expected in vivo when passing ileo-cecal sphincter than in 
pylorus. However, it is questionable if this influence could be observed in vivo 
as a large amount of drug has already been released when tablet reaches the 
end of ileum. 
[1]  Bogataj M, Cof G, Mrhar A. Peristaltic movement simulating stirring device for dissolution testing. PCT, 
WO 2010/014046 A1 (2010). 
[2]  Garbacz G, Wedemeyer R, Nagel S, Giessmann T, Mönnikes H, Wilson CG, Siegmund W, Weitschies 
W. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted 
using a dissolution test apparatus that mimics in vivo physical stresses. Eur J Pharm Biopharm. 2008; 
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The purpose of this work is two fold: it describes the proof of concept of the 
newly introduced bulk video imaging (BVI) method and it presents the 
nucleation detection in comparison with existing process analytical technologies 
(PAT) such as focused beam reflectance measurement (FBRM) and ultra 
violet/visible (UV/Vis) spectroscopy. While the latter two sample the system 
closely to the probe, the BVI approach monitors the entire crystallizer volume.  
The external BVI (eBVI) method is based on a video camera and a capture 
hardware, which captures 25 frames or pictures of the crystallization bulk per 
second [1]. It can also be regarded as a matrix of external turbidity probes. 
Another set of experimental data is generated using in-situ endoscopy and a 
small scale crystallization calorimeter [2] (iBVI). The eBVI can be implemented 
as an external sensor providing significantly lower sensitivity to mixing 
conditions than other probes based on local measurements. Furthermore, the 
contamination related problems are circumvented. The advantage of the eBVI 
approach is that it does not require high speed video camera or advanced 
illumination technologies such as laser or xenon flash. The BVI method is 
proposed as a complementary PAT tool and it is shown that it is able to detect 
the nucleation onset with comparable or better performance to the FBRM and 
UV/VIS probes. Additionally, the endoscopy based BVI is a low cost sensor 
which can be easily integrated in the existing laboratory hardware and software 
environments. Recently, multivariate image analysis methods were evaluated 
for the purpose of nucleation detection [3]. 
[1]  Simon LL, Nagy ZK, Hungerbuhler K. Comparison of external bulk video imaging with focused beam 
reflectance and ultra violet-visible spectroscopy for crystallization nucleation detection and metastable 
zone identification. Chem Eng Sci. 2009; 64: 3344–3351. doi:10.1016/j.ces.2009.04.016 
[2]  Simon LL, Nagy ZK, Hungerbuhler K. Endoscopy-Based in Situ Bulk Video Imaging of Batch 
Crystallization Processes. Org Process Res Dev. 2009; 13: 1254–1261. doi:10.1021/op900019b 
[3]  Simon LL, Abbou Oucherif K, Nagy ZK, Hungerbuhler K. Bulk video imaging based multivariate image 
analysis, process control chart and acoustic signal assisted nucleation detection. Chem Eng Sci. 
2010;65:4983–4995. doi:10.1016/j.ces.2010.05.045 www.scipharm.at Scientia  Pharmaceutica  713 
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One of the key steps in the manufacturing of solid oral dosage formulations is 
the blending of several ingredients in powdered form which are then processed 
further to achieve the final dosage form. Up until this blending process, it is 
relatively straightforward to measure critical quality attributes such as particle 
size and/or shape of the input materials using well established techniques such 
as laser light scattering or particle image analysis. A much more difficult 
challenge is to be able to characterise the size and shape of the individual 
ingredients once they have been through the blending process. This may be 
especially important when trying to understand any possible impact of the 
blending process on the size and shape of the API and how this might impact 
the bioavailability or bioequivalence of the drug. The technique of NIR chemical 
imaging has been used to get some information of the homogeneity of powder 
blends [1], however limitations in spatial resolution impact its applicability for 
smaller particle sizes. 
In this paper we describe a novel approach using a hybrid technique of 
Morphologically directed Raman Spectroscopy to study the effects of 
processing on a laboratory scale of a model formulation consisting of ibuprofen, 
starch and lactose. The sample is first of all dispersed in its dry state, and then 
images are captured of the individual particles in the mixture in order to 
determine their size and shape. Each particle is then targeted in an automated 
manner with a Raman microprobe to obtain a chemical ID. Particle size and 
shape distributions can then be constructed for each of the ingredients and 
compared directly with measurements made before the blending process. 
Results for the model formulation are presented and implications for a number 
of different types of pharmaceutical formulations are discussed. 
[1]  Ma H, Anderson CA, Characterization of pharmaceutical powder blends by NIR chemical imaging. J 
Pharm Sci. 2008; 97: 3305–3320. doi:10.1002/jps.21230 
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14N NQR is a new method in pharmacy that has a potential to establish itself as 
an additional and valuable analytical tool for characterizing solid state of a 
substance [1]. 
14N NQR is a method that can precisely and accurately deter-
mine a specific polymorphic state of a solid compound. It is non-destructive and 
there is usually no spectral interference from other polymorphs or other solids.  
The objective of presented study was to use 
14N NQR as a way to characterize 
qualitatively and quantitatively different solid state forms of sulfanilamide, 
nifedipine and piroxicam [3]. Thermodynamically stable forms of said 
substances were obtained on the market. Subsequently, samples of unstable 
amorphous or polymorphic forms were prepared. DSC and ATR FT-IR were 
used additionally to identify differences between the samples. 
14N NQR method 
was used with the same samples to (re)confirm the already established 
polymorphic states [3]. 
14N NQR method proved itself capable of accurately and 
precisely determining the solid-state forms of studied pure compounds.  
The possibility of accurately determining the mixture composition of different 
forms was also demonstrated. Mixtures of piroxicam forms in different ratios 
were prepared and then measured with 
14N NQR. Determined mixture ratios 
were in close agreement with the known values. 
[1]  Pérez SC, Cerioni L, Wolfenson AE, Faudone S, Cuffini SL. Utilization of pure nuclear quadrupole 
resonance spectroscopy for the study of pharmaceutical crystal forms. Int J Pharm. 2005; 298:  
143–152. doi:10.1016/j.ijpharm.2005.04.015 
[2]  Vrecer F, Vrbinc M, Meden A. Characterization of piroxicam crystal modifications. Int J Pharm. 2003; 
256: 3–15. doi:10.1016/S0378-5173(03)00057-7 
[3]  Lavric Z, Pirnat J, Luznik J, Seliger J, Zagar V, Trontelj Z, Srcic S. Application of 14N NQR to the 
Study of Piroxicam Polymorphism. J Pharm Sci; in press. doi:10.1002/jps.22186 www.scipharm.at Scientia  Pharmaceutica  715 
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For many biomedical applications of proteins the knowledge of the three-
dimensional structure of proteins is of great importance. It is the key to 
understand their function in biological processes. Small-Angle X-ray Scattering 
(SAXS), in contrast to other methods e. g. Protein Crystallography and Cryo-
TEM, allows investigating proteins in solution, i.  e. in their native state and 
under biological conditions. Furthermore SAXS does not need any specific 
sample preparation which might change the protein sample. 
SAXS enables to study structural changes upon changing the external 
conditions and is a valuable tool for determining several important parameters : 
(1) protein size and shape, (2) aggregated structures, (3) folding state, (4) 
subunit structures.  
By knowing these parameters of the proteins in native, valuable conclusions 
can be derived in order to explain the proteins’ functionalities. In this 
contribution the application of laboratory-based small- angle x-ray scattering 
studies performed with the SAXSess mc
2 system in the field of biomedical 
applications is presented and discussed. 716 Scientia  Pharmaceutica  www.scipharm.at 
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Overcoming biological barriers, including the gastrointestinal epithelial barriers, 
is a great challenge for pharmaceutical research. There is a need for new 
absorption enhancers with more favorable profile. Sucrose esters are widely 
used in the food and cosmetic industry, and there are reports on their potential 
use in pharmaceutical formulations as excipients [1, 2], however no data are 
available on their toxicity profile and their usefulness as absorption enhancers in 
epithelial models. 
We tested three water soluble sugar esters having HLB value of 16, laurate 
(L-1695), myristate (M-1695), palmitate (P-1695) esters, with 12, 14 and 16 
carbon fatty acid chains, respectively, on human Caco-2 epithelial monolayers, 
a widely used model for the human intestinal epithelial barrier. Cremophor 
RH40 and Tween 80 were used as reference absorption enhancers. For toxicity 
tests cells were cultured in 96-wells, and MTT dye conversion and lactate 
dehydrogenase relase were determined after treatments. For permeability tests 
cells were cultured on Millipore CM inserts (hydrophilic PTFE membranes, pore 
size: 0.4 μm, surface 4.2 cm
2) in 6-well plates for 3 weeks to reach stationary 
phase and barrier properties. Fluorescein was selected as a marker of 
paracellular permeability. Untreated monolayers formed a good barrier as 
reflected by a transepithelial resistance of 722  ±  80  Ω cm
2 and positive 
immunostaining for tight junction proteins claudin-4 and ZO-1. Sucrose esters 
showed 50 % cytotoxicity (1 h treatment) at 300 μg/ml, while cell death was 
measured at concentrations above 1 000 μg/ml. The reference molecules were 
only toxic at doses above 10  000 μg/ml. L-1695 in non-toxic concentrations 
reduced TEER and increased permeability for fluorescein in Caco-2 monolayers 
indicating an absorption enhancer property. 
This work was supported by TÁMOP-Hungary research project: Development of 
teranostics in cardiovascular, metabolic, and inflammatory diseases (TÁMOP-
4.2.2-08/1-2008-0013). 
[1]  Szuts A, Makai Z, Rajkó R, Szabó-Révész P. Study of the effects of drugs on the structures of sucrose 
esters and the effects of solid-state interactions on drug release J Pharm Biomed Anal. 2008; 48: 
1136–1142. doi:10.1016/j.jpba.2008.08.028  
[2]  Szuts A, Budai-Szucs M, Eros I, Otomo N, Szabó-Révész P. Study of gel-forming properties of 
sucrose ester thermosensitive drug delivery systems. Int J Pharm. 2010; 383: 132–137. 
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Delayed release dosage form development usually requires an effective 
intermediate layer for separation of acid liable drug and acidic gastric polymer. 
A case is presented where an effective intermediate layer was developed for 
duloxetine pellets. Duloxetine pellets were produced in Wurster process using 
suspension/solution layering technique. Neutral pellet cores were coated with 
duloxetine layer, intermediate layer and gastric layer. Intermediate layer usually 
comprises water soluble polymer (e.  g. povidone, hypromellose); additionally 
talc may be added as filler and a processing aid (it reduces tackiness of coating 
dispersion). These kind of intermediate layer compositions provide simple 
separation of API and gastric layer and are usually sufficient for effective 
separation. In duloxetine pellets development, however, accelerated stability 
tests indicated poor long term stability. Diffusion of acidic species (e. g. phthalic 
acid is a hypromellose phthalate degradation product) across intermediate layer 
was suspected. Addition of small amounts of sodium chloride (4.8% wt./wt. 
relative to mass of intermediate layer, dissolved in aqueous coating dispersion) 
drastically improved stability of duloxetine pellets. Increase in coat thickness 
resulted in further decrease of duloxetine degradation products: this fact 
indicates that stabilization is induced by strengthening the diffusion barrier and 
thus minimizing diffusion of acidic species between the layers. Scanning 
electron microscope images were used to determine the structure of 
intermediate coat: talc particles are bonded with hypromellose: within 
hypromellose phase small crystals of sodium chloride (sub micrometer size 
range) were detected. Sodium chloride is dissolved in coating dispersion and 
once applied onto pellet surface it re-crystallizes in form of small crystals (due to 
fast water removal during coating). It is sugested that these finely dispersed 
sodium chloride crystals within hypromellose phase provide effective diffusional 
barrier which prevents migration of acidic species between layers and thus 
enabling stabilization of duloxetine. In order to assure long term stability of 
duloxetine pellets it was shown that an effective diffusional barrier is required. 
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Topotecan (TPT) is a semi-synthetic derivative of the natural extract 
camptothecin, which has been found to act as an inhibitor of the DNA enzyme 
topoisomerase I in a specific and reversible fashion. The drug undergoes 
reversible hydrolysis from the pharmacologically active parent lactone form 
(TPTL) to an inactive hydroxy acid form. In the cytoplasm the irreversible 
inactivation of TPTL is catalysed by the enzyme aldehyde dehydrogenase 
(ALDH). Over-expression of the human breast cancer resistance protein 
(BCRP/ABCG2) has been linked to high levels of resistance to the anti-cancer 
agent TPT by promoting an active efflux pump mechanism. The expressions of 
both ALDH and BCRP have been experimentally identified in a large number of 
solid tumours and thus play an important role in clinical drug resistance of 
cancers. To investigate the catalytic reaction and efflux pump mechanism, a 
compartmental model for the in vitro uptake kinetics of TPT has been extended 
to better describe the drug activity and delivery of TPTL to the DNA target as 
well as the catalysis by ALDH and the elimination of drug from the cytoplasm 
via the efflux pump. All unknown model parameters were uniquely estimated to 
a high level of confidence. Model simulations have been compared with live 
human breast cancer cells (MCF-7 cell line) data and found to give good 
qualitative agreement. The kinetic model has then been linked to a cell cycle 
model, based on [1], which facilitates analysis of the response of the growth of 
single cells in the presence and absence of TPT. Parameter estimation is 
performed using green fluorescent protein tagged cyclin B1 (cell cycle 
regulatory protein) data for the osteosarcoma cell line U-2 OS. Linking both 
models allows the study of drug perturbation to the cell cycle as well as in silico 
estimation and prediction of the relationship between the target binding and the 
dose, also permitting the effects of different expressions of the drug resistance 
protein and the ALDH enzyme. Such a coupled kinetic/dynamic model, once 
fully validated, has the potential for enhancing the design of optimal dosing 
regimens. 
MIA is funded by the University of Warwick Vice Chancellor’s PhD Scholarship. 
[1]  Pomerening JR, Sontag ED, Ferrell JE. Building a cell cycle oscillator: hysteresis and bistability in the 
activation of Cdc2. Nat Cell Biol. 2003; 5: 346–351. doi:10.1038/ncb954 
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In the light of the current trend for natural surfactants to be used as emulsifiers 
[1], a physicochemical characterization of a new mixed alkyl polyglucoside 
(APG) emulsifier (Arahidyl&Behenyl alcohol&Arahidyl glucoside) was per-
formed. The characterization was carried out through the polarization 
microscopy (PLM), x-ray diffraction studies (WAXD and SAXD), thermal 
analysis (DSC and TGA) and rheological measurements. In order to investigate 
the emulsifier potential to build the lyotropic liquid crystalline phase, binary 
systems (with increasing percentage of emulsifier) and series of cream samples 
with fixed emulsifier/water ratio and increasing percentage of oil phase were 
prepared. Additionally, 5 cream samples with different oil phases (Candelilla oil, 
Avocado oil, Isopropyl myristate, Decyl oleate and Liquid Paraffin oil) were 
evaluated.  
Anisotropic structures defined as distorted Maltese crosses were seen in PLM 
micrographs, as well as birefringence at the emulsion oil droplets border, 
indicating the liquid lamellar phase [2]. The DSC, WAXD and SAXD patterns 
additionally proved PLM findings, implying synergism of lamellar liquid and 
lamellar gel phases within the colloidal structure. Complex lamellar structures 
were preserved upon addition of various oils, with the exception of liquid 
paraffin which reduced the specific birefringence (observed in PLM micrographs 
and DSC thermograms). Percentage of water evaporation (TG results) indicated 
that more than one third of the water within the system is entrapped - 
interlamellarly fixed (‘‘depot’’ water). In steady state rheological measurements 
all samples showed “shear-thinning” behavior with thixotropy. Oscillatory 
measurements pointed at more pronounced elastic over viscous component 
(typical for lamellar phase). Overall, investigated APG emulsifier demonstrated 
good potential in lamellar liquid and gel phases formation, a property desirable 
for mixed emulsifier useful in stabilization of vehicles anticipated for 
dermopharmaceutics and dermocosmetics incorporation. 
[1]  Savic S, Savic M, Vesic S, Vuleta G, Muller-Goymann CC. Vehicles based on a sugar surfactant: 
Colloidal structure and its impact on in vitro/in vivo hydrocortisone permeation, Int J Pharm. 2006; 320: 
86–95. doi:10.1016/j.ijpharm.2006.04.019 
[2]  Fairhust CE, Fuller S,Graz J, Holmes MC. Lyotropic surfactant liquid crystals. In: Demus D, Goodby J, 
Gray GW, Spiess HW, Vill V (Eds.), Handbook of liquid crystals, 1998. vol 3. Wiley-VCH, Weinheim, 
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At least three enzymes (i. e., trypsin, chymotrypsin and neutrophil elastase) are 
responsible for the degradation of salmon calcitonin (sCT) in the human body 
[1]. Here, we investigated how these proteinases affect drug disposition of sCT 
in the lungs. 
Stability of sCT was studied in human respiratory epithelial cells. The presence 
of trypsin, chymotrypsin and neutrophil elastase in cell supernatant and 
homogenate was studied by Western blot. Enzymes’ activities were studied in 
cell supernatant by measuring UV absorption, caused by interaction with model 
substrates.  In vitro stability studies were carried out by adding sCT to cell 
supernatant, homogenate, as well as on intact cell monolayers, followed by 
incubation at 37°C for 2 h. Samples were serially withdrawn and analysed by 
HPLC for sCT content. Degradation of sCT by pure trypsin, chymotrypsin and 
neutrophil elastase was investigated after incubation for 2 h at 37°C.  
We observed that sCT concentrations remained unchanged over the period of 
2  h, when incubated in supernatant or on cell monolayers. When cell 
homogenates were studied, sCT concentrations were reduced to 82.5% 
(hBEpC), 45.9% (Calu-3), 45.1% (16HBE14o-), 4.3% (A549) and 18.5% 
(Caco-2), respectively. sCT was also degraded when incubated with pure 
enzymes. Western blot revealed strong signals for all proteinases in the cell 
homogenates and weaker, varying expression in supernatants.  
Calcitonin is rapidly degraded in homogenate, indicating high intracellular 
enzymatic activity. Epithelial proteases hence, appear to play a role in 
interactions of sCT with lung epithelium. Although trypsin, chymotrypsin and 
neutrophil elastase are secreted in vitro, sCT remained intact in supernatant for 
2  h. The concentration of the relevant enzymes (indicated by very low 
measured activities) might be too low to cause degradation. 
This work was funded by a Strategic Research Cluster grant (07/SRC/B1154) 
under the National Development Plan co-funded by EU Structural Funds and 
Science Foundation Ireland and by an IRCSET Embark Postgraduate 
Scholarship. 
[1]  Guggi D, Bernkop-Schnürch A. In vitro evaluation of polymeric excipients protecting calcitonin against 
degradation by intestinal serine proteases. Int J Pharm. 2003; 252: 187–196. doi:10.1016/S0378-
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Aim: Wound healing is a complex process with many potential factors that can 
delay healing.  Imbalance between tissue deposition stimulated by growth 
factors and tissue destruction mediated by proteases causes nonhealing of 
chronic wounds [1]. To overcome the destroyable effect of proteases, the 
application of growth factors or protease's inhibitors has been shown as 
successful. The aim of our research work is to formulate and charaterize the 
biocompatible modern wound dressings with model protein for protease’s 
inhibitor, which would enable protein stability, delivery and controlled release. 
Materials and methods: Hydrogels of hydroxyethylcellulose (HEC) and polyvinyl 
alcohol (PVA) were made at different m/m ratios and their rheological behaviors 
were performed by rotational viscosimeter (Rheolab MC 100, Physica). For 
HEC effects of sterilization process and osmolarity of the medium and for PVA 
effects of freeze-thaw cycles were evaluated. Egg albumin as model protein 
was incorporated into the hydrogels and drug release studies were performed 
by developed chamber simulating conditions at wound place. To increase 
protein stability hydrogels were lyophilized and tested for rehydration ability, 
viscosity and protein release. Electrospinning, which is a nanofiber-forming 
process where polymer solution or melt is charged to high voltages, was used 
for producing nanofibers from the same polymers.  
Results and discussion: HEC hydrogel at 3w/w % has appropriate rheologic 
properties, regardless of the medium used (water, phosphate buffer) or sterili-
zation process performed. Strenght and rigidity of PVA hydrogels increases with 
number of freeze/thaw cycles. Mild process conditions enable homogenous 
incorporation of protein compound into HEC and PVA hydrogel without 
deteoriation of its native structure. The release of protein is in accordance with 
Fick’s diffusion. Freeze-dryed HEC hydrogels were spontaneously rehydrated in 
24 hours. Viscosity and thixothropy of rehydrated samples were reestablished 
and neither lyophilization nor freezing mode affects the protein structure or 
releases kinetics. Additionaly some data about nanofibers obtained by electro-
spinning will be presented. The nanofibers potentially mimic many roles of 
extracellular matrix to promote tissue growth.  
Conclusion: Hydrogels with incorporated drugs that actively interfere in healing 
process and nanofibers with their unique properties represent improvement for 
treatment of chronic wounds. 
[1]  Enoch S, Leaper DJ. Basic science of wound healing. Surgery. 2005; 23; 2: 37–42. 
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Multiple carbohydrate structures in the chondrocyte glycocalyx can serve as 
targets for biorecognitive lectins. Recently, we have outlined the applicability of 
selected plant lectins as mediators of bioadhesion in cartilage research [1]. 
However, given the diversity of glycan structures at cell surfaces as well as the 
limited specificity of most lectins for certain tissues, in-depth knowledge about 
altered oligosaccharide structures under disease conditions is required. We 
therefore aimed at defining in detail the chondrocyte glycome following 
exposure to pro-inflammatory cytokines. 
Primary human chondrocytes were isolated from donors (n=5) and cultured as 
high density monolayers. Cells were treated with 10 ng/ml IL-1ß or 40 ng/ml 
TNF-α. The transcription of 19 glycosyltransferases was quantified using RT-
qPCR. N- and O-glycan analysis was performed using LC-ESI-MS. 
We found that both IL-1ß and TNF-α increased overall sialylation of N- and O-
glycans and induced a major shift from α2,6-linked sialic acid residues towards 
α2,3-linked sialic acids. These results were supported by RT-qPCR showing 
increased expression of α2,3 sialyltransferases in treated cells. In this context, 
ST6Gal1 mRNA levels were markedly reduced 4.7-fold in case of IL-1ß and 3.3-
fold in case of TNF-α, whereas the expression of ST3Gal4 was enhanced 2.8-
fold and 3.2-fold, respectively. Moreover, we found that both cytokines induced 
a considerable shift from oligomannosidic glycans towards complex-type N-
glycans, whereas core α1,6-fucosylation was found to be reduced particularly 
by TNF-α. 
In conclusion, IL-1ß and TNF-α induce a range of specific alterations in 
chondrocyte glycoproteins, which might be of relevance for malfunctioning cell-
matrix interactions in osteoarthritis. Interestingly, such specific changes in the 
chondrocyte glycome could also be exploited to target functionalized 
pharmaceutical delivery systems to osteoarthritic chondrocytes. 
[1]  Toegel S, Harrer N, Plattner VE, Unger FM, Viernstein H, Goldring MB, Gabor F, Wirth M. Lectin 
binding studies on C-28/I2 and T/C-28a2 chondrocytes provide a basis for new tissue engineering and 
drug delivery perspectives in cartilage research. J Control Release 2007; 117: 121–129. 
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This work presents a thorough investigation of the interaction of the novel 
synthetic pyrrolidinone analog MMK3 and other SARTANS (losartan, valsartan 
and candesartan) with the model membrane system of dipalmitoyl-
phosphatidylcholine (DPPC). SARTANS are designed to exert antihypertensive 
activity by functioning as an antagonist of the angiotensin II receptor of subtype 
1 (AT1). Small angle X-ray scattering (SAXS) experiments on the interaction of 
SARTANS with DPPC bilayers were carried out and results demonstrate that all 
studied SARTANS are well incorporated into the membrane leaflets and 
furthermore cause partial bilayer interdigitation. Further structural as well as 
dynamical effects will be discussed, and compared to their overall efficiency as 
antihypertensive drug. 
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Density functional theory studies at the B3LYP/6-31G(d,p) and M06-2X/6-
31G(d,p) levels have been used to determine the geometries and the enthalpies 
of formation of several methylated β-cyclodextrins.  
Various degrees of methylation can be performed at the hydroxyl groups of β-
cyclodextrin at the 2-, 3-, and 6-positions. The number of methyl groups and the 
position influence the physico-chemical properties of the derivatives as well as 
their inclusion ability. Large changes of the association constants with different 
guest molecules are accompanied with increase or decreased solubilities, as 
well as by a modification of the inclusion mechanisms. In this study three 
different types of methylated β-CDs were investigated: Heptakis(2-O-methyl)-β-
cyclodextrin, heptakis(6-O-methyl)-β-cyclodextrin, heptakis(2,6-di-O-methyl)-β-
cyclodextrin, and heptakis(2,3,6-tri-O-methyl)-β-cyclodextrin.  
During building up the various β-CD derivatives C7-symmetry was used 
throughout. By applying systematic B3LYP/6-31G(d,p) and M06-2X/6-31G(d,p) 
calculations, the oxygen-oxygen distances were scanned and all remaining 
geometry parameters were optimized. Three conformational minima were 
obtained. In the lowest energy conformation two homodromic hydrogen bond 
rings were formed, one with very short hydrogen bonds at the primary hydroxyls 
and a second at the secondary hydroxyls of the CD. Four orientations of the 
homodromic hydrogen bond rings, which are different in energy, have been 
taken into consideration: both hydrogen bond rims orientated counterclockwise 
(cccc) or clockwise (cwcw) and the primary rim clockwise and the secondary rim 
counterclockwise (cwcc) and vice versa (cccw). These four conformations were 
used to construct the methyl-derivatives of the β-CD molecules. For the 
optimization with both DFT methods no constraints were imposed on the 
molecules. To compare the calculated energies with related values obtained 
experimentally, the respective energies of five crystallographic structures have 
also been calculated. 
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The essential manufacturing step of probiotic products involves dehydration of 
microorganisms, resulting in cellular stabilization and improved formulation and 
storage characteristics. Spray drying is one of the most common dehydration 
techniques used for the preparation of pharmaceutical formulations containing 
probiotics. This method is less time- and cost- consuming as compared to other 
drying techniques such as lyophilization [1,  2]. However, spray drying of 
probiotics involves the challenge of maintaining viable microorganisms in spite 
of high temperatures involved in the process.  
The aim of the present study was investigation of the impact of heat on the 
cellular activity and culturability of probiotic strains Enterococcus faecium M 74 
and Bifidobacterium bifidum 12. Alterations in membrane permeability, esterase 
activity and production of superoxide radicals were investigated after exposure 
of cells to heat at different time intervals. The measurements were obtained 
using fluorimetry and flow cytometry after staining of cells with fuorochromes.  
The results of heat stress showed deleterious alterations in the membrane 
integrity and esterase activity of both strains after exposure to temperatures of 
60°C to 90°C. However, B. bifidum 12 cells were more affected than E. faecium 
M 74. The maximum damage of cell membrane and active metabolism occurred 
after shorter periods of heat exposure in the case of B. bifidum 12. In addition, 
increasing the temperature or extending the exposure time resulted in a 
remarkable impairment of the esterase activity of B. bifidum 12. The obtained 
results were thereafter used for the improvement of cell stabilization during 
spray drying of Enterococcus faecium M 74 and Bifidobacterium bifidum 12. 
[1]  Novik GI, Samartsev AA, Astapovich NI, Kavrus MA, Mikhalyuk AN. Biological activity of probiotic 
microorganisms. Appl Biochem Microbiol. 2006; 42: 166–172. doi:10.1134/S0003683806020098 
[2]  Ananta E, Volkert M, Knorr D. Cellular injuries and storage stability of spray-dried Lactobacillus 
rhamnosus GG. Int Dairy J. 2005; 15: 399–409. doi:10.1016/j.idairyj.2004.08.004 
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Introduction:  
Oral drug administration is mainly regulated by the step of intestinal absorption. 
For various substances uptake is strongly superimposed by an active efflux 
back into the lumen via ATP-driven pumps like the P-glycoprotein (P-gp), 
significantly decreasing their bioavailability. 
P-gp inhibitory effects can be determined via the calcein accumulation assay 
(CAA) or transport studies in cellular systems. Hereby it was previously shown 
that particular phospholipids (PL) reduce the efflux of a common P-gp substrate 
[2].  
The aim of this study is to identify further potent PL derivatives and their 
molecular mechanism of action and to investigate the influence of different 
experimental parameters. 
Experimental Methods:  
Cell culture: CaCo2 and MDCKII-mdr1 cells were routinely maintained in 
supplemented DMEM. Cells were grown for either 21 days in Transwell
® plates 
in case of transport studies, or for 8, resp. 4 days (MDCKII-mdr1) in 96-well 
plates in case of CAA.  
Lipid formulations: Lipid derivatives were applied as liposomal formulations in 
HBSS. 
Transport studies: CaCo2 cell layers were pre-incubated with lipid and digoxin 
(
3H-labeled) was added apically for absorptive, resp. basolaterally for secretory 
studies. Monolayer integrity was determined via transepithelial electrical 
resistance (TEER) measurements and the ratio of the apparent permeability 
coefficients (Papp) of both directions displayed P-gp effects. 
CAA: After pre-incubation with lipid or Verapamil as a positive control the intra-
cellular accumulation of the fluorescent dye calcein indicated P-gp inhibition. 
Results:  
In the transport studies one achieved a concentration-dependent enhancement 
of netto drug absorption with C12-PG, C6-PS and various unsaturated 
symmetric and asymmetric PC lipids.CAA confirmed these findings in both 
celllines for C12-PG and other middle-chained saturated PC derivatives. 
This work was financially supported by Phospholipid e.V., Heidelberg, Germany 
[1]  Zimmer C: Calcein-AM uptake assay for the screening of TPGS 1000 derivatives as potential P-
glycoprotein inhibitors; Diploma Thesis, Saarbrücken, 2006. 
[2]  Alkatout A: Influence of phospholipids in nanoparticulate lipid carrier systems on the drug absorption 
across the duodenal epithelium determined via the CaCo2 cellular model; PhD Thesis, Freiburg, 2008. 
[3]  He W, Guo X, Zhang M. Transdermal permeation enhancement of N-trimethyl chitosan for 
testosterone. Int J Pharm. 2008; 356: 82–87. doi:10.1016/j.ijpharm.2007.12.050 www.scipharm.at Scientia  Pharmaceutica  727 
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A mathematical model has been developed describing the pharmacokinetics of 
Hoechst 33342 following administration into a culture medium containing a 
population of transfected cells (HEK293 hBCRP) with a potent inhibitor of the 
BCRP, Fumitremorgin C (FTC), present. FTC is reported to almost completely 
annul resistance mediated by BCRP in vitro. The non-linear and multi-
compartmental model describes the relationship between the concentration of 
Hoescht 33342 and FTC initially spiked in the medium and the observed 
change in fluorescence due to Hoescht 33342 binding to DNA. This model has 
been extended to consider multi-cell, multi-input responses. 
Structural identifiability arises from the inverse problem of inferring from the 
known properties of a biomedical or biological system a suitable model structure 
and estimates for the corresponding rate constants and other parameters. 
Structural identifiability analysis considers the uniqueness of the unknown 
model parameters from the input-output structure corresponding to proposed 
experiments to collect data for parameter estimation. This is an important 
theoretical prerequisite to experiment design, system identification and 
parameter estimation, since numerical estimates for unidentifiable parameters 
are effectively meaningless. If parameter estimates are to be used to inform 
about intervention or inhibition strategies, or other critical decisions, then it is 
essential that the parameters be uniquely identifiable. Such analysis is highly 
relevant to large-scale, highly complex systems, typical in chemical kinetics and 
systems biology. 
Structural identifiability analysis has been performed on the Hoechst 33342 
pharmacokinetic models developed using a method based on the similarity 
transformation/exhaustive modelling approach. The analysis demonstrated that 
all models derived are uniquely identifiable for the experiments/observations 
available. This permitted subsequent numerical parameter estimation to be 
performed with greater confidence. 
A kinetic modelling software package, FACSIMILE (MPCA Software, UK), was 
used to obtain numerical solutions for the system equations and for parameter 
fitting. Model fits gave very good agreement with in-vitro data provided by 
AstraZeneca across a variety of experimental scenarios. This should ultimately 
permit predictive analysis to be performed using the model in an attempt to 
optimise targeting of the compound to cancerous tumours. 
Work supported by the UK MRC Capacity Building Intitiative & AstraZeneca.